rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCTTATTATGGAGACACTGAAGCTTTCTTTGGACAA	CASSPYYGDTEAFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	10	2	3	9	0	23	35	-1	44	48			01,02										Vb 1	CASSPYYGDTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACGCCTTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVDALNTGELFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-02	01	0	3	7	1	0	5	23	-1	41	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDALNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCACAGGGGGCCTCCTACGAGCAGTACTTCGGGCCG	CASSAQGASYEQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	0	0	1	0	23	36	-1	37	46			01,02										Vb 1	CASSAQGASYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCGCCTCAGGGGCGAGGTATTTACGAGCAGTACTTCGGGCCG	CASSVAPQGRGIYEQYF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	4	5	9	23	39	50	44	59			01,02										Vb 1	CASSVAPQGRGIYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGCGGAGCCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVGGAPNTGELFF	In	VDJ	1	84	7.952210998665165E-4	9.835835226341303E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	7	5	0	0	5	23	-1	43	39	48			01,02			01,02							Vb 1	CASSVGGAPNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCACCGAGGGGGATACGCAGTATTTTGGCCCA	CASTEGDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	7	5	2	6	3	0	29	39	-1	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASTEGDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCTCACCACCGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	3.502759606554894E-4		31	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	8	3	7	6	2	5	29	38	42	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCACCACAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSTTGTGELFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	5	3	0	29	41	-1	44	50													Vb 16	CASSTTGTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGCAGGGGGATACTGAAGCTTTCTTTGGACAA	CASSQQGDTEAFF	In	VDJ	1	82	7.762872641554089E-4	9.601648673333177E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	5	1	2	29	43	51	44	53													Vb 16	CASSQQGDTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCCTAGGGACAGGAAAACTCTGGAAACACCATATATTTTGGAGAG	CASSS*GQENSGNTIYF	Stop	VDJ	2	91	8.614895248553929E-4		51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	4	0	5	4	29	41	54	46	58													Vb 16	CASSS*GQENSGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTCGGGGGCCACAATGAGCAGTTCTTCGGGCCA	CASSQVGGHNEQFF	In	VDJ	4	252	0.0023856632995995493	0.002950750567902391	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	1	6	0	5	2	1	29	45	53	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVGGHNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAAACACAGGGTCGAAAACTGTTTTTTGGCAGT		Out	VDJ	6	335	0.003171417481610512		44	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	3	10	5	3	29	46	57	51	60													Vb 16	X+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGACAAAACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	15	1.4200376783330651E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	3	5	3	24	36	46	41	49														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGAGGGGGAGGGGATCCCAATGAGCAGTTCTTCGGGCCA	CASSGGGGDPNEQFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	6	5	5	24	36	48	41	53														CASSGGGGDPNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTGCGGCAGGGTAATTCACCCCTCCACTTTGGGAAC	CASSLRQGNSPLHF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	3	6	6	0	24	36	-1	42	47														CASSLRQGNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAACTAGGCCGACGGCCCCAAGAGACCCAGTACTTCGGGCCA	CASSQLGRRPQETQYF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	8	1	3	10	24	35	43	38	53						01,02								CASSQLGRRPQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGAGGACAGGGCGTCCCAATTCACCCCTCCACTTTGGGAAC	CASRRTGRPNSPLHF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	7	2	6	24	35	45	37	51														CASRRTGRPNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAGCCCGCGGTCAGCCCCAGTATTTTGGTGAT		Out	VDJ	1	20	1.8933835711107535E-4		38	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	7	5	17	4	11	24	38	46	42	57						01,02								X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCATGGGGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSMGGYQETQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	0	0	1	1	24	37	45	38	46														CASSMGGYQETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAACCGACTGGAAAAGGGACGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	2.0827219282218288E-4		46	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-04	01	3	0	7	8	12	0	24	38	-1	50	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTCGGGACTAGCGATGGTGAGCAGTTCTTCGGGCCA	CASSFGTSDGEQFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	6	9	3	4	24	36	49	39	53						01,02								CASSFGTSDGEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGTAGCGGGGGATAACTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	2.556067820999517E-4		55	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	0	7	6	24	36	52	43	58														X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGCGAATTCTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	2.650736999555055E-4		38	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	7	6	4	0	7	24	-1	40	37	47						01,02								X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCGGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	2.650736999555055E-4		37	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	3	4	1	0	24	36	-1	37	45														X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATCATGTGGTAGACTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	32	3.0294137137772055E-4		43	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	10	2	7	0	13	0	24	31	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCAAGGGACAGAGATCCTACGAGCAGTACTTCGGGCCG	CASSPKGQRSYEQYF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	1	5	3	24	36	48	41	51														CASSPKGQRSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAATCAAATAGGAATCAGCCCCAGCATTTTGGTGAT	CASSESNRNQPQHF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	6	5	4	4	10	0	24	35	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESNRNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTGGGAGGGTTCCAGCCCCAGCATTTTGGTGAT	CASSLGGFQPQHF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	0	7	3	3	24	35	45	38	48														CASSLGGFQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGCGCTAAGGGAACAGGAGTGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	45	4.2601130349991954E-4		56	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	4	1	9	3	24	41	55	50	58														X+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAGGACAGGGACTGTCCGGGGAGCTGTTTTTTGGAGAA	CASSVGGQGLSGELFF	In	VDJ	1	50	4.733458927776884E-4	5.854663825203156E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	6	6	5	24	36	50	42	55														CASSVGGQGLSGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAACCGGGGGCAGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	53	5.017466463443496E-4		44	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	2	6	0	3	2	3	24	39	47	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGTAGAGGAACTCCAAACTTTCTTTGGACAA	CASSVEELQTFF	In	VDJ	1	58	5.490812356221185E-4	6.791410037235662E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	1	12	4	9	24	35	43	39	52														CASSVEELQTFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGGGAAAACAGGTTTCTATCTGGAAACACCATATATTTTGGAGAG	CASSGENRFLSGNTIYF	In	VDJ	1	65	6.153496606109949E-4	7.611062972764104E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	4	1	7	6	24	36	48	43	54														CASSGENRFLSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAGAATCGCGGGGGGCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	69	6.532173320332099E-4		46	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	1	1	5	1	24	37	50	42	51														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAGTCTTACGGGAGACCCAGTACTTCGGGCCA	CASSEVLRETQYF	In	VDJ	1	69	6.532173320332099E-4	8.079436078780357E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	8	5	5	10	0	24	35	-1	45	48						01,02								CASSEVLRETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGATGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASRMTGNTEAFF	In	VDJ	1	70	6.626842498887637E-4	8.19652935528442E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	1	3	0	24	35	-1	38	44														CASRMTGNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTAGTCAGGGAAATTCACCCCTCCACTTTGGGAAC	CASSVGSQGNSPLHF	In	VDJ	1	75	7.100188391665326E-4	8.781995737804735E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	3	7	9	1	24	36	50	45	51														CASSVGSQGNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTACAACAGGGGGCGCGAACACTGAAGCTTTCTTTGGACAA	CASSPTTGGANTEAFF	In	VDJ	1	76	7.194857570220864E-4	8.899089014308798E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	1	6	2	24	36	51	42	53														CASSPTTGGANTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAATAGACTGTTGCGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	77	7.2895267487764E-4		41	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	2	10	5	2	5	24	39	45	41	50						01,02								X+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTATCCACTTCAAAAGCGGGGGTGGGTTCTTCGGGCCA		Out	VDJ	1	78	7.384195927331938E-4		44	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	2	15	14	3	24	36	58	50	61														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATATTTAGGACCCTCACAGATACGCAGTATTTTGGCCCA	CASIFRTLTDTQYF	In	VDJ	2	98	9.277579498442692E-4	0.0011475141097398187	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	10	1	7	2	9	3	24	31	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIFRTLTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCGTTCGGCAGGGGCGAAGCTTTCTTTGGACAA	CASSPFGRGEAFF	In	VDJ	2	103	9.75092539122038E-4	0.0012060607479918502	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	8	9	1	24	35	50	44	51														CASSPFGRGEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGAGCTAGTGGGAAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	109	0.0010318940462553606		47	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	1	0	8	5	7	3	24	40	51	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTAGCCAACCCTGGGGACTCAGGGAGGTTACAATGAGCAGTTCTTCGGGCCA	CAS*PTLGTQGGYNEQFF	Stop	VDJ	2	113	0.0010697617176775758		54	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	10	0	10	4	14	9	24	31	51	45	60						01,02								CAS*PTLGTQGGYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAATGGATATCCTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSEWISSNTGELFF	In	VDJ	2	117	0.0011076293890997907	0.0013699913350975388	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	6	1	8	0	5	6	24	35	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEWISSNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAATATCGAAGAGCCCAGGGCTGCTTTCTTTGGACAA	CASNIEEPRAAFF	In	VDJ	2	131	0.0012401662390775436	0.0015339219222032271	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	3	11	16	2	24	31	52	47	54														CASNIEEPRAAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGTTTTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	138	0.0013064346640664199		37	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	5	5	3	6	2	3	24	36	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGGGCGGGGGTAGAGACCCAGTACTTCGGGCCA	CASSVGAGVETQYF	In	VDJ	6	350	0.0033134212494438185	0.00409826467764221	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	2	4	6	1	24	36	49	42	50														CASSVGAGVETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTCTAGCGGGATACAATGAGCAGTTCTTCGGGCCA	CASSVGLAGYNEQFF	In	VDJ	92	5156	0.048811428463235225	0.060373293365494955	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	4	3	4	6	0	24	36	-1	42	51														CASSVGLAGYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTACTTCAGTCCGGGGGGGAAGCTTTCTTTGGACAA	CASSLLQSGGEAFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	1	8	8	0	18	33	-1	41	48														CASSLLQSGGEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTACCGGGGAAAAATGAAAAACTGTTTTTTGGCAGT	CASSLVPGKNEKLFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	3	5	3	3	18	34	42	37	45														CASSLVPGKNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD02-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCGCCGGGGGTTTATTCACAGATACGCAGTATTTTGGCCCA	CASAGGLFTDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	2	2	2	6	18	27	35	29	41														CASAGGLFTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCCAGTTCTGGAGGGGTTGGGGTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	22	2.0827219282218288E-4		50	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	0	7	8	7	18	31	45	39	52														X+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD02-01*02	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAACATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLTSGANVLTF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	3	6	1	0	0	18	-1	-1	33	36														CASSLTSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCTAGCAGCTTCTAGGGTTTCGATTCACCCCTCCACTTTGGGAAC	CASSF*GFDSPLHF	Stop	VDJ	1	31	2.9347445352216676E-4		42	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-06	01	3	5	3	8	2	5	18	32	38	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSF*GFDSPLHF+TCRBV07-06+TCRBJ01-06	TCRBV07-06*01		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTCCTAGCGGGGGGCGGGGATACGCAGTATTTTGGCCCA	CASSLLAGGGDTQYF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	1	6	3	4	18	30	44	33	48														CASSLLAGGGDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGGACATCAGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGTDTQYF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	6	1	0	4	18	-1	39	34	43														CASSLGTSGTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGGAACAGGGGGCGATTGGTACGAGCAGTACTTCGGGCCG	CASSGTGGDWYEQYF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	4	3	6	18	30	42	33	48														CASSGTGGDWYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCAAGATCGGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSQDRGGQETQYF	In	VDJ	1	60	5.680150713332261E-4	7.025596590243789E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	1	6	0	18	30	-1	36	44														CASSQDRGGQETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGCAGGCGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAGGSYNEQFF	In	VDJ	1	71	6.721511677443175E-4	8.313622631788483E-4	45	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-01	01	3	4	4	1	2	4	18	32	38	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAGGSYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGGAGGACTGAGCACAGATACGCAGTATTTTGGCCCA	CASSLGGLSTDTQYF	In	VDJ	2	117	0.0011076293890997907	0.0013699913350975388	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	1	10	0	2	1	18	34	41	36	42						01,02								CASSLGGLSTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGCTAGAGGGTTGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	15	1.4200376783330651E-4		44	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	11	0	7	4	4	19	35	44	39	48														X+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGACTAGTCAGAACTACGAGCAGTACTTCGGGCCG	CASSLTSQNYEQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	2	8	3	0	6	19	-1	39	33	45						01,02								CASSLTSQNYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCTCGGACAGGACGGATCCTACGAGCAGTACTTCGGGCCG	CASSLGQDGSYEQYF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	1	3	5	19	31	41	34	46														CASSLGQDGSYEQYF+TCRBV07-05+TCRBJ02-07	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCTGGACAGGGGGTGGCAGAGACCCAGTACTTCGGGCCA	CASSLAGQGVAETQYF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	1	4	2	4	19	35	47	37	51														CASSLAGQGVAETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGAAGCCCAGGGGCAGGGAGAGACCCAGTACTTCGGGCCA	CASSLEAQGQGETQYF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	4	5	5	19	35	46	40	51														CASSLEAQGQGETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTCCAAGGGGGGCGGGAGACCCAGTACTTCGGGCCA	CASSFQGGRETQYF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	42	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-05	01	2	5	1	5	3	4	19	33	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFQGGRETQYF+TCRBV07-05+TCRBJ02-05	TCRBV07-05*01		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCACCCTTCTTACCGACAGGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	34	3.218752070888281E-4		40	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	2	4	9	13	0	19	27	-1	40	46														X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCTTCTCGGGGGATCCACAGATACGCAGTATTTTGGCCCA	CASSEALLGGSTDTQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	51	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	2	2	6	3	23	40	52	46	55														CASSEALLGGSTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGCCGGGACAGATCGAATTCACCCCTCCACTTTGGGAAC	CASSEGRDRSNSPLHF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	48	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	5	7	3	4	23	39	49	42	53														CASSEGRDRSNSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAATCGGCGGCAGGGCACTATGGCTACACCTTCGGTTCG	CASSESAAGHYGYTF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	3	7	1	24	39	51	46	52														CASSESAAGHYGYTF+TCRBV06-01+TCRBJ01-02	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGTATTACAGGACCTACGAGCAGTACTTCGGGCCG	CASSEAYYRTYEQYF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	45	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	4	2	5	1	23	40	50	45	51														CASSEAYYRTYEQYF+TCRBV06-01+TCRBJ02-07	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAGGGACAGGCACAGATACGCAGTATTTTGGCCCA	CAISEGTGTDTQYF	In	VDJ	2	92	8.709564427109466E-4	0.0010772581438373808	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	1	5	1	0	0	23	-1	-1	39	45														CAISEGTGTDTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCATGGGCTATAATTCACCCCTCCACTTTGGGAAC	CASSMGYNSPLHF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	39	TCRBV07	TCRBV07-04	01				TCRBJ01	TCRBJ01-06	01	5	0	9	3	2	0	22	34	-1	36	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSMGYNSPLHF+TCRBV07-04+TCRBJ01-06	TCRBV07-04*01		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCCGCGGACGGGGCTTGAGGACAGATACGCAGTATTTTGGCCCA	CACRGRGLRTDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	6	7	0	3	8	6	26	34	47	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CACRGRGLRTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGACAGGGGCCGGTGGGACGAGCAGTACTTCGGGCCG	CAWRDRGRWDEQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	2	5	0	8	26	-1	46	37	54			unresolved										Vb 20	CAWRDRGRWDEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGGACAGGGGGCTTCTACGAGCAGTACTTCGGGCCG	CAWSVGTGGFYEQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	0	3	1	2	26	40	53	41	55			unresolved										Vb 20	CAWSVGTGGFYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCACAGGGCGCCAAGTTCACCCCTCCACTTTGGGAAC	CAWTHRAPSSPLHF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	3	9	3	7	26	36	45	39	52													Vb 20	CAWTHRAPSSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATTAGAACACGCTATACGTATTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	1.704045213999678E-4		52	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	4	3	6	2	5	14	26	36	44	41	58			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGACAGGGGTCAATGAGCAGTTCTTCGGGCCA	CAWSETGVNEQFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	2	6	1	1	26	39	48	40	49													Vb 20	CAWSETGVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAGGGGCCGGCGGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	1.9880527496662911E-4		43	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	3	5	10	0	26	37	-1	47	53						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATCCCGACAGGTGGGATTCACCCCTCCACTTTGGGAAC	CAWNPDRWDSPLHF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	2	4	8	5	4	26	36	47	41	51			unresolved										Vb 20	CAWNPDRWDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGATGGTCTTGGGGGGGAGACCCAGTACTTCGGGCCA	CAWDGLGGETQYF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	1	5	9	0	26	35	-1	44	50													Vb 20	CAWDGLGGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CAWSLSSYNEQFF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	5	8	0	3	0	26	37	-1	40	43						01,02							Vb 20	CAWSLSSYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCAGGGACAGCTAATGAAAAACTGTTTTTTGGCAGT	CAWSVPGTANEKLFF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	5	3	4	0	26	40	-1	44	51			unresolved										Vb 20	CAWSVPGTANEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTCCGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSSGSGANVLTF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	2	8	4	1	2	0	26	38	-1	40	44						01,02							Vb 20	CAWSSGSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*02	TCRBD02-01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTATTATTTTATGGCTACACCTTCGGTTCG	CAWSVLFYGYTF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	5	9	5	2	3	26	40	44	42	47			unresolved			01,02							Vb 20	CAWSVLFYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCTTCAGGGGGAGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSGGETGELFF	In	VDJ	1	48	4.5441205706658086E-4	5.62047727219503E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	1	5	3	4	26	33	43	36	47													Vb 20	CASSGGETGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGACTAGCGGGGTGGGCCGGGGAGCTGTTTTTTGGAGAA	CAWSGLAGWAGELFF	In	VDJ	1	53	5.017466463443496E-4	6.205943654715346E-4	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	2	3	6	0	4	26	-1	50	39	54													Vb 20	CAWSGLAGWAGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCAGGCAACACTGAAGCTTTCTTTGGACAA	CAWSPGNTEAFF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	2	2	1	26	37	43	39	44													Vb 20	CAWSPGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAGGGGGACGGGACCCGAACATTCACCCCTCCACTTTGGGAAC	CAWRRGTGPEHSPLHF	In	VDJ	1	62	5.869489070443335E-4	7.259783143251915E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	5	1	8	1	13	26	37	44	38	57													Vb 20	CAWRRGTGPEHSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACGGCGGGGTACAATTCACCCCTCCACTTTGGGAAC	CAWGTAGYNSPLHF	In	VDJ	1	62	5.869489070443335E-4	7.259783143251915E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	5	7	3	7	6	3	26	35	47	41	50			unresolved										Vb 20	CAWGTAGYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCGAACAGGGGGCAGTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	63	5.964158248998873E-4		43	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	3	0	4	4	2	26	33	46	37	48													Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCTCCTTGGACAGCCCCCCACTGAAGCTTTCTTTGGACAA	CAWTLLGQPPTEAFF	In	VDJ	1	65	6.153496606109949E-4	7.611062972764104E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	4	8	5	26	36	50	44	55													Vb 20	CAWTLLGQPPTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGACAGAACCATCAGCCCCAGCATTTTGGTGAT	CAWSVGQNHQPQHF	In	VDJ	1	67	6.342834963221024E-4	7.84524952577223E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	5	5	1	4	26	40	47	41	51													Vb 20	CAWSVGQNHQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCATACGACTCAGGGCCCCTATGGCTACACCTTCGGTTCG	CAWSHTTQGPYGYTF	In	VDJ	1	75	7.100188391665326E-4	8.781995737804735E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	4	9	3	26	38	52	47	55													Vb 20	CAWSHTTQGPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAAGGCCTAGCTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	80	7.573534284443014E-4		41	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	7	5	5	2	26	40	50	45	52						01,02							Vb 20	X+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCGGGCATGGGACACTGAAGCTTTCTTTGGACAA	CAWSRAWDTEAFF	In	VDJ	2	100	9.466917855553768E-4	0.0011709327650406313	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	2	8	0	3	1	5	26	38	43	39	48			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSRAWDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATGGTGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWNGGNTGELFF	In	VDJ	2	101	9.561587034109306E-4	0.0011826420926910376	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	4	0	10	1	2	3	26	36	40	38	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNGGNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCAAACAGGGCGAAGCTTTCTTTGGACAA	CAWSFKQGEAFF	In	VDJ	2	133	0.0012591000747886512	0.0015573405775040398	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	8	5	1	26	38	49	43	50			unresolved										Vb 20	CAWSFKQGEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACGGGGGGCATCAAAGCACCGGGGAGCTGTTTTTTGGAGAA	CAWDGGHQSTGELFF	In	VDJ	2	135	0.0012780339104997585	0.0015807592328048524	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	1	4	2	8	26	35	44	37	52			unresolved										Vb 20	CAWDGGHQSTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGATCTGGGGACCTCGCGAAACACCATATATTTTGGAGAG	CAWDLGTSRNTIYF	In	VDJ	3	188	0.0017797805568441083	0.002201353598276387	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-03	01	5	0	7	5	6	5	26	35	46	41	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWDLGTSRNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGCCGACTAGCGGCAAGAGACCCAGTACTTCGGGCCA	CAWRAD*RQETQYF	Stop	VDJ	4	222	0.0021016557639329365		42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	5	2	4	0	26	37	-1	41	50			unresolved			01,02							Vb 20	CAWRAD*RQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATACAGGGGAACACTGAAGCTTTCTTTGGACAA	CAWSIQGNTEAFF	In	VDJ	9	502	0.004752392763487991	0.00587808248050397	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	1	2	0	26	38	-1	40	46			unresolved										Vb 20	CAWSIQGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCAGGACAGGCTTACACAGATACGCAGTATTTTGGCCCA	CASSPGQAYTDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	4	2	3	4	19	31	41	34	45													Vb 5.1	CASSPGQAYTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGATAGGGTCGACCGGGGAGCTGTTTTTTGGAGAA	CASSPIGSTGELFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	4	5	3	5	5	3	19	31	40	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSPIGSTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAAACGTAGGACAGGGGATTATGGAAACACCATATATTTTGGAGAG	CASKRRTGDYGNTIYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	2	3	6	4	19	29	44	35	48													Vb 5.1	CASKRRTGDYGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTGGACAGGGGGCTGCACGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.5147068568886028E-4		46	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	0	5	0	6	19	-1	44	35	50													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGGGCAACTCTGGAAACACCATATATTTTGGAGAG	CASSLEGNSGNTIYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-03	01	0	5	3	0	0	3	19	-1	39	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLEGNSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCCGGGGGCAGGGTCATTACACGAGCAGTACTTCGGGCCG	CASSLPGAGSLHEQYF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	1	6	0	5	2	11	19	34	42	36	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLPGAGSLHEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACCGCCTGGAAACACCATATATTTTGGAGAG	CASSLGPPGNTIYF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-03	01	0	2	7	2	0	3	19	-1	38	35	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGPPGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCAAACGATTGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	1.8933835711107535E-4		47	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	2	2	8	0	5	3	19	33	40	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGGGCGGGAACCTATGATATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	23	2.1773911067773664E-4		52	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	7	3	4	5	8	19	31	42	36	50													Vb 5.1	X+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTAACGGTTTCGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLVTVSSTGELFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	5	4	3	7	19	35	41	38	48						01,02							Vb 5.1	CASSLVTVSSTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAATGGGGACAGGTAACCATAACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	28	2.650736999555055E-4		59	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	1	0	4	2	4	9	19	34	46	38	55													Vb 5.1	X+TCRBV05-01+TCRBJ02-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCCGGAATAATGAAAAACTGTTTTTTGGCAGT	CASSLGRNNEKLFF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	0	1	8	4	3	1	19	35	41	38	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGRNNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGGTGGTCTCCCAGGGTCAGATACGCAGTATTTTGGCCCA	CASSGGLPGSDTQYF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	4	10	1	19	31	46	41	47													Vb 5.1	CASSGGLPGSDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTGACCACACCATATCCTACGAGCAGTACTTCGGGCCG	CASSFDHTISYEQYF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	2	2	7	1	1	9	19	33	37	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSFDHTISYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTACCCTCTCAAGTACCGGGGAGCTGTTTTTTGGAGAA	CASSLVTLSSTGELFF	In	VDJ	3	174	0.0016472437068663554	0.0020374230111706985	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-02	01	0	3	7	5	2	10	19	35	39	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVTLSSTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTTGGACAGGGAAACACTGAAGCTTTCTTTGGACAA	CASSLGQGNTEAFF	In	VDJ	6	335	0.003171417481610512	0.003922624762886115	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	2	3	1	19	31	42	34	43													Vb 5.1	CASSLGQGNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGTAGACCCAACAGGGTGTAATGGTCGTGGCTACACCTTCGGTTCG		Out	VDJ	1	41	3.8814363207770444E-4		49	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	3	3	7	16	11	22	25	47	41	58														X+TCRBV17-01+TCRBJ01-02	TCRBV17-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGGACAGGATCCGCTCTGGAAACACCATATATTTTGGAGAG	CASSWDRIRSGNTIYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	4	0	0	5	25	-1	46	38	51													Vb 3	CASSWDRIRSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTCTTTGCGGCCAGGGTTGACACTGAAGCTTTCTTTGGACAA	CASSLFAARVDTEAFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	3	11	3	25	37	53	48	56													Vb 3	CASSLFAARVDTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTTCGGCAGGCTGGTCGGGCGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	1.5147068568886028E-4		55	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	7	2	0	17	0	25	34	-1	51	58													Vb 3	X+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGGCGCCGACAGAATCACTGAAGCTTTCTTTGGACAA	CASTGADRITEAFF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	5	4	8	3	25	35	48	43	51													Vb 3	CASTGADRITEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGTTCGGGGAGGGGAAGAAGCTTTCTTTGGACAA	CASRVRGGEEAFF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	8	6	3	25	36	49	42	52													Vb 3	CASRVRGGEEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAAGCGGGGGGACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	2.0827219282218288E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	6	1	0	0	0	25	-1	-1	40	49													Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCGGGACAGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.0827219282218288E-4		43	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	4	1	3	0	25	39	-1	42	50													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTGCGGGGACAACAAGAGACCCAGTACTTCGGGCCA	CASSFLRGQQETQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	3	0	6	2	6	1	25	39	51	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSFLRGQQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAGGGACAGGGGGAATTTATCAGCCCCAGCATTTTGGTGAT	CASRGTGGIYQPQHF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	1	5	1	5	25	36	48	37	53													Vb 3	CASRGTGGIYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCTAGCGGGGGGGCAAACAGATACGCAGTATTTTGGCCCA	CASSPLAGGQTDTQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	3	3	3	25	37	52	40	55													Vb 3	CASSPLAGGQTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTGGGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSSGVSGNTIYF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	4	6	2	0	2	1	25	38	44	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSGVSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGGGACTAGCGGGGGGCCCCGGAGAGCAGTACTTCGGGCCG	CASSPGLAGGPGEQYF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	7	2	7	25	37	54	39	61													Vb 3	CASSPGLAGGPGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCCAGGACTAGCGGGGGGGCAGAAGAGACCCAGTACTTCGGGCCA	CASSSRTSGGAEETQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	1	0	3	5	3	25	36	56	41	59													Vb 3	CASSSRTSGGAEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACGCCAGCGCGAGCAGTACTTCGGGCCG	CASSLRQREQYF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	6	6	6	4	0	25	40	-1	44	48						01,02							Vb 3	CASSLRQREQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCCCTCGAGACTCCTATGGCTACACCTTCGGTTCG	CASSFPRDSYGYTF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	2	10	4	7	1	25	39	50	46	51						01,02							Vb 3	CASSFPRDSYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCTGGCCGACTTCTCTGGAAACACCATATATTTTGGAGAG	CASLADFSGNTIYF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	8	2	10	0	6	1	25	34	44	40	45						01,02							Vb 3	CASLADFSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD02-01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCGGGGGGGTGGCAATCAGCCCCAGCATTTTGGTGAT	CASSFRGGGNQPQHF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	3	8	0	2	1	2	25	39	48	40	50													Vb 3	CASSFRGGGNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCTTCGGGACAGGACCCACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFLRDRTHSGANVLTF	In	VDJ	1	40	3.786767142221507E-4	4.6837310601625254E-4	57	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	0	4	0	5	5	24	38	51	43	56													Vb 3	CASSFLRDRTHSGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTGGACTTCAGGGGCGGGCCTACGAGCAGTACTTCGGGCCG	CASGLQGRAYEQYF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	4	2	2	7	4	25	33	46	40	50													Vb 3	CASGLQGRAYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTCGGGACAGAGTACCCGTTTGGATGGCTACACCTTCGGTTCG	CASSSGQSTRLDGYTF	In	VDJ	1	42	3.9761054993325823E-4	4.917917613170652E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	6	3	13	25	36	46	39	59													Vb 3	CASSSGQSTRLDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCAAAGTTTATGCAGGAGGTCAGCCCCAGCATTTTGGTGAT	CASSKVYAGGQPQHF	In	VDJ	1	53	5.017466463443496E-4	6.205943654715346E-4	45	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	10	1	6	13	0	25	36	-1	49	54													Vb 3	CASSKVYAGGQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTACAGGGGTATGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLQGYGGTEAFF	In	VDJ	1	54	5.112135641999034E-4	6.323036931219409E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	4	2	8	25	37	46	39	54													Vb 3	CASSLQGYGGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACCCAGGGGACTGAAGCTTTCTTTGGACAA	CASSTQGTEAFF	In	VDJ	1	57	5.396143177665647E-4	6.674316760731599E-4	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	5	4	0	25	36	-1	40	46													Vb 3	CASSTQGTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGTCGGGGGAAGCAGATACGCAGTATTTTGGCCCA	CASSPSGEADTQYF	In	VDJ	1	63	5.964158248998873E-4	7.376876419755978E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	2	4	4	3	25	37	47	41	50													Vb 3	CASSPSGEADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCTACGGACAGGGGAAGATTCACCCCTCCACTTTGGGAAC	CASSLPLRTGEDSPLHF	In	VDJ	1	64	6.058827427554411E-4	7.493969696260041E-4	51	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	1	2	8	7	3	25	40	56	47	59													Vb 3	CASSLPLRTGEDSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACCCCAGGGACTAGCGGTGAGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASRPQGLAVRVQETQYF	In	VDJ	1	72	6.816180855998712E-4	8.430715908292546E-4	54	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	1	6	7	25	36	53	42	60						01,02							Vb 3	CASRPQGLAVRVQETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCGCCCGGGGAAAGAGTCAAAGAAAAACTGTTTTTTGGCAGT	CASSPPGERVKEKLFF	In	VDJ	1	74	7.005519213109788E-4	8.664902461300672E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	8	5	11	25	37	47	42	58													Vb 3	CASSPPGERVKEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGTCCGGGACAGGGAAATGAAAAACTGTTTTTTGGCAGT	CASSSPGQGNEKLFF	In	VDJ	1	79	7.478865105887476E-4	9.250368843820988E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	5	5	1	25	37	51	42	52													Vb 3	CASSSPGQGNEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCAAGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASSSQGANEKLFF	In	VDJ	2	87	8.236218534331777E-4	0.0010187115055853492	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	3	4	0	25	38	-1	42	47													Vb 3	CASSSQGANEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCGGACTAGCGGGGGGGCGGAGGAGACCCAGTACTTCGGGCCA	CASSSRTSGGAEETQYF	In	VDJ	2	118	0.0011170963069553445	0.001381700662747945	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	0	5	3	5	25	38	56	41	61													Vb 3	CASSSRTSGGAEETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCAGACGCAGATACGCAGTATTTTGGCCCA	CASSLADADTQYF	In	VDJ	2	124	0.001173897814088667	0.001451956628650383	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	2	2	7	4	3	1	25	40	46	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLADADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGGACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSQGDRGNTEAFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	2	1	0	0	23	-1	-1	39	49														CASSQGDRGNTEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTGCTGACAGGGAACTATGGCTACACCTTCGGTTCG	CASSQVLTGNYGYTF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	2	4	0	23	39	-1	43	50														CASSQVLTGNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCGACAGAATGAATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPRQNEYSNQPQHF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	5	0	3	8	23	36	44	39	52														CASSPRQNEYSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTGGGTACATTGTGCGAAAGACCTATGGCTACACCTTCGGTTCG	CTSSGYIVRKTYGYTF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	6	0	9	4	1	17	23	34	38	35	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSGYIVRKTYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGCACTAACGTTGGATGAGCAGTTCTTCGGGCCA	CASSQALTLDEQFF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	3	9	8	1	7	23	39	44	40	51						01,02								CASSQALTLDEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATACGGCAGGGGGCATCTACGAGCAGTACTTCGGGCCG	CASSQDTAGGIYEQYF	In	VDJ	2	90	8.520226069998391E-4	0.0010538394885365682	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	0	3	5	2	23	40	53	45	55														CASSQDTAGGIYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGTCCGGGACAGGGTTGGACCGGGGAGCTGTTTTTTGGAGAA	CASPGQGWTGELFF	In	VDJ	1	54	5.112135641999034E-4	6.323036931219409E-4	42	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	3	5	1	4	18	28	38	29	42														CASPGQGWTGELFF+TCRBV12-02+TCRBJ02-02	TCRBV12-02*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCGGACAGGAAAACAATTCACCCCTCCACTTTGGGAAC	CASSGQENNSPLHF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	7	0	5	22	-1	41	34	46														CASSGQENNSPLHF+TCRBV07-01+TCRBJ01-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCAAGGGACAGGGAATTCACCCCTCCACTTTGGGAAC	CASSQGTGNSPLHF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	42	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	3	7	3	0	22	34	-1	37	46														CASSQGTGNSPLHF+TCRBV07-01+TCRBJ01-06	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTAGAGGGCTTGGGTGAGCAGTTCTTCGGGCCA	CASSLEGLGEQFF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	39	TCRBV07	TCRBV07-08					TCRBJ02	TCRBJ02-01	01	1	5	3	9	0	6	20	-1	40	36	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGLGEQFF+TCRBV07-08+TCRBJ02-01	TCRBV07-08		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGACCCTCTTCGACAGGGGGATATAATTCACCCCTCCACTTTGGGAAC	CASRPSSTGGYNSPLHF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	1	4	9	1	23	34	52	43	53													Vb 12	CASRPSSTGGYNSPLHF+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTCTCAGAATACAGGGGCTCTCCTACGAGCAGTACTTCGGGCCA		Out	VDJ	1	16	1.5147068568886028E-4		49	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	2	11	9	12	23	35	51	44	63													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCCCGGACCGACTACACAATGAAAAACTGTTTTTTGGCAGT	CASTPDRLHNEKLFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	7	2	9	5	9	3	23	33	47	42	50						01,02							Vb 12	CASTPDRLHNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD02-01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGAGGGAAAGAGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSEEGKRAGELFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	0	6	0	8	23	-1	43	38	51													Vb 12	CASSEEGKRAGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGAGGGTGTAGCCGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	1.8933835711107535E-4		53	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	0	0	1	11	23	37	43	38	54													Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGACGTCCCGGGACAGGGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	22	2.0827219282218288E-4		50	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	0	8	1	23	36	53	44	54													Vb 12	X+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGTGACAGCGGCGGGGGGCGATGCACAGATACGCAGTATTTTGGCCCA	CASDSGGGRCTDTQYF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	9	7	1	1	8	4	23	31	47	39	51													Vb 12	CASDSGGGRCTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTTTAGACAGGCCGCAGATACGCAGTATTTTGGCCCA	CASSEFRQAADTQYF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	4	4	3	3	23	39	48	42	51													Vb 12	CASSEFRQAADTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGAAGCTCCTACTGGGCCAGGGCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	36	3.408090427999356E-4		47	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	4	3	7	15	1	23	31	51	46	52													Vb 12	X+TCRBV10-02+TCRBJ01-06	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCTTCCTCCCGGGACACAAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	3.9761054993325823E-4		43	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	6	5	8	4	23	32	46	40	50													Vb 12	X+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACGGGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTGSGANVLTF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	7	8	4	1	0	1	23	-1	37	33	38						01,02							Vb 12	CASTGSGANVLTF+TCRBV10-02+TCRBJ02-06	TCRBV10-02*01	TCRBD02-01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAAGGACTAGCGGGGGGGCCTTTGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	54	5.112135641999034E-4		55	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	1	0	2	2	6	23	37	54	39	60													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGGACAGGGCCAAGAAAAACTGTTTTTTGGCAGT	CASSEGQGQEKLFF	In	VDJ	1	65	6.153496606109949E-4	7.611062972764104E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	3	8	0	4	23	-1	46	38	50													Vb 12	CASSEGQGQEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAAGGAAACAGGACCCCTACAATGAGCAGTTCTTCGGGCCA	CASRRKQDPYNEQFF	In	VDJ	2	117	0.0011076293890997907	0.0013699913350975388	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	4	2	6	3	23	34	45	40	48													Vb 12	CASRRKQDPYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCCGCTTAGGAGGGTCGGCTGAAGCTTTCTTTGGACAA	CASSRLGGSAEAFF	In	VDJ	2	131	0.0012401662390775436	0.0015339219222032271	42	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	0	6	7	4	23	34	47	41	51													Vb 12	CASSRLGGSAEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAGGACAGAGAGGACTGAAGCTTTCTTTGGACAA	CASSERTERTEAFF	In	VDJ	3	187	0.0017703136389885545	0.0021896442706259805	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	5	1	5	23	38	45	39	50													Vb 12	CASSERTERTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCAAAAGGGCTAGCGGGGGCGGGAATGAGCAGTTCTTCGGGCCA	CAISESKRASGGGNEQFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	54	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	7	8	4	23	40	58	48	62													Vb 12	CAISESKRASGGGNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCTTCACAGGGGCCCTACGAGCAGTACTTCGGGCCG	CAISESSQGPYEQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	3	2	2	3	1	23	40	50	43	51													Vb 12	CAISESSQGPYEQYF+TCRBV10-03+TCRBJ02-07	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCGGGGTTGACTAGCGGGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	41	3.8814363207770444E-4		50	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	10	2	2	2	8	2	24	31	51	39	53													Vb 12	X+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGGTAGCCTTCGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	42	3.9761054993325823E-4		40	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	5	7	5	1	7	24	37	42	38	49						01,02							Vb 12	X+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGATAGACAGGGAAGAGGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	60	5.680150713332261E-4		52	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	2	3	4	4	5	23	38	49	42	54													Vb 12	X+TCRBV10-03+TCRBJ02-06	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCAGGGGGAGAGCAGTTCTTCGGGCCA	CAISESGGEQFF	In	VDJ	12	678	0.006418570306065454	0.00793892414697548	36	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	5	1	10	0	1	23	-1	46	40	47													Vb 12	CAISESGGEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAACGACAGGTTTAATGAAAAACTGTTTTTTGGCAGT	CASNDRFNEKLFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	9	2	4	4	4	2	27	35	45	39	47			01,02										Vb 17	CASNDRFNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACGGGACAGGGGGGATAGAGCCCCAGCATTTTGGTGAT	CASSHGTGGIEPQHF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	1	8	3	5	27	39	53	42	58			01,02										Vb 17	CASSHGTGGIEPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGACAGCGGGACACTGAAGCTTTCTTTGGACAA	CASRQRDTEAFF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	6	4	3	5	0	27	35	-1	40	46			01,02			01,02							Vb 17	CASRQRDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGGGACAGGGCTTTGGAGGCCAACGTCCTGACTTTCGGGGCC	CATRDRALEANVLTF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	10	0	3	6	3	7	27	34	46	37	53			01,02										Vb 17	CATRDRALEANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAACAGGGGTGGGAACGAGCAGTACTTCGGGCCG	CASSNRGGNEQYF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	5	0	5	27	-1	47	40	52			01,02										Vb 17	CASSNRGGNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTATCTGCGTGAAAATCAGCCCCAGCATTTTGGTGAT	CASSYLRENQPQHF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	7	6	4	5	4	27	39	47	44	51			01,02			01,02							Vb 17	CASSYLRENQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTTTGCGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSIFAGGTDTQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	4	1	4	2	27	41	50	45	52			01,02			01,02							Vb 17	CASSIFAGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTGGACTAGCGGGGGACACAGATACGCAGTATTTTGGCCCA	CATGLAGDTDTQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	1	2	2	2	1	27	34	49	36	50			01,02										Vb 17	CATGLAGDTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAACTACAGGGTAACTCAGCCCCAGCATTTTGGTGAT	CASSINYRVTQPQHF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	3	6	4	4	27	42	52	46	56			01,02										Vb 17	CASSINYRVTQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCGACAGGGGCAGATTCACCCCTCCACTTTGGGAAC	CASSISTGADSPLHF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	2	8	3	3	27	41	52	44	55			01,02										Vb 17	CASSISTGADSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGACAGACTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSDRLGANVLTF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	5	3	2	3	27	39	47	41	50			01,02										Vb 17	CASSSDRLGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGACGCGGGAGAGGTTAACTATGGCTACACCTTCGGTTCG	CASSIDAGEVNYGYTF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	7	2	1	4	4	27	41	52	45	56			01,02										Vb 17	CASSIDAGEVNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTTGCAGGGGCCTGCACTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	31	2.9347445352216676E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	3	5	8	27	39	50	44	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTTGGCACTTACAATGAGCAGTTCTTCGGGCCA	CASSIVGTYNEQFF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	1	9	0	4	2	3	27	43	48	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVGTYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGTGTTAGCGGGGGGACAGAAGATACGCAGTATTTTGGCCCA	CASSIGVSGGTEDTQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	1	5	6	5	27	41	57	47	62			01,02										Vb 17	CASSIGVSGGTEDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCTTTTCCGGTTCTATCTCCTACGAGCAGTACTTCGGGCCG	CASIFSGSISYEQYF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	9	0	12	1	27	37	52	49	53			01,02			01,02							Vb 17	CASIFSGSISYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGGGCAGGTTTGAACACTGAAGCTTTCTTTGGACAA	CASSIRAGLNTEAFF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	4	4	0	5	2	27	41	50	46	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRAGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACAGGGGTAACTGAAGCTTTCTTTGGACAA	CASSRTGVTEAFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	2	5	0	2	27	-1	49	40	51			01,02										Vb 17	CASSRTGVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGCGGGATAGCGGGGGAGTCAGATACGCAGTATTTTGGCCCA	CASSIRGIAGESDTQYF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	5	2	4	8	3	27	41	58	49	61			01,02										Vb 17	CASSIRGIAGESDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAGAGGGGGCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	41	3.8814363207770444E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	5	0	1	3	0	27	37	-1	40	47			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTAGCGACAGCCGCTCATAATTCACCCCTCCACTTTGGGAAC	CASSIVATAAHNSPLHF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	51	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	1	2	5	5	4	6	27	43	52	47	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVATAAHNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCACGACAGGGGCGCTTCACTGAAGCTTTCTTTGGACAA	CASRARQGRFTEAFF	In	VDJ	1	48	4.5441205706658086E-4	5.62047727219503E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	4	5	5	27	38	51	43	56			01,02										Vb 17	CASRARQGRFTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAACAGGGATCGTACCACTGAAGCTTTCTTTGGACAA	CASNRDRTTEAFF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	3	3	4	2	7	27	35	43	37	50			01,02										Vb 17	CASNRDRTTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACCGGGACAGGGAAGGAGACCCAGTACTTCGGGCCA	CASSIGTGTGKETQYF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	3	5	5	3	27	43	57	48	60			01,02										Vb 17	CASSIGTGTGKETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGAGGAGTTCGCAGCTACACCTTCGGTTCG	CASSPGGVRSYTF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	10	1	9	3	8	27	39	47	42	55			01,02										Vb 17	CASSPGGVRSYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAGGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSQGMNTEAFF	In	VDJ	1	53	5.017466463443496E-4	6.205943654715346E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	3	0	1	2	27	38	44	39	46			01,02										Vb 17	CASSQGMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCAAGGGGGACAGGGGAGCGGACATTCAGTACTTCGGCGCC	CASKGDRGADIQYF	In	VDJ	1	57	5.396143177665647E-4	6.674316760731599E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	9	0	2	8	5	5	27	35	50	40	55			01,02										Vb 17	CASKGDRGADIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCTCGATGGAACACTGAAGCTTTCTTTGGACAA	CASSPRWNTEAFF	In	VDJ	1	57	5.396143177665647E-4	6.674316760731599E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	2	8	1	4	2	27	39	45	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRWNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCTTCGACAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSPSTGTNEKLFF	In	VDJ	1	59	5.585481534776723E-4	6.908503313739725E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	3	2	6	0	27	38	-1	44	51			01,02										Vb 17	CASSPSTGTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCCCCTCGGGGGCTATGGCTACACCTTCGGTTCG	CASSAPLGGYGYTF	In	VDJ	1	65	6.153496606109949E-4	7.611062972764104E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	4	8	0	27	39	-1	47	53			01,02										Vb 17	CASSAPLGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGCGGGCGGGGGCGTCGACTGAAGCTTTCTTTGGACAA	CASSTRAGASTEAFF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	4	7	2	5	5	5	27	40	52	45	57			01,02										Vb 17	CASSTRAGASTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTCGCCGGGACAGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASFAGTGYSNQPQHF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	3	0	6	2	27	36	51	42	53			01,02										Vb 17	CASFAGTGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTCGCACCGGGACAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATRTGTANTGELFF	In	VDJ	1	67	6.342834963221024E-4	7.84524952577223E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	5	0	8	0	27	34	-1	42	49			01,02										Vb 17	CATRTGTANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACAGGGGTAACCGGGGAGCTGTTTTTTGGAGAA	CASRTGVTGELFF	In	VDJ	1	68	6.437504141776562E-4	7.962342802276293E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	5	0	2	27	-1	46	38	48			01,02										Vb 17	CASRTGVTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCCGGGACAGGTGGGGAACACTGAGGCTTTCTTTGGACAA	CASKPGQVGNTEAFF	In	VDJ	1	72	6.816180855998712E-4	8.430715908292546E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	4	11	4	14	27	37	49	41	63			01,02										Vb 17	CASKPGQVGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGGAGGGGCAGGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	76	7.194857570220864E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	8	0	1	1	5	27	38	47	39	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGGGCCCGTTCGGGTACTAACAATCAGCCCCAGCATTTTGGTGAT	CASRARSGTNNQPQHF	In	VDJ	1	78	7.384195927331938E-4	9.133275567316925E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	8	8	0	3	1	15	27	36	41	37	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRARSGTNNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGAGTATGCAGGCTATCCGGAACACTGAAGCTTTCTTTGGACAA	CASSIGSMQAIRNTEAFF	In	VDJ	1	79	7.478865105887476E-4	9.250368843820988E-4	54	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	4	4	1	8	7	27	43	55	51	62			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGSMQAIRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGGGACCTTGGGACAGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	80	7.573534284443014E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	0	5	3	7	0	27	35	-1	42	49			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCACGGGATCCTATGGGGGCTACACCTTCGGTTCG	CASSATGSYGGYTF	In	VDJ	1	81	7.668203462998552E-4	9.484555396829114E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	3	8	4	9	27	39	48	43	57			01,02										Vb 17	CASSATGSYGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGGGGCGATCTGGAAACACCATATATTTTGGAGAG	CASSIRGRSGNTIYF	In	VDJ	2	87	8.236218534331777E-4	0.0010187115055853492	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	5	0	1	1	2	27	41	49	42	51			01,02										Vb 17	CASSIRGRSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACGACAGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRRQGSSYNEQFF	In	VDJ	2	89	8.425556891442853E-4	0.0010421301608861619	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	0	2	3	27	38	47	40	50			01,02										Vb 17	CASRRQGSSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCAGGCAGGGTCGTCCAGATACGCAGTATTTTGGCCCA	CASSIRQGRPDTQYF	In	VDJ	2	89	8.425556891442853E-4	0.0010421301608861619	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	4	4	5	27	41	50	45	55			01,02										Vb 17	CASSIRQGRPDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAATCAGCGGGGGGATACACAGATACGCAGTATTTTGGCCCA	CASSKSAGGYTDTQYF	In	VDJ	2	92	8.709564427109466E-4	0.0010772581438373808	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	1	2	4	3	27	40	53	44	56			01,02										Vb 17	CASSKSAGGYTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGGATAGAATGGCTGGCTACACCTTCGGTTCG	CASTPDRMAGYTF	In	VDJ	2	94	8.898902784220541E-4	0.0011006767991381934	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	7	1	8	7	4	9	27	37	44	41	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPDRMAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATATAGAGTCCGGGTGGGGCGCTGAAGCTTTCTTTGGACAA	CASNIESGWGAEAFF	In	VDJ	2	101	9.561587034109306E-4	0.0011826420926910376	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	6	8	1	27	44	57	52	58			01,02										Vb 17	CASNIESGWGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGGGCAGGGCAAAAACATTCAGTACTTCGGCGCC	CASSPGQGKNIQYF	In	VDJ	2	102	9.656256212664842E-4	0.001194351420341444	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	3	3	6	0	27	39	-1	45	50			01,02										Vb 17	CASSPGQGKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATAGGTAAGGGTTCCACTGAAGCTTTCTTTGGACAA	CASIGKGSTEAFF	In	VDJ	2	102	9.656256212664842E-4	0.001194351420341444	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	5	3	4	6	3	27	37	47	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASIGKGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTGGTCCGACAGGAGAACTGGAAACACCATATATTTTGGAGAG	CASSIWSDRRTGNTIYF	In	VDJ	2	110	0.0010413609641109144	0.0012880260415446946	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	4	2	7	4	27	41	54	48	58			01,02										Vb 17	CASSIWSDRRTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGAACAGGGAGTAGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	117	0.0011076293890997907		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	4	3	4	27	40	49	43	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGGGGGTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRRGSTNEKLFF	In	VDJ	2	127	0.0012022985676553284	0.0014870846116016019	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	5	1	0	1	1	27	38	45	39	46			01,02										Vb 17	CASRRGSTNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGGCAGGCATTTGAAGCTTTCTTTGGACAA	CASSIGQAFEAFF	In	VDJ	2	127	0.0012022985676553284	0.0014870846116016019	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	4	4	7	4	4	27	41	49	45	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGQAFEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCTACACAGGGGGAGGAACACTGAAGCTTTCTTTGGACAA	CASLHRGRNTEAFF	In	VDJ	2	129	0.001221232403366436	0.0015105032669024145	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	1	1	4	2	27	36	48	40	50			01,02										Vb 17	CASLHRGRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCGGGACAGTCAGTGGCGCAGTATTTTGGCCCA	CASSTPGQSVAQYF	In	VDJ	3	143	0.0013537692533441888	0.0016744338540081029	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	5	10	4	7	27	40	51	44	58			01,02										Vb 17	CASSTPGQSVAQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSRGLNTEAFF	In	VDJ	3	152	0.0014389715140441727	0.0017798178028617597	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	6	1	0	0	1	27	-1	45	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGCCCCTCGAGGCAGCTGCTTGGAAACACCATATATTTTGGAGAG	CASSSPSRQLLGNTIYF	In	VDJ	4	200	0.0018933835711107535	0.0023418655300812626	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	11	1	3	7	8	27	40	51	47	59			01,02										Vb 17	CASSSPSRQLLGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGGGGGGTTCGAGAACACTGAAGCTTTCTTTGGACAA	CASSPGGFENTEAFF	In	VDJ	4	215	0.00203538733894406	0.0025175054448373572	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	1	1	6	27	39	47	40	53			01,02										Vb 17	CASSPGGFENTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCACCCAGCGGGGGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSHPAGGSYNEQFF	In	VDJ	4	236	0.002234192613910689	0.00276340132549589	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	1	0	5	0	27	39	-1	44	53			01,02										Vb 17	CASSHPAGGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAACTCAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSLTQGSTEAFF	In	VDJ	5	257	0.002432997888877318	0.0030092972061544227	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	4	6	2	27	39	51	45	53			01,02										Vb 17	CASSLTQGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCACTAGTAAAGAACCTACGAGCAGTACTTCGGGCCG	CASSIDH**RTYEQYF	Stop	VDJ	6	335	0.003171417481610512		48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	3	8	2	2	7	27	44	51	46	58			01,02			01,02							Vb 17	CASSIDH**RTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCATCGGACAGGGGCAGCCCCAGCATTTTGGTGAT	CASSTIGQGQPQHF	In	VDJ	6	346	0.0032755535780216033	0.004051427367040584	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	7	5	0	27	40	-1	45	54			01,02										Vb 17	CASSTIGQGQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGTCCGGGTGGGGCGCTGAAGCTTTCTTTGGACAA	CASSIESGWGAEAFF	In	VDJ	13	739	0.006996052295254234	0.008653193133650266	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	6	8	1	27	44	57	52	58			01,02										Vb 17	CASSIESGWGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGAACCTAGCGGTTCCACACAGATACGCAGTATTTTGGCCCA	CASSGT*RFHTDTQYF	Stop	VDJ	1	15	1.4200376783330651E-4		48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	5	2	4	5	23	36	47	40	52						01,02							Vb 11	CASSGT*RFHTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCCTGACAGGGGGCAGTTTCTATGGCTACACCTTCGGTTCG	CASSLTGGSFYGYTF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	0	4	3	5	23	34	47	37	52													Vb 11	CASSLTGGSFYGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTACGGGGGGGCACGGGCAATGAGCAGTTCTTCGGGCCA	CASSELRGGTGNEQFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	8	0	6	2	6	23	39	49	41	55													Vb 11	CASSELRGGTGNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGGAGGACAGGGGGCTTGAGGGAGCAGTACTTCGGGCCG	CASRRTGGLREQYF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	0	7	2	6	23	34	47	36	53													Vb 11	CASRRTGGLREQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCGGGAAAGACAGGAGGACAATAATACAATGAGCAGTTCTTCGGGCCA	CASSAGKTGGQ*YNEQFF	Stop	VDJ	1	42	3.9761054993325823E-4		54	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	4	4	7	10	23	36	49	43	59													Vb 11	CASSAGKTGGQ*YNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATTCAACCAAGAGACCCAGTACTTCGGGCCA	CASSEFNQETQYF	In	VDJ	1	53	5.017466463443496E-4	6.205943654715346E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	6	0	1	0	23	39	-1	40	42													Vb 11	CASSEFNQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCGGGACAACTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	59	5.585481534776723E-4		41	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	0	6	3	2	3	23	33	41	35	44													Vb 11	X+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCCCCCCAGCCGGGAGTCAGCCCCAGCATTTTGGTGAT	CASPPAGSQPQHF	In	VDJ	1	64	6.058827427554411E-4	7.493969696260041E-4	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	8	8	2	6	8	0	23	32	-1	40	46													Vb 11	CASPPAGSQPQHF+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAATCGGATTAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSEIGLGGNTEAFF	In	VDJ	1	81	7.668203462998552E-4	9.484555396829114E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	1	1	8	0	23	38	-1	46	52													Vb 11	CASSEIGLGGNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGACCCCCGGGGAAACATTCAGTACTTCGGCGCC	CASSEDPRGNIQYF	In	VDJ	2	93	8.804233605665003E-4	0.0010889674714877871	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	8	3	6	6	0	23	38	-1	44	49													Vb 11	CASSEDPRGNIQYF+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCTGGGACTAGCGGGGGGCGAAGAAACGCAGTATTTTGGCCCA	CASSLGLAGGEETQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	48	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	1	9	2	7	23	35	52	37	59													Vb 14	CASSLGLAGGEETQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGTTCCCAGGAGTCCTCCTACGAGCAGTACTTCGGGCCG	CSGSQESSYEQYF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	7	4	4	0	5	4	25	32	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGSQESSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAGACAGGGCCACACTGGGGATATCTCCGGACAA	CSVRQGHTGDIS	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	20	2	19	25	33	42	35	61													Vb 4	CSVRQGHTGDIS+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTCCAGGGCACCCAGCATTTTGGTGAT	CSVEDLQGTQHF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	11	4	2	25	39	48	43	50													Vb 4	CSVEDLQGTQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGGGGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVQGASGANVLTF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	0	0	0	0	25	-1	-1	34	42													Vb 4	CSVQGASGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCGACAGGGGGGTACAGATACGCAGTATTTTGGCCCA	CSVRQGGTDTQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	3	1	2	25	34	44	35	46													Vb 4	CSVRQGGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCCGTCCCGGGACAGCACTCGGGAATGAGCAGTTCTTCGGGCCA	CSVGRPGTALGNEQFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	7	8	8	25	35	50	43	58													Vb 4	CSVGRPGTALGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTACCGGACAGGGGTTATGGCTACACCTTCGGTTCG	CSVVPDRGYGYTF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	2	5	4	1	25	35	48	39	49													Vb 4	CSVVPDRGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTCCCCCGTCGGCTATGGCTACACCTTCGGTTCG	CSVESPVGYGYTF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	5	4	9	0	25	36	-1	45	48						01,02							Vb 4	CSVESPVGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCAAGGCACCCACTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	25	2.366729463888442E-4		46	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	4	5	4	0	2	6	25	35	40	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCGCAGGGGAACTGAAGCTTTCTTTGGACAA	CSVVRRGTEAFF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	5	4	1	25	35	45	39	46													Vb 4	CSVVRRGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCTACAAAATGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	2.556067820999517E-4		43	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	6	3	6	0	3	7	25	33	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGACGAATGAGCAGTTCTTCGGGCCA	CSVGTGTNEQFF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	3	7	0	3	25	-1	43	35	46													Vb 4	CSVGTGTNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGGGATTAAGGGTCAGCCCCAGCATTTTGGTGAT	CSAGIKGQPQHF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	7	0	8	6	2	7	25	32	38	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSAGIKGQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGTCATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVGTGSSGANVLTF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	3	1	0	3	25	-1	43	35	46													Vb 4	CSVGTGSSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAAGCAGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CSVSRGGTDTQYF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	1	3	1	25	33	43	36	44													Vb 4	CSVSRGGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAAGCCCTGACCTACGAGCAGTACTTCGGGCCG	CSVEEALTYEQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	3	1	8	2	0	8	25	-1	39	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEEALTYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACTAGCCGGACCGGGGAGCTGTTTTTTGGAGAA	CSVGTSRTGELFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	7	5	0	3	25	-1	43	35	46						01,02							Vb 4	CSVGTSRTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAACGGGCGGACCCTATGGCTACACCTTCGGTTCG	CSVVTGGPYGYTF	In	VDJ	1	35	3.3134212494438187E-4	4.09826467764221E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	4	1	7	4	8	1	25	35	47	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVTGGPYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAGCCCGGGACGGCACAGATACGCAGTATTTTGGCCCA	CSGARDGTDTQYF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	7	0	7	1	6	1	25	32	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSGARDGTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCACAACAAACGGAGGGTTGAACACTGAAGCTTTCTTTGGACAA	CSTTNGGLNTEAFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	8	10	0	0	9	1	25	31	46	40	47													Vb 4	CSTTNGGLNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGTGAGAGCTAACTATGGCTACACCTTCGGTTCG	CSVDVRANYGYTF	In	VDJ	1	40	3.786767142221507E-4	4.6837310601625254E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	11	2	0	3	2	25	36	42	39	44													Vb 4	CSVDVRANYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAAGGGCGGCACTGAAGCTTTCTTTGGACAA	CSVEDKGGTEAFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	0	5	3	4	2	3	25	39	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEDKGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTTTCTTACAGGGGGCGCCGCCTACAATGAGCAGTTCTTCGGGCCA	CSVEFLTGGAAYNEQFF	In	VDJ	1	42	3.9761054993325823E-4	4.917917613170652E-4	51	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	3	0	2	7	4	25	36	52	43	56													Vb 4	CSVEFLTGGAAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTACTACCCAGCTACGAGCAGTACTTCGGGCCG	CSVEVLPSYEQYF	In	VDJ	1	45	4.2601130349991954E-4	5.269197442682841E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	3	9	3	1	5	25	38	43	39	48						01,02							Vb 4	CSVEVLPSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCGTCGGGCACTGAAGCTTTCTTTGGACAA	CSVGASGTEAFF	In	VDJ	1	58	5.490812356221185E-4	6.791410037235662E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	8	0	4	0	6	25	-1	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGASGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCCCGGGACAGGGTCTCCGAGCAGTACTTCGGGCCG	CSVSRDRVSEQYF	In	VDJ	1	65	6.153496606109949E-4	7.611062972764104E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	6	5	4	25	33	47	38	51													Vb 4	CSVSRDRVSEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTAGAGACAGGGGTAGAAACACTGAAGCTTTCTTTGGACAA	CSVRDRGRNTEAFF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	2	2	3	4	25	34	45	37	49													Vb 4	CSVRDRGRNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGAATACGGGGATGAGCAGTTCTTCGGGCCA	CSVEEYGDEQFF	In	VDJ	1	67	6.342834963221024E-4	7.84524952577223E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	3	8	3	0	25	39	-1	42	47													Vb 4	CSVEEYGDEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTACCGGGACAGAGGTGAAAAACTGTTTTTTGGCAGT	CSYRDRGEKLFF	In	VDJ	2	97	9.182910319887154E-4	0.0011358047820894124	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	5	7	4	3	25	31	42	35	45													Vb 4	CSYRDRGEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGTAGTCTAGCGGGGGGCATGGGAAGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	187	0.0017703136389885545		55	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	3	6	10	25	36	53	42	63													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCCCGGGCCGAACACTGAAGCTTTCTTTGGACAA	CSVPGPNTEAFF	In	VDJ	3	190	0.0017987143925552158	0.0022247722535771995	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	1	3	1	25	34	41	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVPGPNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATAACAAGTATGGCTACACCTTCGGTTCG	CSVEDNKYGYTF	In	VDJ	5	293	0.0027738069316772538	0.00343083300156905	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	6	5	2	2	25	39	44	41	46													Vb 4	CSVEDNKYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCTAGCGGGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	8	463	0.0043831829671213945		40	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	4	3	0	2	0	25	35	-1	37	46													Vb 4	X+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTTGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	11	594	0.005623349206198938		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	3	1	2	0	25	35	-1	37	49													Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGGTCAGGAGGAATCACCCCTCCACTTTGGGAAC	CASSGQEESPLHF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	4	10	1	10	4	2	23	36	45	40	47													Vb 22	CASSGQEESPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGAACGGGGCTCATTTCCTCGAGACCCAGTACTTCGGGCCA	CASRNGAHFLETQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	45	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-05	01	6	7	0	5	4	10	23	34	43	38	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRNGAHFLETQYF+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGACCCGGGAGAAAAACTGTTTTTTGGCAGT	CASRDPGEKLFF	In	VDJ	1	73	6.91085003455425E-4	8.547809184796609E-4	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	8	3	8	5	0	23	34	-1	39	44													Vb 22	CASRDPGEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCTCCGAGCTGAGGGGACGCTACACCTTCGGTTCG	CASSSELRGRYTF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	39	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-02	01	6	0	7	9	12	0	26	37	-1	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSELRGRYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGATCACAGGGCTCGGGGACAGCCCCAGCATTTTGGTGAT	CASSDHRARGQPQHF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	7	4	8	26	38	48	42	56														CASSDHRARGQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCCTCTCTCGGGGAACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	1.9880527496662911E-4		49	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	3	0	8	2	26	41	54	49	56														X+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGAATCCAGGGCTCCCCTACGAGCAGTACTTCGGGCCG	CASSYSNPGLPYEQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	2	5	4	26	43	53	48	57														CASSYSNPGLPYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCGGCTTGGACAGGGGACCCACAGATACGCAGTATTTTGGCCCA	CASGLDRGPTDTQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	2	2	5	3	26	35	49	40	52														CASGLDRGPTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCTGGACAGGGGAGAGTCAGCCCCAGCATTTTGGTGAT	CASTWTGESQPQHF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	2	6	3	4	26	36	48	39	52														CASTWTGESQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGAAGGACTGACCCAATATGGCTACACCTTCGGTTCG	CASSEGLTQYGYTF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	1	10	5	3	7	26	38	46	41	53						01,02								CASSEGLTQYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCGGCTGACGGGGTCAACGGAGACCCAGTACTTCGGGCCA	CASSRLTGSTETQYF	In	VDJ	1	61	5.774819891887798E-4	7.142689866747852E-4	45	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	8	3	5	8	6	26	37	50	45	56														CASSRLTGSTETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTTCGGCGGGGAGCTGTTTTTTGGAGAA	CASSFGGELFF	In	VDJ	2	111	0.0010508278819664682	0.001299735369195101	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	5	7	1	0	26	39	-1	40	43						01,02								CASSFGGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCCTACTGGGACAGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	10	547	0.005178404066987911		44	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	3	7	6	0	26	37	-1	43	52														X+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTACTGGACAGGAACGTTATAATAAGTGGCCCCAGCATTTTGGTGAT	CASSTGQERYNKWPQHF	In	VDJ	16	899	0.008510759152142836	0.010526685557715276	51	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	9	3	16	26	38	48	41	64														CASSTGQERYNKWPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCCTCAGCAGGGAGCTATGGCTACACCTTCGGTTCG	CASSSSAGSYGYTF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	42	TCRBV07	TCRBV07-07	01				TCRBJ01	TCRBJ01-02	01	4	4	3	4	6	2	19	32	43	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSAGSYGYTF+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TTTGTGCCAGCAGCCCCCGGAGAGTGTTACCTACCCAAACCGAAGGGGTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	1.704045213999678E-4		65	TCRBV16	TCRBV16-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	5	2	2	28	1	2	15	48	43	49			01,02											X+TCRBV16-01+TCRBJ02-05	TCRBV16-01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTGTGTATCTCTATGCCAGCAGTTTACAGCGGGGCAATCAGCCCCAGCATTTTGGTGAT	YASSLQRGNQPQHF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	42	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	4	6	4	2	3	0	27	40	-1	43	49						01,02								YASSLQRGNQPQHF+TCRBV26-01+TCRBJ01-05	TCRBV26-01*01	TCRBD02-01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTGTGTATCTCTATGGGAGCAAAGGAGGCAATCAGCCCCAGCATTTTGGTGAT	YGSKGGNQPQHF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	36	TCRBV26	TCRBV26-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	13	10	2	2	0	8	27	-1	35	31	43														YGSKGGNQPQHF+TCRBV26-01+TCRBJ01-05	TCRBV26-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACACCCCCGGGGGGGCTGTACAATGAGCAGTTCTTCGGGCCA	CASTPPGGLYNEQFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV12	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	8	0	4	6	3	22	32	46	38	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTPPGGLYNEQFF+TCRBV12-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCCAGGGGGTTCGGGGTACGAGCAGTACTTCGGGCCG	CASSPGGSGYEQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	1	4	1	7	28	40	48	41	55		TCRBV06-04,TCRBV06-08												CASSPGGSGYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCGCCGGTAACTCCTACGAGCAGTACTTCGGGCCG	CASAGNSYEQYF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	36	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	8	5	0	2	3	26	35	40	37	43		TCRBV06-07,TCRBV06-08				01,02								CASAGNSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCAGTAGCGGGGGCGTGTTGGAGACCCAGTACTTCGGGCCA	CAISSGGVLETQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	2	5	0	7	28	-1	48	40	55		TCRBV06-04,TCRBV06-08												CAISSGGVLETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGGACAGGGACACTGAAGCTTTCTTTGGACAA	CASRDRDTEAFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	36	TCRBV06	unresolved		unresolved			TCRBJ01	TCRBJ01-01	01	6	1	3	3	0	0	23	-1	-1	34	42		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02										CASRDRDTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCCACAGTTCGATAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	30	2.8400753566661303E-4		43	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	3	5	0	1	10	24	30	35	31	45		TCRBV10-02,TCRBV10-03												X+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGTCACCCGCCGGGACAGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	31	2.9347445352216676E-4		44	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	5	5	9	0	23	36	-1	45	52		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACCCCATGGGACACCGGTGAATCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	3.1240828923327434E-4		47	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	5	6	11	26	36	48	42	59		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCACGATGGGCAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTMGSNQPQHF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	8	0	1	5	0	19	31	-1	36	40		TCRBV07-05,TCRBV07-06												CASSTMGSNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGTTGGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLLGATNEKLFF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	9	2	0	3	0	19	33	-1	36	41		TCRBV11-01,TCRBV11-03												CASSLLGATNEKLFF+TCRBV11-X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTTCCTCCCCCCAGCCAGGGGTACTAATGAAAAACTGTTTTTTGGCAGT	CASSEFLPPARGTNEKLFF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	57	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	2	2	13	1	24	40	59	53	60		TCRBV10-01,TCRBV10-02												CASSEFLPPARGTNEKLFF+TCRBV10-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGGGACTCAGCYRTGTATCKCTGTGCCAGCAGCTTAAGGTTGAGGGCCCGAGCAGTTCTTCGGGCCA		Out	VDJ	1	37	3.502759606554894E-4		40	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	11	0	10	5	3	22	37	47	42	50		TCRBV07-04,TCRBV07-07												X+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCGACGGACCAAGAGACCCAGTACTTCGGGCCA	CASSPTDQETQYF	In	VDJ	1	42	3.9761054993325823E-4	4.917917613170652E-4	39	TCRBV06	unresolved					TCRBJ02	TCRBJ02-05	01	6	2	7	0	3	2	23	34	40	37	42		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTDQETQYF+TCRBV06-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACAGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	4.354782213554733E-4		38	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	2	0	0	26	-1	-1	40	44		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAAAGACAGGGAGAAATTCACCCCTCCACTTTGGGAAC	CASRKTGRNSPLHF	In	VDJ	1	48	4.5441205706658086E-4	5.62047727219503E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	3	7	3	3	26	37	47	40	50		TCRBV06-07,TCRBV06-08												CASRKTGRNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACGGGGGGAGGGAGACCCAGTACTTCGGGCCA	CASSYGGRETQYF	In	VDJ	1	53	5.017466463443496E-4	6.205943654715346E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	9	1	5	0	3	23	-1	44	38	47		TCRBV06-07,TCRBV06-08				01,02								CASSYGGRETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCTTAAGCAGCAACGGCTACGAGCAGTACTTCGGGCCG	CASSLSSNGYEQYF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-07	01	2	4	5	3	2	6	19	34	39	36	45		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSNGYEQYF+TCRBV07-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCGGCATTTCCTACGAGCAGTACTTCGGGCCG	CASGISYEQYF	In	VDJ	1	79	7.478865105887476E-4	9.250368843820988E-4	33	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	9	0	1	0	3	28	-1	40	37	43		TCRBV06-04,TCRBV06-07												CASGISYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGTACTTGGACAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	209	0.001978585831810737		46	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	0	5	0	18	34	-1	39	45		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGCGGGCGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	227	0.0021489903532107054		41	TCRBV10	unresolved					TCRBJ02	TCRBJ02-07	01	2	8	0	0	1	2	23	38	43	39	45		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGACAGGCGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	4	240	0.0022720602853329042		49	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	3	4	0	0	4	23	-1	43	38	47		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCAGTTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	254	0.002404597135310657		41	TCRBV10	unresolved					TCRBJ02	TCRBJ02-03	01	0	5	5	2	0	3	23	-1	42	40	45		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCGGGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASGTGGTGELFF	In	VDJ	5	279	0.002641270081699501	0.0032669024144633615	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	0	1	4	0	0	23	-1	-1	32	43		TCRBV10-01,TCRBV10-02												CASGTGGTGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ACGTTTGGTGCATCCTGAAGACAGCAGCTTCTMATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	1.4200376783330651E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	18	2	1	5	21	1	37	33	63	54	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTCACTTTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.4200376783330651E-4		37	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	3	10	7	4	1	26	42	49	46	50		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATTCGAGGCAGATACGCAGTATTTTGGCCCA	CASSPFEADTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	11	1	4	5	0	26	39	-1	44	48		TCRBV03-01,TCRBV03-02												CASSPFEADTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGTCCGGACAGGGCGAAAAACTGTTTTTTGGCAGT	CASSRSGQGEKLFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	3	8	5	1	26	39	52	44	53		TCRBV03-01,TCRBV03-02												CASSRSGQGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCGGGGGGCTCTACTGAAGCTTTCTTTGGACAA	CSASPGGSTEAFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	5	2	4	26	37	46	39	50		TCRBV20-01,TCRBV20-or09_02												CSASPGGSTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAACCCAGACGGGGTATATGGCTACACCTTCGGTTCG	CASNPDGVYGYTF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	8	3	5	7	2	22	32	44	39	46		TCRBV12-03,TCRBV12-04												CASNPDGVYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAGCGATGGACAGGGTCTATGGCTACACCTTCGGTTCG	CASSEAMDRVYGYTF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	4	8	1	22	34	50	42	51		TCRBV12-03,TCRBV12-04												CASSEAMDRVYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCACCAGTGAACGGACAGGGGCACTATGGGAATTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	15	1.4200376783330651E-4		53	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	2	9	2	12	24	38	49	40	61	TCRBV24,TCRBV27													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGACCCAGGGGGCGGAGGAGCACAGATACGCAGTATTTTGGCCCA	CASRPRGRRSTDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	0	0	3	5	24	35	46	38	51	TCRBV24,TCRBV27													CASRPRGRRSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAARCYYRRGGAYTCAGCWGTGTATTTTTGTGCCAGCAGTTTGGGGGCCCGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGARNTGELFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	6	0	2	3	4	29	40	49	43	53	TCRBV12,TCRBV16													CASSLGARNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGARGACTCRGCCCTKTATCTYTGCGCCAGCAGCGAATCACAGGGGGCTGTTGGCACTGAAGCTTTCTTTGGACAA	CASSESQGAVGTEAFF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	4	5	6	19	31	45	36	51	TCRBV04,TCRBV05													CASSESQGAVGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGGGGACTATGGGAGACCCAGTACTTCGGGCCA	CASSGGLWETQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	9	5	3	3	26	37	47	40	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSGGLWETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGGAGACAGGGGGACGGTGAAAAACTGTTTTTTGGCAGT	CASRRQGDGEKLFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	1	7	2	4	26	37	48	39	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRRQGDGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCTTGGACGGAGAACACTGAAGCTTTCTTTGGACAA	CASSPWTENTEAFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	1	7	1	4	3	26	38	46	42	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWTENTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGGGAAGATACGCAGTATTTTGGCCCA	CASSSGEDTQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	2	5	0	1	26	-1	45	39	46		TCRBV12-03,TCRBV12-04												CASSSGEDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTGGGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSLGGLNTEAFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	9	0	0	0	1	26	-1	47	40	48		TCRBV12-03,TCRBV12-04												CASSLGGLNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCCCTCAGGGGCCTGGGTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	1.5147068568886028E-4		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	11	4	2	5	3	9	24	30	39	33	48	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCACCGGACCAAACCCAAATCAGCCCCAGCATTTTGGTGAT	CASTGPNPNQPQHF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	7	1	7	4	2	8	26	36	42	38	50	TCRBV03,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGPNPNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCGCCAAAGCCAACACCGGGGAGCTGTTTTTTGGAGAA	CSAKANTGELFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	6	7	2	6	1	26	31	40	37	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSAKANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCCTGACAGCCACCGGGGAGCTGTTTTTTGGAGAA	CSAPLTATGELFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	5	4	6	1	26	34	45	40	46		TCRBV20-01,TCRBV20-or09_02												CSAPLTATGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAACCCCTAAAGCGGGGGGGCGGGATACGCAGTATTTTGGCCCA	CSARETPKAGGRDTQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	6	9	3	26	40	59	49	62		TCRBV20-01,TCRBV20-or09_02												CSARETPKAGGRDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGTGGGGGGACCCGGGGAGCTGTTTTTTGGAGAA	CSARDVGGPGELFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	9	1	6	3	2	26	40	49	43	51		TCRBV20-01,TCRBV20-or09_02												CSARDVGGPGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTTTCAGGGGGCTAATTCACCCCTCCACTTTGGGAAC	CSARFQGANSPLHF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	0	6	4	0	26	37	-1	41	49		TCRBV20-01,TCRBV20-or09_02												CSARFQGANSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCGACACTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSAIDTYSNQPQHF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	6	0	2	4	26	36	42	38	46		TCRBV20-01,TCRBV20-or09_02												CSAIDTYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTCCCCGAGGACAGGCGCTAGTACCACCCCTCCACTTTGGGAAC	XASSPRGQALVPPLHF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	11	6	9	25	37	50	43	59	TCRBV26,TCRBV28													XASSPRGQALVPPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTGTAAGGACAGGGAGGGGCACTGAAGCTTTCTTTGGACAA	CASSVRTGRGTEAFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	4	4	5	22	34	46	38	51	TCRBV02,TCRBV12													CASSVRTGRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACGAACGGGGGGAAACGGGGATGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	1.5147068568886028E-4		46	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	11	8	1	7	5	12	24	31	43	36	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGACAGGCCCGATAAACACTGAAGCTTTCTTTGGACAA	CASSLTGPINTEAFF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	2	2	7	24	36	44	38	51		TCRBV24-01,TCRBV24-or09_02												CASSLTGPINTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAAGATGACGGCGGGGGGGCAAACGAGCAGTACTTCGGGCCG	CASSQDDGGGANEQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	7	0	5	5	3	18	35	49	40	52	TCRBV04,TCRBV07,TCRBV11													CASSQDDGGGANEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGGACGGCAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPRTAAKNIQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	43	unresolved						TCRBJ02	TCRBJ02-04	01	13	1	7	0	11	3	20	23	38	34	41	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTAAKNIQYF+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAGGGACAGGGGGCTTTTGGCTACACCTTCGGTTCG		Out	VDJ	1	16	1.5147068568886028E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	0	7	1	3	18	33	46	34	49	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAAGTGGAACCATGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	1.5147068568886028E-4		50	unresolved						TCRBJ01	TCRBJ01-02	01	2	1	8	4	3	13	18	33	39	36	52	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCTCGGGACAGCTAGAACTCCCTATGGCTACACCTTCGGTTCG	CASSLGTARTPYGYTF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	4	3	10	19	31	41	34	51	TCRBV05,TCRBV11													CASSLGTARTPYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGCTCCTCCTTACTAGCGGGGAAGCAAGAGACCCAGTACTTCGGGCCA	CASSSSLLAGKQETQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	3	3	2	6	3	22	36	52	42	55	TCRBV07,TCRBV23													CASSSSLLAGKQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCTGGGCAGGGGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	16	1.5147068568886028E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	10	4	1	4	10	1	24	31	48	41	49	TCRBV09,TCRBV21													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGACAGGAACACTGAAGCTTTCTTTGGACAA	CASSVDRNTEAFF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	4	0	26	37	-1	41	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSVDRNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGGTCGGGGTTCTGCTGGCTACACCTTCGGTTCG		Out	VDJ	1	17	1.6093760354441404E-4		44	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	3	7	5	6	26	41	51	46	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAACAGACAGATACGCAGTATTTTGGCCCA	CASSQQQTDTQYF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	5	3	2	0	26	41	-1	43	47		TCRBV03-01,TCRBV03-02												CASSQQQTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCACGGACTCTGGAAACACCATATATTTTGGAGAG	CSASTDSGNTIYF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	3	1	8	0	3	0	26	37	-1	40	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASTDSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGCCGACAGGAGAATCAGCCCCAGCATTTTGGTGAT	XASSRQENQPQHF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	4	4	2	2	25	36	44	38	46	TCRBV26,TCRBV28													XASSRQENQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCWMMCAKACMTCTMWGTACCTCTGTGCCAGCAGTTGTGAGCCCCCTGACAGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	1.6093760354441404E-4		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	6	8	11	0	25	38	-1	49	53	TCRBV25,TCRBV28													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGCGACAGCCTTCACGGGCCCCAGCATTTTGGTGAT	CASSDSLHGPQHF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	5	9	1	9	23	34	40	35	49	TCRBV24,TCRBV27													CASSDSLHGPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCATTCGCAGGGGTAGGGACTGAAGCTTTCTTTGGACAA	CASSPFAGVGTEAFF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	5	7	5	24	36	49	43	54		TCRBV24-01,TCRBV24-or09_02												CASSPFAGVGTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCAAGGGTTCAGGGGGAGCAGTACTTCGGGCCG	CASSLARVQGEQYF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	2	7	7	0	18	35	-1	42	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARVQGEQYF+X+TCRBJ02-07		TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTTTCTCGGGACTAGCGGGGGCCCTACCTCCGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	1.6093760354441404E-4		56	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	6	7	9	25	38	59	45	68		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTTTATCTTTGCCAGCAGCCCCCGGACGGCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	17	1.6093760354441404E-4		43	unresolved						TCRBJ02	TCRBJ02-04	01	13	1	7	0	11	3	19	22	37	33	40	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-04	unresolved		TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGGTGGGAACAGGGCTCTAACTATGGCTACACCTTCGGTTCG	CASSLGWEQGSNYGYTF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	0	9	2	26	40	55	49	57		TCRBV12-03,TCRBV12-04												CASSLGWEQGSNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCCCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQDPGGTDTQYF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	1	3	0	26	43	-1	46	51		TCRBV03-01,TCRBV03-02												CASSQDPGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACCCAGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAPRTNTGELFF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	4	0	3	1	26	34	41	37	42		TCRBV20-01,TCRBV20-or09_02												CSAPRTNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGATGAGGCAGTGGGGGAGCAGTACTTCGGGCCG	CASSQDEAVGEQYF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	42							TCRBJ02	TCRBJ02-07	01	0	6	2	7	9	0	18	35	-1	44	48	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDEAVGEQYF+X+TCRBJ02-07			TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCAAGCCGGGGAGGGCTATGGCTACACCTTCGGTTCG	CASSQAGEGYGYTF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	0	4	7	0	19	31	-1	38	45	TCRBV05,TCRBV11													CASSQAGEGYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCGTCAGGGGCCAGTGAAGCTTTCTTTGGACAA	CASSPSGASEAFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	7	4	4	26	38	48	42	52		TCRBV12-03,TCRBV12-04												CASSPSGASEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCCTTCCCCCGGGGAGGTACTGAAGCTTTCTTTGGACAA	CASSPFPRGGTEAFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	5	11	1	24	36	53	47	54	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPFPRGGTEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACCTCCTACGCGAACTATGGCTACACCTTCGGTTCG	CASSQTSYANYGYTF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45	TCRBV03						TCRBJ01	TCRBJ01-02	01	3	2	7	2	0	10	26	-1	43	40	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTSYANYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCCCCTAGTGGGGGAGTGAGAGCAGTACTTCGGGCCG	CASSHPLVGE*EQYF	Stop	VDJ	1	19	1.798714392555216E-4		45	TCRBV03						TCRBJ02	TCRBJ02-07	01	3	6	1	7	9	5	26	40	54	49	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHPLVGE*EQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCGAGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CSASRTGGYNEQFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	1	3	5	0	26	34	-1	39	49		TCRBV20-01,TCRBV20-or09_02												CSASRTGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGAATTAAATCAAGAGACCCAGTACTTCGGGCCA	CSAPELNQETQYF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	5	2	1	8	26	35	39	36	47		TCRBV20-01,TCRBV20-or09_02												CSAPELNQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCCACCCAGGAGATACTGAAGCTTTCTTTGGACAA	CSALHPGDTEAFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	4	4	5	7	4	26	35	46	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSALHPGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTAGCGGGGTTGTGCCCGGGGAGCTGTTTTTTGGAGAA	CSAGSGVVPGELFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	5	3	6	2	6	26	35	45	37	51		TCRBV20-01,TCRBV20-or09_02												CSAGSGVVPGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGGGGGTCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	19	1.798714392555216E-4		44	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	9	1	3	0	1	24	-1	48	42	49		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCACCCGGGACAACACTGAAGCTTTCTTTGGACAA	CASTRDNTEAFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	7	0	7	2	3	0	26	36	-1	39	44	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTRDNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAACAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSLNRGQETQYF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	1	2	1	0	26	41	-1	42	50		TCRBV12-03,TCRBV12-04												CASSLNRGQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGTCCATCTATGGCTACACCTTCGGTTCG	CASSLASIYGYTF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	6	4	3	1	26	43	48	46	49		TCRBV12-03,TCRBV12-04												CASSLASIYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CASCWSCCARACAKCTKTGTACTTCTGTGCCAGCAGTACGAATCACCCGGGGGGATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSTNHPGGSNTGELFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	8	1	0	10	2	24	36	53	46	55	TCRBV06,TCRBV10,TCRBV22													CASSTNHPGGSNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCACCGAGGCCCCCGGGGCCAACGTCCTGACTTTCGGGGCC	XASTEAPGANVLTF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	11	1	4	2	5	25	35	41	37	46	TCRBV26,TCRBV28													XASTEAPGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTCCCCTTCTAGGGGCTATAACTATGGCTACACCTTCGGTTCG	XASSSPSRGYNYGYTF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	5	2	1	8	3	25	38	51	46	54	TCRBV26,TCRBV28													XASSSPSRGYNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AMMCCAGSSAMWCAGCTKTGTAYTTYTGTGCCAGCAGTTTCTCGGAACGTGGAGCTTTCTTTGGACAA	CASSFSERGAFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	36	unresolved						TCRBJ01	TCRBJ01-01	01	13	1	8	10	14	6	25	28	45	42	51	TCRBV12,TCRBV22			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSERGAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGGGACAGGGATTTTCACTGAAGCTTTCTTTGGACAA	CASSQDGTGIFTEAFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	3	4	1	5	23	40	50	41	55	TCRBV01,TCRBV04													CASSQDGTGIFTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCATCGGAGGCAGTCTAGGCGAAAAACTGTTTTTTGGCAGT	CAIGGSLGEKLFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	10	10	1	8	2	10	22	29	36	31	46	TCRBV09,TCRBV12													CAIGGSLGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGCTCGGGGAGACCCAATACTTCGGGCCA	CATSDWLGETQYF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	3	14	4	8	24	40	49	44	57		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDWLGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTATAGCCCCAGGGTTTTTTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	1.8933835711107535E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	3	7	6	5	19	34	45	40	50	TCRBV07,TCRBV11													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGTGTTGGAGGGCTAGCGGGGGATGAGCAGTTCTTCGGGCCA	CASSVGGLAGDEQFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	8	10	0	18	29	-1	39	49	TCRBV11,TCRBV12													CASSVGGLAGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCCCACAGACAGGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSPTDRGANYGYTF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	0	6	2	19	31	45	37	47	TCRBV05,TCRBV11													CASSPTDRGANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCRGGRGACWYRGCWSKGTATYTCTGTGCCAGCAGCCTAAGGGACACCTATTCACCCCTCCACTTTGGGAAC	CASSLRDTYSPLHF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	8	4	3	22	34	44	38	47	TCRBV07,TCRBV21													CASSLRDTYSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCGGGACAAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASGTRLNTEAFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	0	6	0	0	4	22	-1	37	31	41	TCRBV07,TCRBV23													CASGTRLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGACGGGGGGGGACAGTCTCCTACGAGCAGTACTTCGGGCCG	CASRRGGTVSYEQYF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	8	0	0	1	6	23	34	43	35	49	TCRBV02,TCRBV21													CASRRGGTVSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCACACCCCCTGACGGGGGGGGACTACGAGCAGTACTTCGGGCCG	CASSSHPLTGGDYEQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	51	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	3	12	2	26	39	59	51	61		TCRBV12-03,TCRBV12-04												CASSSHPLTGGDYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ACGTTTGGTGCATCCTGAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	5	4	1	36	50	63	54	64		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCAGCGGGGGGGCGCGAGCAGTACTTCGGGCCG	CASSHPAGGREQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	0	6	3	2	26	40	53	43	55		TCRBV03-01,TCRBV03-02												CASSHPAGGREQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTAGCGGGGGGGTCAGAGACCCAGTACTTCGGGCCA	CASSLAGGSETQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	5	0	4	1	2	26	38	50	39	52		TCRBV03-01,TCRBV03-02												CASSLAGGSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGAATGGACAGTGATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	1.9880527496662911E-4		37	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	6	7	2	26	34	47	41	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTAGCCCTCCCAGGGGGATCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	1.9880527496662911E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	1	3	11	2	22	33	51	44	53	TCRBV12,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACAGGACAGGATCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	21	1.9880527496662911E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	4	5	4	4	24	36	47	40	51		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCTAGATGGGTCCGGGGAGCTGTTTTTTGGAGAA	CASSLDGSGELFF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	39	unresolved			unresolved			TCRBJ02	TCRBJ02-02	01	0	0	9	6	2	1	23	39	44	41	45	TCRBV02,TCRBV09			TCRBD01,TCRBD02										CASSLDGSGELFF+X+TCRBJ02-02	unresolved	unresolved	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGCGGGTTTCAAGAGACCCAGTACTTCGGGCCA	CASSPGGFQETQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	7	4	2	4	3	26	38	47	42	50		TCRBV12-03,TCRBV12-04				01,02								CASSPGGFQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTGAGACTAGATAGAGACCCAGTACTTCGGGCCA	CASSH*D*IETQYF	Stop	VDJ	1	22	2.0827219282218288E-4		42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	2	8	4	4	2	26	40	50	44	52		TCRBV03-01,TCRBV03-02				01,02								CASSH*D*IETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTTTAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLLAGGTDTQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	1	3	0	26	39	-1	42	51		TCRBV03-01,TCRBV03-02												CASSLLAGGTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGTGGAGCGGGGGATACAATGAGCAGTTCTTCGGGCCA	CSAAWSGGYNEQFF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	2	4	7	1	26	34	49	41	50		TCRBV20-01,TCRBV20-or09_02												CSAAWSGGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCCGCTCTATGCTTAGCACAGATACGCAGTATTTTGGCCCA	CSARSRSMLSTDTQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	9	0	7	5	26	38	48	45	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSRSMLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAAATAGGGCTAACAGGGGGCGCTTACGAGCAGTACTTCGGGCCG	CASSEIGLTGGAYEQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	4	12	3	22	34	55	46	58		TCRBV12-03,TCRBV12-04												CASSEIGLTGGAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCTGGAGGGGTTAACACTGAAGCTTTCTTTGGACAA	CASSLAGGVNTEAFF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	0	2	1	3	18	35	42	36	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAGGVNTEAFF+X+TCRBJ01-01		TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGAGGACGGAGAACACTGAAGCTTTCTTTGGACAA	CSARRTENTEAFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	1	1	2	5	26	34	41	36	46		TCRBV20-01,TCRBV20-or09_02												CSARRTENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCCCGCAGGGGGCACAGAGACCCAGTACTTCGGGCCA	CSARVPAGGTETQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	4	6	2	26	39	53	45	55		TCRBV20-01,TCRBV20-or09_02												CSARVPAGGTETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCTATCCACTCCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLSTPYNSPLHF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	3	10	2	6	1	23	35	44	41	45	TCRBV06,TCRBV10					01,02								CASSLSTPYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGGAGGGCAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSERRAGNQPQHF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	TCRBV06			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	10	0	2	1	3	23	38	45	39	48		TCRBV06-01,TCRBV06-08												CASSERRAGNQPQHF+TCRBV06-X+TCRBJ01-05	TCRBV06	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGTCCAGGGGAGAATCAGCCCCAGCATTTTGGTGAT	CASSLGPGENQPQHF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	4	3	2	18	34	43	37	45	TCRBV07,TCRBV11													CASSLGPGENQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCAGGGAGGTCGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	2.1773911067773664E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	9	1	2	3	4	18	31	40	34	44	TCRBV05,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCCCATTCACCGGGACAGGCCTAATAGGGGCCCAGTACTTCGGGCCA	CASSLAPFTGTGLIGAQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	57				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	0	4	9	10	11	18	35	53	45	64	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAPFTGTGLIGAQYF+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAGCTAGCTTCACCGGGGAGCTGTTTTTTGGAGAA	CASSVASFTGELFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	7	4	4	2	24	36	45	40	47	TCRBV12,TCRBV21					01,02								CASSVASFTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCGAAGACAAGGACAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASRRQGQGAYEQYF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	1	1	2	11	0	24	31	-1	42	52	TCRBV06,TCRBV10													CASRRQGQGAYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCGGGGGGTAGGGGCTGAAGCTTTCTTTGGACAA	CSAPRGVGAEAFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	6	3	6	26	35	45	38	51		TCRBV20-01,TCRBV20-or09_02												CSAPRGVGAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCATCAGTAGGGACACCAGGAGCGGAGATACGCAGTATTTTGGCCCA	CAISRDTRSGDTQYF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	6	5	1	10	23	35	42	36	52	TCRBV06,TCRBV24													CAISRDTRSGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCCCCGGGGGCCGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSAPGAANTGELFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	5	6	0	0	5	2	18	30	41	35	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPGAANTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCGCCGGGACAGGTTTTGGCTACACCTTCGGTTCG	CASSAGTGFGYTF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	7	4	3	20	31	43	35	46	TCRBV07,TCRBV23													CASSAGTGFGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCATCAGGGGACAGGGGGCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	24	2.2720602853329043E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	3	0	0	23	-1	-1	34	45	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCCCCTCTGGAGCGGGGGGGCATAAATGAGCAGTTCTTCGGGCCA	CASSSPLERGGINEQFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	51	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	0	7	9	4	19	32	51	41	55		TCRBV05-06,TCRBV05-07												CASSSPLERGGINEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCGGACAGGCCTAGAGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	24	2.2720602853329043E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	4	4	1	7	22	36	44	37	51	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTAGCGGACACCAACACAGATACGCAGTATTTTGGCCCA	CASSVADTNTDTQYF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	5	2	1	7	24	36	43	37	50	TCRBV12,TCRBV21					01,02								CASSVADTNTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTATCGGGGTATGGGGAGCTGTTTTTTGGAGAA	CASSVSGYGELFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	1	8	3	8	1	3	23	38	44	39	47	TCRBV09,TCRBV12													CASSVSGYGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAARCYYRRGGAYTCAGCWGTGTATTTTTGTGCCAGCAGTTCTGGGACTAGCGGGGGGGTGAGGGAGACCCAGTACTTCGGGCCA	CASSSGTSGGVRETQYF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	0	5	2	5	26	39	57	41	62	TCRBV12,TCRBV16													CASSSGTSGGVRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAGGGCGTTCCATTTCCATTCCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	2.366729463888442E-4		52	TCRBV03						TCRBJ02	TCRBJ02-01	01	5	5	3	5	1	18	26	38	43	39	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCCTACAGGGGGGTAGAAATCAGCCCCAGCATTTTGGTGAT	CSARDLLQGGRNQPQHF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	1	4	6	5	26	40	54	46	59		TCRBV20-01,TCRBV20-or09_02												CSARDLLQGGRNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGGCAGTACACTGGAAACACCATATATTTTGGAGAG	CSARDEGQYTGNTIYF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	48	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	5	2	2	2	7	26	40	47	42	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDEGQYTGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCWMMCAKACMTCTMWGTACCTCTGTGCCAGCAGTTTGAGGGGCGTCACAGATACGCAGTATTTTGGCCCA	CASSLRGVTDTQYF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	3	5	2	2	1	3	25	39	45	40	48	TCRBV25,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGVTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGAACTATGGCTACACCTTCGGTTCG	CATSEGNYGYTF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	36	TCRBV24						TCRBJ01	TCRBJ01-02	01	4	5	3	2	0	0	24	-1	-1	38	42		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSEGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCGTAAGGGAAACCTACAATGAGCAGTTCTTCGGGCCA	CASSLVRETYNEQFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	6	0	8	2	7	2	24	36	47	43	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVRETYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCTTGCTTGGGCAGGGTCATGGCTACACCTTCGGTTCG	CASSLLGQGHGYTF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	6	6	2	19	34	45	40	47	TCRBV05,TCRBV23													CASSLLGQGHGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGCCTTTATCGGGGATGAGCAGTTCTTCGGGCCA	CASSAFIGDEQFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	3	8	7	0	23	36	-1	43	48	TCRBV09,TCRBV12													CASSAFIGDEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ACGTTTGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	2.461398642443979E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	21	2	1	5	24	1	37	30	63	54	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGACAGGGGTTACGAGCAGTACTTCGGGCCG	CSARDRDRGYEQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	4	2	1	26	40	52	42	53		TCRBV20-01,TCRBV20-or09_02												CSARDRDRGYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGAGAAGCGGGGCGGGGGAGCAGTACTTCGGGCCG	CSARGRSGAGEQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	3	7	5	5	26	39	51	44	56		TCRBV20-01,TCRBV20-or09_02												CSARGRSGAGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCACCCTGGACAGGGGTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	2.461398642443979E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	1	6	1	26	35	50	41	51		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCCAGGGACTCCTAAACTATGGCTACACCTTCGGTTCG	CASSQGLLNYGYTF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	0	10	2	2	4	18	30	38	32	42	TCRBV11,TCRBV15					01,02								CASSQGLLNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGGACCGTCGGTGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	26	2.461398642443979E-4		41							TCRBJ01	TCRBJ01-03	01	9	2	7	0	0	8	18	-1	29	26	37	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-03			TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCCGGGGACAGGGGCACGCGACGAGCAGTACTTCGGGCCG	CASSPGTGARDEQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	5	3	6	22	34	47	37	53	TCRBV07,TCRBV11													CASSPGTGARDEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTACCGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLPENTEAFF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	2	1	8	1	2	0	26	41	-1	43	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPENTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGAGGTACCGGGGGAAAAACTGTTTTTTGGCAGT	CASSEVPGEKLFF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	8	7	0	22	34	-1	41	46		TCRBV12-03,TCRBV12-04												CASSEVPGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CATSDGSNQPQHF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	39	TCRBV24						TCRBJ01	TCRBJ01-05	01	3	0	10	0	0	0	24	-1	-1	39	41		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDGSNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCAGGGACATGGGAAACATTCAGTACTTCGGCGCC	CATSDSRDMGNIQYF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	6	6	3	4	24	40	49	43	53		TCRBV24-01,TCRBV24-or09_02												CATSDSRDMGNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCAGGGACAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	2.556067820999517E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	5	2	2	0	24	36	-1	38	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGTACGACAGGGGGCCACAATGAGCAGTTCTTCGGGCCA	CASTTGGHNEQFF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	2	0	5	3	1	23	31	44	34	45	TCRBV06,TCRBV27													CASTTGGHNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGAGGGATCCCCGGCCGGACAGGGTAAGATCACCCCTCCACTTTGGGAAC		Out	VDJ	1	27	2.556067820999517E-4		53	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	3	10	14	5	19	30	52	44	57		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-06	TCRBV05	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTCCCGACAGGGTACTATGGCTACACCTTCGGTTCG	CASSFPTGYYGYTF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	3	3	3	1	19	33	43	36	44	TCRBV05,TCRBV11													CASSFPTGYYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCACAGGGGGCGCGTGGGACTGAAGCTTTTTTTGGACAA	CSAAQGARGTEAFF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	0	17	3	19	26	34	46	37	65		TCRBV20-01,TCRBV20-or09_02												CSAAQGARGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAGGGGGGCCTCTGAAGCTTTCTTTGGACAA	CSARRGASEAFF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	36	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	5	1	6	1	4	26	37	44	38	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRGASEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGACTAGCGGGCGATACTCTAGCACAGATACGCAGTATTTTGGCCCA	CSARTSGRYSSTDTQYF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	4	0	1	9	26	35	47	36	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARTSGRYSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTCCACGGACAGGGGTAGCGGGGGCCGGCTAGATACGCAGTATTTTGGCCCA	CASSSTDRGSGGRLDTQYF	In	VDDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	5	0	6	18	-1	53	44	59	TCRBV05,TCRBV07													CASSSTDRGSGGRLDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCCAGGGACAGGGAGGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSPGTGRGKETQYF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	3	3	7	19	31	43	34	50	TCRBV05,TCRBV07													CASSPGTGRGKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCTGGGACAGATGAAGCTTTCTTTGGACAA	CASSPGTDEAFF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	7	3	1	26	38	48	41	49		TCRBV12-03,TCRBV12-04												CASSPGTDEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGCCTGGGTTTTTACGAGCAGTACTTCGGGCCG	CASSGLGFYEQYF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	39	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	0	9	4	5	4	26	38	46	43	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGLGFYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGGGGTTGCGTATAATTCACCCCTCCACTTTGGGAAC	CASSQGGVAYNSPLHF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	48	TCRBV03						TCRBJ01	TCRBJ01-06	01	1	5	2	4	1	5	26	42	48	43	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGGVAYNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGCCAGGGGGAGGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CSQGEVSNQPQHF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	9	4	1	1	1	5	26	31	39	32	44		TCRBV20-01,TCRBV20-or09_02												CSQGEVSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCAGGGGGGAACTGAAGCTTTCTTTGGACAA	CSATQGGTEAFF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	5	4	2	26	34	45	38	47		TCRBV20-01,TCRBV20-or09_02												CSATQGGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAACTCCGGGACTAGCAACAATGAGCAGTTCTTCGGGCCA	CSARNSGTSNNEQFF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	7	5	6	1	26	38	53	44	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARNSGTSNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATGATAGGGACAGGATCATCTCTGGAAACACCATATATTTTGGAGAG	XASSQDDRDRIISGNTIYF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	0	4	0	5	5	22	39	52	44	57	TCRBV01,TCRBV04													XASSQDDRDRIISGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCCCCAGCCAAGGGGGCAGAGAAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	2.7454061781105924E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	11	5	0	6	11	9	22	25	43	36	52	TCRBV17,TCRBV23													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCTCGACTAGCGGGGGGATATTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPRLAGGYLAKNIQYF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	57	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	5	2	1	0	4	6	24	36	53	40	59		TCRBV06-01,TCRBV06-05,TCRBV06-06												CASSPRLAGGYLAKNIQYF+TCRBV06-X+TCRBJ02-04	TCRBV06	TCRBD02-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTAGCTTACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLAYNTGELFF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	45	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	7	2	3	4	26	39	46	42	50		TCRBV03-01,TCRBV03-02				01,02								CASSPLAYNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGCCTCCCATGTGACAGGGTGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	2.8400753566661303E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	3	4	11	3	26	31	49	42	52		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACAGTTTAGTGGGGGGGGCACACAATGAGCAGTTCTTCGGGCCA	CANSLVGGAHNEQFF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	9	0	5	5	4	24	36	48	41	52		TCRBV24-01,TCRBV24-or09_02												CANSLVGGAHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCCGGGGGGGAGTAGGACTGAAGCTTTCTTTGGACAA	CASSPPGGSRTEAFF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	5	4	6	26	38	50	42	56		TCRBV12-03,TCRBV12-04												CASSPPGGSRTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCCGGGACAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSGRDRSTDTQYF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	4	0	4	0	26	38	-1	42	50		TCRBV03-01,TCRBV03-02												CASSGRDRSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAGGACAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSAQGQSGANVLTF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	1	5	1	4	0	26	34	-1	38	44		TCRBV20-01,TCRBV20-or09_02												CSAQGQSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCTCCGACCAGGGGGCGACCTCACTAGCGAACTATGGCTACACCTTCGGTTCG	CSASDQGATSLANYGYTF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	2	7	13	26	34	49	41	62		TCRBV20-01,TCRBV20-or09_02												CSASDQGATSLANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACAGGGGCACACTGAAGCTTTCTTTGGACAA	CASSEQGHTEAFF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	39	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	3	0	1	23	-1	44	38	45		TCRBV06-01,TCRBV06-08												CASSEQGHTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCATGGGACTAGCGAAGATACGCAGTATTTTGGCCCA	YASSHGTSEDTQYF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	6	5	1	1	22	36	47	37	48	TCRBV04,TCRBV07,TCRBV17	TCRBV04-01,TCRBV07-03,TCRBV17-01				01,02								YASSHGTSEDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGACTGTTATCAGACACCGGGGAGCTGTTTTTTGGAGAA	CASRLLSDTGELFF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	42	unresolved						TCRBJ02	TCRBJ02-02	01	6	4	5	3	8	0	19	30	-1	38	41	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLLSDTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCCCCCGGGACCTGTCCTTCGGGGAGCTGTTTTTTGGAGAA	CASSPRDLSFGELFF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	5	0	7	7	4	8	24	36	45	40	53	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDLSFGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATGCGTACACCCCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	32	3.0294137137772055E-4		49	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	18	0	26	38	-1	56	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGGGGACCTACAATGAGCAGTTCTTCGGGCCA	CSARGTGGTYNEQFF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	1	2	0	2	26	-1	49	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGTGGTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGGAAGCACAGCACAGATACGCAGTATTTTGGCCCA	CASRKHSTDTQYF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	7	0	2	2	23	34	39	36	41	TCRBV06,TCRBV10					01,02								CASRKHSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCATTAGCACAGATACGCAGTATTTTGGCCCA	CASSISTDTQYF	In	VJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	36	unresolved						TCRBJ02	TCRBJ02-03	01	4	0	0	0	0	3	23	-1	35	-1	38	TCRBV09,TCRBV21													CASSISTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGTCTAGAGCTCCATGGCTACACCTTCGGTTCG	CASSVGLELHGYTF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	4	8	6	2	6	23	39	45	41	51	TCRBV09,TCRBV21					01,02								CASSVGLELHGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ACGTTTGGTGCATCCTGAAGACAGCAGYTCTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	5	4	1	36	50	63	54	64		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACGGTCGAAGTCAATGAGCAGTTCTTCGGGCCA	CSARDTVEVNEQFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	8	5	6	2	7	26	40	45	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDTVEVNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTCCCGCGGAGGGGCCGACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	3.1240828923327434E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	10	0	2	6	5	24	36	48	42	53	TCRBV24,TCRBV27													X+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTCCGCCGGGACAACCCCCTACGAGCAGTACTTCGGGCCG	CASSSAGTTPYEQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	2	6	4	24	36	48	42	52	TCRBV06,TCRBV24													CASSSAGTTPYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTACTAGCGGGGGGTGGCAATGAGCAGTTCTTCGGGCCA	CASSLLAGGGNEQFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	6	0	3	18	-1	44	33	47	TCRBV07,TCRBV11													CASSLLAGGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTTACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFTGNTGELFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	4	1	1	0	19	33	-1	34	39	TCRBV05,TCRBV07													CASSFTGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTTAGACAGGGGGCGAATGAAAAACTGTTTTTTGGCAGT	CSARDFRQGANEKLFF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	2	0	5	5	1	26	40	55	45	56		TCRBV20-01,TCRBV20-or09_02												CSARDFRQGANEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGATCCGGGACAGGGGGCCACCTACAATGAGCAGTTCTTCGGGCCA	CSADPGQGATYNEQFF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	0	2	5	2	26	35	52	40	54		TCRBV20-01,TCRBV20-or09_02												CSADPGQGATYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCCCTAGCGGGGGACCTAGCACAGATACGCAGTATTTTGGCCCA	CATSGPSGGPSTDTQYF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	0	3	4	24	37	50	40	54		TCRBV24-01,TCRBV24-or09_02												CATSGPSGGPSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCCGGCCCTCAACAGATCAGCCCCAGCATTTTGGTGAT	CASSFRPSTDQPQHF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	5	5	12	0	24	36	-1	48	52		TCRBV24-01,TCRBV24-or09_02												CASSFRPSTDQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCCCGCCCCCCTTTCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	34	3.218752070888281E-4		46	unresolved						TCRBJ01	TCRBJ01-05	01	6	10	0	3	4	10	23	34	40	38	50	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTGGGCGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSELGGTGGYEQYF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	1	3	6	0	23	38	-1	44	55		TCRBV06-01,TCRBV06-08												CASSELGGTGGYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGTAGCGTCCCCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	35	3.3134212494438187E-4		38	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	6	4	4	4	26	34	43	38	47		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCATATCGGGGCCTAAGAACACTGAAGCTTTCTTTGGACAA	CSVISGPKNTEAFF	In	VDJ	1	35	3.3134212494438187E-4	4.09826467764221E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	7	7	0	1	7	4	26	33	45	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVISGPKNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAAGACTCGGCCSTGTATSTCTGYGCCAGCAGCCAAGGAAATAGCGGGGGACCAGATACGCAGTATTTTGGCCCA	CASSQGNSGGPDTQYF	In	VDJ	1	35	3.3134212494438187E-4	4.09826467764221E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	2	4	4	2	21	37	50	41	52	TCRBV04,TCRBV11													CASSQGNSGGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACACAGGGGTCCCTCTAACTATGGCTACACCTTCGGTTCG	CASSLHRGPSNYGYTF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	0	1	5	26	41	49	42	54		TCRBV12-03,TCRBV12-04												CASSLHRGPSNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACCGCCTATGGGACAGCGAGGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	36	3.408090427999356E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	5	2	10	5	26	42	59	52	64		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCGCCCGACCCCAGACGGGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	36	3.408090427999356E-4		55	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	8	4	0	14	0	24	39	-1	53	57		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTGTCAGGGGGACTTAATTCACCCCTCCACTTTGGGAAC	CASSLLSGGLNSPLHF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	1	6	7	3	24	36	50	43	53		TCRBV24-01,TCRBV24-or09_02												CASSLLSGGLNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATCTAGCGGGGGTTCTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSANLAGVLSSYNEQFF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	0	2	7	26	36	48	38	55		TCRBV20-01,TCRBV20-or09_02												CSANLAGVLSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACCGGACGGAACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	37	3.502759606554894E-4		40	TCRBV20						TCRBJ01	TCRBJ01-02	01	2	1	7	4	3	5	26	38	45	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGAATAGGACAGGGACGACTATGGCTACACCTTCGGTTCG	CSAREE*DRDDYGYTF	Stop	VDJ	1	37	3.502759606554894E-4		48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	3	6	3	26	40	54	46	57		TCRBV20-01,TCRBV20-or09_02												CSAREE*DRDDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATATAGCGGGGCGGAGGGAGACCCAGTACTTCGGGCCA	CSARDIAGRRETQYF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	3	5	5	6	26	37	50	42	56		TCRBV20-01,TCRBV20-or09_02												CSARDIAGRRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCACCCGATCCTGTCAGGGTTCTACGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	37	3.502759606554894E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	4	3	7	11	8	24	31	47	42	55	TCRBV12,TCRBV21													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCCCTTCAGGGGGCTACACCTTCGGTTCG	CASSLAPSGGYTF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	8	5	0	26	43	-1	48	53		TCRBV12-03,TCRBV12-04												CASSLAPSGGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGGGCTAGGGGAGGGGAACTATGGCTACACCTTCGGTTCG	CASSFGLGEGNYGYTF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	0	2	8	1	26	40	55	48	56		TCRBV12-03,TCRBV12-04												CASSFGLGEGNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCACCCGGGACAGGGGGCGTCCAGATACGCAGTATTTTGGCCCA	CSARPTRDRGRPDTQYF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	0	4	8	3	26	37	57	45	60		TCRBV20-01,TCRBV20-or09_02												CSARPTRDRGRPDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAACAGGGGACGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGDVTGELFF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	3	2	4	0	4	18	-1	40	33	44	TCRBV07,TCRBV11													CASSLTGDVTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGGGGACTAGCGGGGGCAACGCAGTATTTTGGCCCA		Out	VDJ	1	39	3.692097963665969E-4		43	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	9	3	2	26	38	55	41	57		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGGAACAGGGGGATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRGTGGSGANVLTF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	3	1	1	4	1	26	37	49	41	50		TCRBV03-01,TCRBV03-02												CASRGTGGSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTTCAGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CASSRSGVYNEQFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	3	3	1	26	39	48	42	49		TCRBV03-01,TCRBV03-02												CASSRSGVYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGAAGAAGGGGGCGCACAGATACGCAGTATTTTGGCCCA	XASRRRGRTDTQYF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	1	4	0	25	36	-1	40	47	TCRBV26,TCRBV28													XASRRRGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAACTTTAGGGTAGGGACATCCTACGAGCAGTACTTCGGGCCG	CASSENFRVGTSYEQYF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	6	1	12	0	23	38	-1	50	56		TCRBV06-01,TCRBV06-08												CASSENFRVGTSYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCCGGGACAGCGCGGAGAATGAAAAACTGTTTTTTGGCAGT	CASRDSAENEKLFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	5	5	1	7	23	32	40	33	47	TCRBV02,TCRBV12													CASRDSAENEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGCGGGGGGTCTCCTACGAGCAGTACTTCGGGCCG	CASSWRGVSYEQYF	In	VDJ	1	40	3.786767142221507E-4	4.6837310601625254E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	7	1	0	1	1	26	39	48	40	49		TCRBV12-03,TCRBV12-04												CASSWRGVSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGCGACGGTCAGCCCCAGCATTTTGGTGAT	CASSRDGQPQHF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	36	TCRBV12						TCRBJ01	TCRBJ01-05	01	5	2	7	6	3	2	26	38	44	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGTCTGGGGGTGGCTTTCTTTGGACAA	CASSQDRLGVAFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	39	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	6	1	11	6	2	26	43	54	49	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRLGVAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACCCTACAGGGAGCCCGGACTATGGCTACACCTTCGGTTCG	CASSHPTGSPDYGYTF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	3	3	3	4	7	26	40	50	44	57		TCRBV03-01,TCRBV03-02												CASSHPTGSPDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGGACAGGGACGACGGGGAGCTGTTTTTTGGAGAA	CSARDRDDGELFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	7	2	4	26	34	45	36	49		TCRBV20-01,TCRBV20-or09_02												CSARDRDDGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGGCCCGACCTTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASRPDLSGGADTQYF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	0	4	9	0	23	34	-1	43	54	TCRBV06,TCRBV10													CASRPDLSGGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAACTTAGCGTGGACTAGCGGGTCCACAGATACGCAGTATTTTGGCCCA	CASNLAWTSGSTDTQYF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	1	4	2	5	2	19	33	49	38	51	TCRBV05,TCRBV07,TCRBV11					01,02								CASNLAWTSGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCGGCCGGGACAGGGGGCCGAATGAGCAGTTCTTCGGGCCA	CASGRDRGPNEQFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	0	7	4	2	23	32	48	36	50	TCRBV02,TCRBV09													CASGRDRGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGGGCAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDRAASTDTQYF	In	VDJ	1	42	3.9761054993325823E-4	4.917917613170652E-4	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	0	8	0	0	2	4	26	43	49	45	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRAASTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCCAAACAGGGAGAGAGACTGAAGCTTTCTTTGGACAA	CSARGQTGRETEAFF	In	VDJ	1	42	3.9761054993325823E-4	4.917917613170652E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	5	5	6	26	39	50	44	56		TCRBV20-01,TCRBV20-or09_02												CSARGQTGRETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCTGCAGCTATGAATCTAGCGGACAAGAGGGATACGAGCAGTACTTCGGGCCG	XASSCSYESSGQEGYEQYF	In	VDJ	1	42	3.9761054993325823E-4	4.917917613170652E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	5	4	12	10	22	35	54	47	64	TCRBV01,TCRBV07					01,02								XASSCSYESSGQEGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTCTTATATCCCTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	43	4.07077467788812E-4		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	6	5	16	2	26	38	57	54	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGAGCCCCCTAGCGGGGGGAAAAACACAGATACGCAGTATTTTGGCCCA	CSAEPPSGGKNTDTQYF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	2	8	5	26	34	53	42	58		TCRBV20-01,TCRBV20-or09_02												CSAEPPSGGKNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCTACCGGGACAGCTGGAAACACCATATATTTTGGAGAG	CSARATGTAGNTIYF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	2	7	0	26	37	-1	44	51		TCRBV20-01,TCRBV20-or09_02												CSARATGTAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGTTGGGAAGTCATAACACCGGGGAGCTGTTTTTTGGAGAA	CASRLGSHNTGELFF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	6	0	8	2	3	6	22	33	40	36	46	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGSHNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGCCGGGACTAACAATAACTCTAGCAGTTCTTCGGGCCA		Out	VDJ	1	43	4.07077467788812E-4		43	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	9	11	3	11	24	35	45	38	56		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTACACGGACAGCAAGAGACCCAGTACTTCGGGCCA	CASSLHGQQETQYF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	5	2	3	0	18	33	-1	36	42	TCRBV07,TCRBV11													CASSLHGQQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGGACGTATGGGACTCACCAATGAGCAGTTCTTCGGGCCA	CASSVGRMGLTNEQFF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	6	11	3	24	36	53	47	56	TCRBV09,TCRBV21					01,02								CASSVGRMGLTNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	44	4.1654438564436575E-4		34	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	4	10	5	2	2	26	39	43	41	45		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGGGACTAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTSGGTDTQYF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	1	3	1	0	0	18	-1	-1	34	46	TCRBV05,TCRBV07													CASSLGTSGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGAACCCTTCGTATCGACAGGGACTGGAAACACCATATATTTTGGAGAG	CASSLEPFVSTGTGNTIYF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	3	2	12	1	18	35	54	47	55	TCRBV07,TCRBV11													CASSLEPFVSTGTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGGGACCCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSWGPGNQPQHF	In	VDJ	1	45	4.2601130349991954E-4	5.269197442682841E-4	42	TCRBV12						TCRBJ01	TCRBJ01-05	01	4	0	7	2	1	3	26	39	45	40	48		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGPGNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGAAGGATGGACAGAATTCACCCCTCCACTTTGGGAAC	CSARDLKDGQNSPLHF	In	VDJ	1	45	4.2601130349991954E-4	5.269197442682841E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	5	7	10	0	26	40	-1	50	56		TCRBV20-01,TCRBV20-or09_02												CSARDLKDGQNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTAGACTAGCGGGGGAGGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	4.2601130349991954E-4		49	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	2	2	4	2	4	26	39	53	41	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAAAGGAGAGRGCAATGAAGCTTTCTTTGGACAA	CASKGEXNEAFF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	36	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	2	7	2	7	26	36	42	38	49		TCRBV03-01,TCRBV03-02												CASKGEXNEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCTAACAGGAAACACTGAAGCTTTCTTTGGACAA	CASSPLTGNTEAFF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	4	2	5	1	26	39	49	44	50		TCRBV03-01,TCRBV03-02												CASSPLTGNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTCCGTCGGGGGATAGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	4.354782213554733E-4		47	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	2	6	7	6	26	38	51	45	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAAAGCTTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	46	4.354782213554733E-4		37	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	6	7	0	5	2	26	34	42	39	44		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTACTTAGGACAGGGGAGGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CSARVLRTGEVSNQPQHF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	2	1	6	5	26	39	54	45	59		TCRBV20-01,TCRBV20-or09_02												CSARVLRTGEVSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCACCCTACCGGGACAGGGGGCTTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	4.354782213554733E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	0	0	6	7	1	23	30	49	37	50	TCRBV02,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTACTGTAGGGCAAGAGGGACACTGAAGCTTTCTTTGGACAA	CASSLL*GKRDTEAFF	Stop	VDJ	1	47	4.4494513921102707E-4		48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	3	11	0	26	41	-1	52	57		TCRBV12-03,TCRBV12-04												CASSLL*GKRDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCGGGACTAGCGCGGGAGACCCAGTACTTCGGGCCA	CASSSGLARETQYF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	6	5	1	3	26	39	50	40	53		TCRBV12-03,TCRBV12-04				01,02								CASSSGLARETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGATCACAGATACGCAGTATTTTGGCCCA	CATSDSITDTQYF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	39	TCRBV24						TCRBJ02	TCRBJ02-03	01	4	2	8	2	3	1	24	38	43	41	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSITDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCTCGAGGACAGGGGGCGACCAGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPRGQGATRGTDTQYF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	57	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	0	1	7	8	24	35	53	42	61		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPRGQGATRGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCGGGGGGGGCGAGGGAGCAGTTCTTCGGGCCA	CASRPGGAREQFF	In	VDJ	1	48	4.5441205706658086E-4	5.62047727219503E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	10	2	6	26	37	47	39	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGGAREQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTCGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSLGTGGTDTQYF	In	VDJ	1	48	4.5441205706658086E-4	5.62047727219503E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	2	1	3	0	26	38	-1	41	51		TCRBV12-03,TCRBV12-04												CASSLGTGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCTGAGCCCAGCGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	48	4.5441205706658086E-4		44	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	6	5	3	9	0	19	32	-1	41	46	TCRBV07,TCRBV11					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTCCAGCGGGGGTAACGAGCAGTACTTCGGGCCG	CASSFSSGGNEQYF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	2	5	4	2	26	40	52	44	54		TCRBV12-03,TCRBV12-04												CASSFSSGGNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGGGCACACTACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CRAHYPNTGELFF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	9	3	9	0	5	2	26	31	40	36	42		TCRBV20-01,TCRBV20-or09_02				01,02								CRAHYPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATACAGGGAATAATGAAAAACTGTTTTTTGGCAGT	CSARDTGNNEKLFF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	3	4	1	2	26	40	47	41	49		TCRBV20-01,TCRBV20-or09_02												CSARDTGNNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACACCAGCGGGGGGGCAATAGATACGCAGTATTTTGGCCCA	CATSDTSGGAIDTQYF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	0	5	4	4	24	38	52	42	56		TCRBV24-01,TCRBV24-or09_02												CATSDTSGGAIDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGTCTCCTGGGACAGGGGGACGGGGAGCTGTTTTTTGGAGAA	CASLLGQGDGELFF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	1	7	7	1	24	31	49	38	50	TCRBV12,TCRBV21													CASLLGQGDGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCAGAAGTTTGGGGGACTAGCGGGGGAAAGACCCAGTACTTCGGGCCA	CSASEVWGTSGGKTQYF	In	VDJ	1	50	4.733458927776884E-4	5.854663825203156E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	6	12	2	26	35	61	47	63		TCRBV20-01,TCRBV20-or09_02												CSASEVWGTSGGKTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAAGGACCGGTACACAGATACGCAGTATTTTGGCCCA	CATKDRYTDTQYF	In	VDJ	1	50	4.733458927776884E-4	5.854663825203156E-4	39	TCRBV24						TCRBJ02	TCRBJ02-03	01	8	1	7	2	1	5	24	34	39	35	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATKDRYTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACATCGATCGGAAAAACTGTTTTTTGGCAGT	CASSLHRSEKLFF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	39	TCRBV12						TCRBJ01	TCRBJ01-04	01	2	2	8	8	4	3	26	41	47	45	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLHRSEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGATCGTCGGTACACAGATACGCAGTATTTTGGCCCA	CASSLDRRYTDTQYF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	6	1	8	2	2	9	24	36	41	38	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDRRYTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTCCCCGTCGACAGATAACCACGAGCAGTACTTCGGGCCG	CASSSPSTDNHEQYF	In	VDJ	1	53	5.017466463443496E-4	6.205943654715346E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	5	7	6	19	32	44	39	50	TCRBV07,TCRBV11													CASSSPSTDNHEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCATACAGGGGCAGGGGCTAATGAAAAACTGTTTTTTGGCAGT	CASNHTGAGANEKLFF	In	VDJ	1	54	5.112135641999034E-4	6.323036931219409E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	2	3	1	6	26	40	48	41	54		TCRBV03-01,TCRBV03-02												CASNHTGAGANEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGGCAACTAGCGGGAATAAATACGCAGTATTTTGGCCCA	XASSRQLAGINTQYF	In	VDJ	1	55	5.206804820554572E-4	6.440130207723473E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	3	3	7	5	4	22	34	49	39	53	TCRBV04,TCRBV07,TCRBV17													XASSRQLAGINTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTGGTTGGGACAGGGAGGGACTGAAGCTTTCTTTGGACAA	CASSWLGQGGTEAFF	In	VDJ	1	55	5.206804820554572E-4	6.440130207723473E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	5	4	4	19	32	45	36	49	TCRBV05,TCRBV11													CASSWLGQGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGCGATTGGGTGGCGACTCTGGAAACACCATATATTTTGGAGAG	CASRRLGGDSGNTIYF	In	VDJ	1	55	5.206804820554572E-4	6.440130207723473E-4	48	unresolved						TCRBJ01	TCRBJ01-03	01	6	0	9	0	6	6	23	34	43	40	49	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRLGGDSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTCTATCTGGACGGGAGGGAGCTTTCTTTGGACAA	CASSLSGREGAFF	In	VDJ	1	55	5.206804820554572E-4	6.440130207723473E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	0	10	10	0	23	34	-1	44	52	TCRBV09,TCRBV21													CASSLSGREGAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTGCGGGACAGGGCTTAGCACAGATACGCAGTATTTTGGCCCA	CSARCGTGLSTDTQYF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	3	0	4	3	26	37	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSARCGTGLSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATCCGCAGAGTGAAAAACTGTTTTTTGGCAGT	CASSQDPQSEKLFF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	0	4	5	7	4	2	23	40	47	44	49	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPQSEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCARCCAGACCTMTCTGTACYWCTGTGCCAGCAGTCCAGGACAGGTCAATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	58	5.490812356221185E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	0	3	4	23	35	45	38	49	TCRBV08,TCRBV27													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGCTACGAGAAGCACAGATACGCAGTATTTTGGCCCA	CSARDATRSTDTQYF	In	VDJ	1	59	5.585481534776723E-4	6.908503313739725E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	9	0	2	5	26	40	45	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDATRSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCCTACGTTCGGGCGGGGTGGCTACACCTTCGGTTCG	CASSPTFGRGGYTF	In	VDJ	1	59	5.585481534776723E-4	6.908503313739725E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	7	3	7	11	0	18	30	-1	41	47	TCRBV11,TCRBV23													CASSPTFGRGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCTAGCGGGGGGGCCGCAGATACGCAGTATTTTGGCCCA	CSASSGGAADTQYF	In	VDJ	1	60	5.680150713332261E-4	7.025596590243789E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	4	1	3	26	35	48	36	51		TCRBV20-01,TCRBV20-or09_02												CSASSGGAADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTGATCCCCGACAGTCACAAGGTGAAAAACTGTTTTTTGGCAGT	CASSDPRQSQGEKLFF	In	VDJ	1	61	5.774819891887798E-4	7.142689866747852E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	5	7	7	8	26	38	50	45	58	TCRBV02,TCRBV12													CASSDPRQSQGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCAAGCGGGGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAPSGASYNEQFF	In	VDJ	1	61	5.774819891887798E-4	7.142689866747852E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	3	0	4	1	26	34	45	38	46		TCRBV20-01,TCRBV20-or09_02												CSAPSGASYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGGGGGAGAGACCCAGTACTTCGGGCCA	CSATGGETQYF	In	VDJ	1	61	5.774819891887798E-4	7.142689866747852E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	4	0	0	26	-1	-1	36	43		TCRBV20-01,TCRBV20-or09_02												CSATGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCACGACAGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASTTTGTNEKLFF	In	VDJ	1	61	5.774819891887798E-4	7.142689866747852E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	2	3	2	7	0	24	31	-1	38	45		TCRBV24-01,TCRBV24-or09_02												CASTTTGTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTCGCAGGGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	62	5.869489070443335E-4		41	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	3	3	0	26	40	-1	43	50		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGTGTTGAGGGGGCGTACACTGAAGCTTTCTTTGGACAA	CASSRVEGAYTEAFF	In	VDJ	1	62	5.869489070443335E-4	7.259783143251915E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	3	6	2	26	39	52	45	54		TCRBV03-01,TCRBV03-02												CASSRVEGAYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTGGGGTCGGAATGGAACACTGAAGCTTTCTTTGGACAA	CSARDLGSEWNTEAFF	In	VDJ	1	62	5.869489070443335E-4	7.259783143251915E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	6	2	1	3	8	26	40	47	43	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLGSEWNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAACAGGGCGACGGGCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	63	5.964158248998873E-4		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	3	3	2	2	7	26	43	51	45	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATTCTATCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	63	5.964158248998873E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	4	4	9	4	4	14	26	39	46	43	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGCGGGTTAGCGGGGCGCCTAGCACAGATACGCAGTATTTTGGCCCA	CSAQRVSGAPSTDTQYF	In	VDJ	1	64	6.058827427554411E-4	7.493969696260041E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	3	0	9	5	26	34	51	43	56		TCRBV20-01,TCRBV20-or09_02												CSAQRVSGAPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGGCGAACAGGGGGCTTGGAGACCCAGTACTTCGGGCCA	XASRRTGGLETQYF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	5	4	3	25	36	49	40	52	TCRBV26,TCRBV28													XASRRTGGLETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCCACCGACAGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASSHRQGGEKLFF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	3	7	4	3	19	31	42	35	45	TCRBV05,TCRBV07													CASSHRQGGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTGGACGAGGGACGGCACTGAAGCTTTCTTTGGACAA	XASSWTRDGTEAFF	In	VDJ	1	67	6.342834963221024E-4	7.84524952577223E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	4	0	7	4	6	2	27	40	51	46	53	TCRBV26,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSWTRDGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCAGAGGACACTTCGAGAGACCCAGTACTTCGGGCCA	CASTQRTLRETQYF	In	VDJ	1	67	6.342834963221024E-4	7.84524952577223E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	6	4	2	5	26	40	47	42	52		TCRBV03-01,TCRBV03-02												CASTQRTLRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCTTCCGGGACTAGCGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	68	6.437504141776562E-4		35	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	11	0	6	5	4	0	26	32	-1	36	46		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCAACCCCACCGGGACAGCGACTGGAAACACCATATATTTTGGAGAG	CASSNPTGTATGNTIYF	In	VDJ	1	69	6.532173320332099E-4	8.079436078780357E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	2	9	3	23	35	51	44	54	TCRBV01,TCRBV04													CASSNPTGTATGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGGACAGGACCCGTAGACTATGGCTACACCTTCGGTTCG	CASSQGTGPVDYGYTF	In	VDJ	1	69	6.532173320332099E-4	8.079436078780357E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	4	3	1	8	26	40	49	41	57		TCRBV03-01,TCRBV03-02												CASSQGTGPVDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGGACAGGGCCTACGAGCAGTACTTCGGGCCG	CSATDRAYEQYF	In	VDJ	1	69	6.532173320332099E-4	8.079436078780357E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	2	1	0	26	36	-1	37	45		TCRBV20-01,TCRBV20-or09_02												CSATDRAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATTTCCTTCCTACAGGGATACCTATGGCTACACCTTCGGTTCG	CASSPFPSYRDTYGYTF	In	VDJ	1	70	6.626842498887637E-4	8.19652935528442E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	4	12	4	26	39	57	51	61		TCRBV03-01,TCRBV03-02												CASSPFPSYRDTYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGAAGGCAACTACAATGAGCAGTTCTTCGGGCCA	CASSLEGNYNEQFF	In	VDJ	1	71	6.721511677443175E-4	8.313622631788483E-4	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	3	1	8	3	0	6	26	-1	43	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGNYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGTGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	72	6.816180855998712E-4		38	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	0	9	4	3	0	26	43	-1	46	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTAGGGGTCCGGACAGATACGCAGTATTTTGGCCCA	CASSLLGVRTDTQYF	In	VDJ	1	73	6.91085003455425E-4	8.547809184796609E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	3	2	5	26	41	48	43	53		TCRBV12-03,TCRBV12-04												CASSLLGVRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGGGACAGGATGGTAGGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	73	6.91085003455425E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	5	2	9	26	38	48	40	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGYCAGCAGTTCTACCTCCCCATATAGGAATTACGAGCAGTACTTCGGGCCG	CXSSSTSPYRNYEQYF	In	VDJ	1	74	7.005519213109788E-4	8.664902461300672E-4	48	TCRBV12						TCRBJ02	TCRBJ02-07	01	4	1	8	4	15	2	26	39	57	54	59		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CXSSSTSPYRNYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGACAGGGTAACGGTGAAGCTTTCTTTGGACAA	CSARQGNGEAFF	In	VDJ	1	74	7.005519213109788E-4	8.664902461300672E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	7	2	6	26	34	43	36	49		TCRBV20-01,TCRBV20-or09_02												CSARQGNGEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCAGGGAGAGGAAACACCATATATTTTGGAGAG	CASSQDSGRGNTIYF	In	VDJ	1	76	7.194857570220864E-4	8.899089014308798E-4	45	TCRBV03						TCRBJ01	TCRBJ01-03	01	0	4	3	4	2	3	26	43	50	45	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSGRGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTCRGCYRTGTAYYKCTGTGCCAGCAGCCACGCACTAGCGCCCGGTGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	77	7.2895267487764E-4		50	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	3	6	4	5	7	18	30	42	35	49	TCRBV07,TCRBV12					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGACAGGGGTAAGGCTTTCTTTGGACAA	CSAPDRGKAFF	In	VDJ	1	78	7.384195927331938E-4	9.133275567316925E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	11	4	4	26	34	46	38	50		TCRBV20-01,TCRBV20-or09_02												CSAPDRGKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGATGGACTAGCGTCATGATGAATGAGCAGTTCTTCGGGCCA	CSARGWTSVMMNEQFF	In	VDJ	1	79	7.478865105887476E-4	9.250368843820988E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	1	6	7	3	8	26	39	51	42	59		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGWTSVMMNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGGACAGGCCCCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	79	7.478865105887476E-4		40	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	4	3	1	3	26	36	44	37	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTTGRCGGGCCTTCCTACGAGCAGTACTTCGGGCCG	CASSFXGPSYEQYF	In	VDJ	1	80	7.573534284443014E-4	9.367462120325051E-4	42	TCRBV12			unresolved			TCRBJ02	TCRBJ02-07	01	6	7	4	1	5	3	26	37	47	42	50		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02										CASSFXGPSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	unresolved	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACGGCARGGGGCACGGGTGAGCAGTTCTTCGGGCCA	CASSQTAXGTGEQFF	In	VDJ	1	80	7.573534284443014E-4	9.367462120325051E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	9	4	5	26	41	53	45	58		TCRBV03-01,TCRBV03-02												CASSQTAXGTGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTGACATAAGGCGGACATGAGGGGAATCGAGCAGTACTTCGGGCCG		Out	VDJ	1	80	7.573534284443014E-4		50	unresolved						TCRBJ02	TCRBJ02-07	01	5	1	6	6	10	10	23	35	50	45	60	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCGAGGAGGCGGATATGAAAAACTGTTTTTTGGCAGT	CASSLARGGGYEKLFF	In	VDJ	1	80	7.573534284443014E-4	9.367462120325051E-4	48				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	0	10	1	6	4	5	18	35	44	39	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARGGGYEKLFF+X+TCRBJ01-04		TCRBD02-01*02	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCGAGGGACAGTAGGGAAACACCATATATTTTGGAGAG	CASTEGQ*GNTIYF	Stop	VDJ	1	80	7.573534284443014E-4		42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	5	4	4	3	23	33	44	37	47	TCRBV09,TCRBV21													CASTEGQ*GNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCGGCGTACAGTCAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASGVQSGTGELFF	In	VDJ	1	81	7.668203462998552E-4	9.484555396829114E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	5	4	5	5	19	28	37	33	42	TCRBV05,TCRBV11													CASGVQSGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGCTACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSSATANTEAFF	In	VDJ	1	82	7.762872641554089E-4	9.601648673333177E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	5	1	1	1	18	35	40	36	41	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSSATANTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCACCGAGGGTTATAATTCACCCCTCCACTTTGGGAAC	CASTEGYNSPLHF	In	VDJ	1	83	7.857541820109627E-4	9.71874194983724E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	7	11	0	4	2	1	23	33	40	35	41	TCRBV06,TCRBV10													CASTEGYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTAAAGGGCCTCTTGACGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	84	7.952210998665165E-4		50	unresolved						TCRBJ01	TCRBJ01-02	01	5	5	3	4	2	16	25	37	43	39	59	TCRBV26,TCRBV28			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCCTAGCGGGGGGGCCAACGAGCAGTACTTCGGGCCG	CSAPPSGGANEQYF	In	VDJ	2	86	8.14154935577624E-4	0.001007002177934943	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	4	0	5	4	3	26	35	51	39	54		TCRBV20-01,TCRBV20-or09_02												CSAPPSGGANEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAAAGGGGGACAGGGGACCACTGAAGCTTTCTTTGGACAA	CASSKGGQGTTEAFF	In	VDJ	2	86	8.14154935577624E-4	0.001007002177934943	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	4	5	2	18	30	45	35	47	TCRBV07,TCRBV11													CASSKGGQGTTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCGAAGGCATGGGGCAGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	87	8.236218534331777E-4		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	1	3	13	1	26	35	55	48	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACAGTAATGAAAAACTGTTTTTTGGCAGT	CSAYSNEKLFF	In	VDJ	2	88	8.330887712887315E-4	0.0010304208332357556	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	4	1	0	26	35	-1	36	40		TCRBV20-01,TCRBV20-or09_02												CSAYSNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAGGGACAGACCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	90	8.520226069998391E-4		41	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	3	1	2	24	35	43	36	45		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTAGCAGGGGTCAATCAAGATACGCAGTATTTTGGCCCA	CASSVAGVNQDTQYF	In	VDJ	2	91	8.614895248553929E-4	0.0010655488161869745	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	5	4	7	24	36	46	40	53	TCRBV09,TCRBV21													CASSVAGVNQDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGGTCGTGGAGGAGACACAAATTGGGTAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	94	8.898902784220541E-4		56	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	1	6	7	14	25	36	48	43	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGACAGGGAGCCTACGAGCAGTACTTCGGGCCG	CASSQGQGAYEQYF	In	VDJ	2	95	8.993571962776079E-4	0.0011123861267885997	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	3	2	0	2	26	-1	49	40	51		TCRBV03-01,TCRBV03-02												CASSQGQGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGTTTGCGGACAGGGAACCTCTACGAGCAGTAYTTCGGGCCG	CASSESLRTGNLYEQYF	In	VDJ	2	96	9.088241141331617E-4	0.001124095454439006	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	3	7	5	23	38	53	45	58		TCRBV06-01,TCRBV06-08												CASSESLRTGNLYEQYF+TCRBV06-X+TCRBJ02-07	TCRBV06	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAGGGGTGGAGGACTAGCGGTGGGGGAGACCCAGTACTTCGGGCCA	CASSRGGGLAVGETQYF	In	VDJ	2	96	9.088241141331617E-4	0.001124095454439006	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	1	5	5	9	5	18	30	49	39	54	TCRBV07,TCRBV11					01,02								CASSRGGGLAVGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTCCTAGGAGGAGCGGGGGCCCTTTACAATGAGCAGTTCTTCGGGCCA	CASSVLGGAGALYNEQFF	In	VDJ	2	96	9.088241141331617E-4	0.001124095454439006	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	2	4	11	5	24	36	55	47	60	TCRBV12,TCRBV21													CASSVLGGAGALYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTTCTAGCGGGGGGTGGCCCCCATGAGCAGTTCTTCGGGCCA	CASSVLAGGGPHEQFF	In	VDJ	2	98	9.277579498442692E-4	0.0011475141097398187	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	1	8	2	8	24	37	50	39	58		TCRBV24-01,TCRBV24-or09_02												CASSVLAGGGPHEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGGACAGGGGGGCTTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	2	98	9.277579498442692E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	1	0	0	4	23	-1	45	36	49	TCRBV02,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCGGGAGTTATAATTCACCCCTCCACTTTGGGAAC	CSARAGSYNSPLHF	In	VDJ	2	102	9.656256212664842E-4	0.001194351420341444	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	8	2	4	3	1	26	37	46	40	47		TCRBV20-01,TCRBV20-or09_02												CSARAGSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01*02	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGACAGGTTTCTACGAGCAGTACTTCGGGCCG	CSAQTGFYEQYF	In	VDJ	2	104	9.845594569775917E-4	0.0012177700756422565	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	4	3	3	3	26	34	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSAQTGFYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGTCGGGACAGGTGAATGATGGCTACACCTTCGGTTCG	CASSLSSGQVNDGYTF	In	VDJ	2	105	9.940263748331455E-4	0.0012294794032926628	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	6	8	6	24	36	52	44	58	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSSGQVNDGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGAATGGCTGGAAACACCATATATTTTGGAGAG	CASSLGMAGNTIYF	In	VDJ	2	107	0.001012960210544253	0.0012528980585934755	42	unresolved						TCRBJ01	TCRBJ01-03	01	2	0	8	2	0	4	19	-1	37	33	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGMAGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGTGATTGTCCCATATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	112	0.001060294799822022		49	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	0	10	5	0	15	26	-1	40	38	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAAGGGGGGGATTTTAATTCACCCCTCCACTTTGGGAAC	CASSQEGGDFNSPLHF	In	VDJ	2	115	0.0010886955533886832	0.0013465726797967262	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	0	9	0	6	1	4	23	40	48	41	52	TCRBV01,TCRBV04													CASSQEGGDFNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGTCCGGGACAGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAESGTGNTGELFF	In	VDJ	2	116	0.001098162471244237	0.0013582820074471325	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	1	6	0	26	35	-1	41	49		TCRBV20-01,TCRBV20-or09_02												CSAESGTGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTGAGGAACACTGAAGCTTTCTTTGGACAA	CASSPLRNTEAFF	In	VDJ	2	117	0.0011076293890997907	0.0013699913350975388	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	11	2	1	4	0	26	39	-1	43	46		TCRBV03-01,TCRBV03-02												CASSPLRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACAGAGCATTAAGGGGAACACCATATATTTTGGAGAG	CASRQSIKGNTIYF	In	VDJ	2	121	0.001145497060522006	0.001416828645699164	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	5	2	7	11	0	26	37	-1	48	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRQSIKGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGGRGACWYGGCWSTGTATCTCTGYGCCAGCAGTTTTACTAGCGGCAATGAGCAGTTCTTCGGGCCA	CASSFTSGNEQFF	In	VDJ	2	122	0.0011549639783775597	0.0014285379733495703	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	6	3	0	20	32	-1	35	43	TCRBV07,TCRBV23					01,02								CASSFTSGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDSNSNQPQHF	In	VDJ	2	124	0.001173897814088667	0.001451956628650383	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	8	0	0	3	26	-1	43	40	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSNSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAGGGGTGGGGGAACACTGAAGCTTTCTTTGGACAA	CSASQGWGNTEAFF	In	VDJ	2	125	0.0011833647319442208	0.0014636659563007893	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	2	1	1	5	26	37	44	38	49		TCRBV20-01,TCRBV20-or09_02												CSASQGWGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACWCGGCMSTGTATCTCTGYGCTGGGGAGAGGAGCTCTGGAAACACCATATATTTTGGAGAG	CAGERSSGNTIYF	In	VDJ	2	126	0.0011928316497997746	0.0014753752839511956	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	12	9	2	0	2	5	20	25	32	27	37	TCRBV07,TCRBV23													CAGERSSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCACTGACAGTCTCTGGAAACACCATATATTTTGGAGAG	CASSSLTVSGNTIYF	In	VDJ	2	129	0.001221232403366436	0.0015105032669024145	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	2	5	0	5	1	26	38	48	43	49		TCRBV03-01,TCRBV03-02												CASSSLTVSGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGGACCGCTAAACTATGGCTACACCTTCGGTTCG	CSARDWGPLNYGYTF	In	VDJ	2	131	0.0012401662390775436	0.0015339219222032271	45	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	7	2	3	5	26	40	48	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDWGPLNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTTTAGGTAGCTACACAGATACGCAGTATTTTGGCCCA	CASSLGSYTDTQYF	In	VDJ	2	133	0.0012591000747886512	0.0015573405775040398	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	5	7	2	6	2	24	35	45	41	47	TCRBV09,TCRBV21					01,02								CASSLGSYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGGGGACATCGGAATTCACCCCTCCACTTTGGGAAC	CSASGGHRNSPLHF	In	VDJ	2	140	0.0013253684997775275	0.001639305871056884	42	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	0	6	7	3	4	26	37	46	40	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASGGHRNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTAACGGGACTAGACTACGAGCAGTACTTCGGGCCG	CASSVTGLDYEQYF	In	VDJ	3	141	0.0013348354176330813	0.0016510151987072902	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	8	3	5	1	24	36	49	41	50	TCRBV12,TCRBV21					01,02								CASSVTGLDYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTTCCAGGGTCAGTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	142	0.001344302335488635		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	4	3	4	18	32	40	35	44	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTCGATGAAGCTTTCTTTGGACAA	CASSQGVDEAFF	In	VDJ	3	144	0.0013632361711997424	0.0016861431816585092	36	TCRBV03						TCRBJ01	TCRBJ01-01	01	1	0	9	7	0	4	26	-1	45	42	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGVDEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTCCACGACAGGACAAAACTATGGCTACACCTTCGGTTCG	CASSSTTGQNYGYTF	In	VDJ	3	147	0.0013916369247664038	0.001721271164609728	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	2	4	4	19	32	42	36	46	TCRBV05,TCRBV11													CASSSTTGQNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGAGGCGGCGGTAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	151	0.001429504596188619		46	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	1	4	0	7	24	-1	47	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*02	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGTGGACGGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSVDGSSYNEQFF	In	VDJ	3	155	0.0014673722676108339	0.0018149457858129786	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	5	1	7	0	1	5	24	37	42	38	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSVDGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGACGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLDGSGNTIYF	In	VDJ	3	160	0.0015147068568886028	0.0018734924240650101	42	unresolved						TCRBJ01	TCRBJ01-03	01	3	1	7	0	0	2	18	-1	36	32	38	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTCATTATCTAGCGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	3	167	0.0015809752818774791		46	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	5	3	8	0	26	40	-1	48	55		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTGGGGCGGGAAACACTGAAGCTTTCTTTGGACAA	CSAPGAGNTEAFF	In	VDJ	3	172	0.001628309871155248	0.002014004355869886	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	7	3	2	7	0	26	34	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSAPGAGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTGCGACCCCAAAGGGACACTGAAGCTTTCTTTGGACAA	CASSLRPQRDTEAFF	In	VDJ	3	176	0.001666177542577463	0.002060841666471511	45	unresolved						TCRBJ01	TCRBJ01-01	01	3	5	3	3	10	0	18	32	-1	42	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRPQRDTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCACCCCGGGGACCGTAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	183	0.0017324459675663393		43	unresolved						TCRBJ01	TCRBJ01-01	01	10	0	7	1	8	4	24	31	44	39	48	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGCCAGGGGTCGCCAAAAACATTCAGTACTTCGGCGCC	CSAGPGVAKNIQYF	In	VDJ	3	185	0.001751379803277447	0.002166225615325168	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	4	2	1	4	2	26	35	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSAGPGVAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAACAGGGGGCAGACCTACGAGCAGTACTTCGGGCCG	CSANRGQTYEQYF	In	VDJ	3	186	0.0017608467211330007	0.0021779349429755742	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	0	2	2	3	26	34	45	36	48		TCRBV20-01,TCRBV20-or09_02												CSANRGQTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCAGAGCGGACAAAAAGGTCAGCCCCAGCATTTTGGTGAT	CASSQSGQKGQPQHF	In	VDJ	3	192	0.0018176482282663234	0.002248190908878012	45	TCRBV12						TCRBJ01	TCRBJ01-05	01	6	1	6	6	7	6	26	37	49	44	55		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQSGQKGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCGGTCCATAACTATGGCTACACCTTCGGTTCG	CASSPVHNYGYTF	In	VDJ	3	193	0.001827115146121877	0.0022599002365284184	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	8	5	1	2	4	26	37	42	39	46		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPVHNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGTGTCGGTCAGGGGACAGGGGTAGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSVGQGTGVGSYNEQFF	In	VDJ	3	193	0.001827115146121877	0.0022599002365284184	57	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	1	10	5	23	34	54	44	59	TCRBV09,TCRBV21													CASSVGQGTGVGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGCTGGACCCTCCTACGAGCAGTACTTCGGGCCG	CASSFAGPSYEQYF	In	VDJ	4	199	0.0018839166532551997	0.0023301562024308563	42	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	1	7	0	4	1	26	40	48	44	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAGPSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGATTTGGGACTAGCGGGGGGTTATGTTTTTGCCCAGTACTTCGGGCCA	CASSQEDLGLAGGYVFAQYF	In	VDJ	4	209	0.001978585831810737	0.0024472494789349194	60	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	0	1	9	6	11	15	32	53	38	64		TCRBV03-01,TCRBV03-02												CASSQEDLGLAGGYVFAQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTTACAGGTTGCGACACCCCTCCACTTTGGGAAC	CASSFLQVATPLHF	In	VDJ	4	217	0.0020543211746551675	0.00254092410013817	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	4	11	3	6	26	40	48	43	54		TCRBV12-03,TCRBV12-04												CASSFLQVATPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCCCATGACAGGGAGGAGGTCTACACCTTCGGTTCG	CASSSHDREEVYTF	In	VDJ	4	253	0.002395130217455103	0.0029624598955527975	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	10	6	7	24	36	49	42	56		TCRBV24-01,TCRBV24-or09_02												CASSSHDREEVYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCCTGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLALTGGTGELFF	In	VDJ	6	330	0.003124082892332743	0.0038640781246340834	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	1	4	3	0	26	43	-1	46	55		TCRBV12-03,TCRBV12-04												CASSLALTGGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCATAGTGGGTGGGAGAACACTGAAGCTTTCTTTGGACAA	CSAHSGWENTEAFF	In	VDJ	7	367	0.0034743588529882324	0.004297323247699117	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	8	1	10	0	26	35	-1	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAHSGWENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTCTCAGGGATCGGTTCACCCCTCCACTTTGGGAAC	CASSQVSGIGSPLHF	In	VDJ	7	374	0.003540627277977109	0.004379288541251961	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	4	3	9	3	5	23	39	47	42	52	TCRBV01,TCRBV04													CASSQVSGIGSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCGGGGCGGGGAGAGGGACTGAAGCTTTCTTTGGACAA	CSARDPGAGRGTEAFF	In	VDJ	9	486	0.004600922077799131	0.005690733238097469	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	7	3	5	7	6	26	40	53	47	59		TCRBV20-01,TCRBV20-or09_02												CSARDPGAGRGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCGGGGGGCGGTGAAAAACTGTTTTTTGGCAGT	CASRPGGGEKLFF	In	VDJ	9	531	0.00502693338129905	0.006217652982365753	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	6	8	1	7	2	3	26	37	46	39	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGGGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD02-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCCGGGTAGCGGGAGTTACAATGAGCAGTTCTTCGGGCCA	CASTPGSGSYNEQFF	In	VDJ	11	607	0.005746419138321137	0.007107561883796632	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	5	2	4	10	1	24	31	50	41	51	TCRBV09,TCRBV21													CASTPGSGSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCTGACTAGCGGGGGGCGTGGAGATACGCAGTATTTTGGCCCA	CSASLTSGGRGDTQYF	In	VDJ	17	983	0.009305980252009353	0.011510269080349406	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	2	1	5	3	5	26	37	53	40	58		TCRBV20-01,TCRBV20-or09_02												CSASLTSGGRGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTCAGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGQGAYEQYF	In	VDJ	29	1614	0.01527960541886378	0.01889885482775579	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	1	2	2	0	26	42	-1	44	51		TCRBV03-01,TCRBV03-02												CASSQGQGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCACCTGACAGGCGCTCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	43	2442	0.0231182134032623		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	4	4	3	6	24	37	46	40	52	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGACAGGGGGAACAATGAGCAGTTCTTCGGGCCA	CSARDLDRGNNEQFF	In	VDJ	78	4380	0.0414651002073255	0.05128685510877965	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	1	5	4	1	26	40	53	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDLDRGNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCGCCCGGGGGGAGCGCCGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLAPGGSAAYNEQFF	In	VDJ	101	5710	0.05405610095521201	0.06686026088382005	54	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	1	2	3	7	26	43	53	46	60		TCRBV12-03,TCRBV12-04												CASSLAPGGSAAYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGGACTCGCCGAAGCGAGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	2.650736999555055E-4		49	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	2	10	4	0	18	25	-1	40	36	58						01,02								X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGAGCCCGACGGTCGGGAAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	32	3.0294137137772055E-4		53	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	8	3	2	12	2	22	38	55	50	57													Vb 7.1	X+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCAAGGCAGGCCTAGTGAAAAACTGTTTTTTGGCAGT	CASSQDQGRPSEKLFF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	48	TCRBV04	TCRBV04-01	01				TCRBJ01	TCRBJ01-04	01	0	4	4	7	6	5	23	40	50	46	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 7.1	CASSQDQGRPSEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACAGGGGGCTCCAAGAGACCCAGTACTTCGGGCCA	CASSQDRGLQETQYF	In	VDJ	1	35	3.3134212494438187E-4	4.09826467764221E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	1	0	1	23	-1	48	40	49													Vb 7.1	CASSQDRGLQETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAACTAGCGGGGGGTGGGAATGAGCAGTTCTTCGGGCCA	CASSQELAGGGNEQFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	1	7	0	4	23	-1	52	40	56													Vb 7.1	CASSQELAGGGNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTAATACGTCAGCGAGGTTCACCCCTCCACTTTGGGAAC	CASSQVIRQRGSPLHF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	1	6	6	9	9	3	23	39	52	48	55						01,02							Vb 7.1	CASSQVIRQRGSPLHF+TCRBV04-01+TCRBJ01-06	TCRBV04-01*01	TCRBD02-01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGAGAGGCCAGGGCCTTAGAAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	84	7.952210998665165E-4		58	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	1	7	7	23	40	52	47	59													Vb 7.1	X+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGACCTTACGGGGTCCGACATACACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	142	0.001344302335488635		52	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	3	5	8	23	40	50	45	58													Vb 7.1	X+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTCCGGACCTAGCGGGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSSGPSGGDTDTQYF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	51	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	2	6	1	22	35	53	41	54														CASSSGPSGGDTDTQYF+TCRBV12-01+TCRBJ02-03	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCCACGTCCGTAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	59	5.585481534776723E-4		52	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	10	5	22	34	49	44	54														X+TCRBV12-01+TCRBJ02-06	TCRBV12-01*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GCCTATATTTCTGTGCCAGCAGCTCTCGGGACTAGCGGGAGAATTTTGGACGCGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	73	6.91085003455425E-4		64	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	0	2	0	3	11	11	24	41	27	52														X+TCRBV12-01+TCRBJ02-02	TCRBV12-01*01	TCRBD02-01*02	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGCCCCCGGACAAGGGGCCGGGGAGCTGTTTTTTGGAGAA	CATSRAPGQGAGELFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	1	6	6	7	5	18	32	44	39	49														CATSRAPGQGAGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTTGCAGGGGGGGTCCAAGAGACCCAGTACTTCGGGCCA	CASSFAGGVQETQYF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-05	01	5	4	1	1	4	3	18	30	41	34	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAGGVQETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGTGGGGGCCTAATCAGCCCCAGCATTTTGGTGAT	CATSRWGPNQPQHF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	6	0	4	2	2	18	32	40	34	42														CATSRWGPNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGGGGGCATTGATGGCTACACCTTCGGTTCG	CATSRVGGIDGYTF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-02	01	1	6	0	6	2	4	18	34	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVGGIDGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGTAGAGCCTACGCTGAAGCTTTCTTTGGACAA	CATSRGRAYAEAFF	In	VDJ	1	43	4.07077467788812E-4	5.035010889674715E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	4	9	6	7	2	18	34	44	41	46						01,02								CATSRGRAYAEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTACAGTGCGACTAATGAAAAACTGTTTTTTGGCAGT	CATSRDYSATNEKLFF	In	VDJ	1	45	4.2601130349991954E-4	5.269197442682841E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	5	2	2	4	18	35	41	37	45														CATSRDYSATNEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCACCCGCGAGACAGGGAGGAGCTACACCTTCGGTTCG	CATSTRETGRSYTF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	9	7	4	18	31	45	38	49														CATSTRETGRSYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGGACAGGGGACTACGAGCAGTACTTCGGGCCG	CATSRGTGDYEQYF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	2	3	0	1	18	-1	43	34	44														CATSRGTGDYEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAAAGGGACAACCCCTCACTGAAGCTTTCTTTGGACAA	CATSRKGQPLTEAFF	In	VDJ	1	65	6.153496606109949E-4	7.611062972764104E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	4	2	6	18	33	41	35	47														CATSRKGQPLTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGGGTTGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CATSRGLTGGTEAFF	In	VDJ	1	81	7.668203462998552E-4	9.484555396829114E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	4	6	0	18	32	-1	38	47														CATSRGLTGGTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGCGGGACAGGGGGGATGAACACTGAAGCTTTCTTTGGACAA	CATSSGTGGMNTEAFF	In	VDJ	2	85	8.046880177220702E-4	9.952928502845366E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	1	0	1	2	18	32	44	33	46														CATSSGTGGMNTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCCGCTCCACTCGGGGCGGCTACAATGAGCAGTTCTTCGGGCCA	CATRSTRGGYNEQFF	In	VDJ	2	88	8.330887712887315E-4	0.0010304208332357556	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	8	7	0	3	10	2	18	27	42	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRSTRGGYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCGGGCGGGGGATGTCGACGAAGACTGAAGCTTTCTTTGGACAA	CATSRGGRGMSTKTEAFF	In	VDJ	2	97	9.182910319887154E-4	0.0011358047820894124	54	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	2	5	4	12	18	34	45	38	57														CATSRGGRGMSTKTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCATTTTCAGGACTGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CATIFRTGSYNSPLHF	In	VDJ	2	98	9.277579498442692E-4	0.0011475141097398187	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	1	10	0	6	2	18	28	39	34	41						01,02								CATIFRTGSYNSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01	TCRBD02-01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGCTCACGAGGGAACGAATTGTGAGCAATCAGCCCCAGCATTTTGGTGAT	CATSRLTRERIVSNQPQHF	In	VDJ	2	104	9.845594569775917E-4	0.0012177700756422565	57	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	0	1	6	11	18	32	43	38	54														CATSRLTRERIVSNQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGTCGCAGACAGGGATCTTCTATGGCTACACCTTCGGTTCG	CATSRSQTGIFYGYTF	In	VDJ	2	111	0.0010508278819664682	0.001299735369195101	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	3	4	6	5	18	32	45	38	50														CATSRSQTGIFYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGAGCTCGATTCTGGCTACACCTTCGGTTCG	CATSRDELDSGYTF	In	VDJ	5	303	0.0028684761102327917	0.003547926278073113	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	6	7	7	2	7	18	35	40	37	47						01,02								CATSRDELDSGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAATCCGGCGGGTCAGAAAGAGACCCAGTACTTCGGGCCA	CASSLNPAGQKETQYF	In	VDJ	1	17	1.6093760354441404E-4	1.9905857005690734E-4	48	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	7	4	3	6	5	18	33	44	39	49						01,02								CASSLNPAGQKETQYF+TCRBV07-02+TCRBJ02-05	TCRBV07-02*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAGCCTTTGGGAACAAGACCAATACAATGAGCAGTTCTTCGGGCCA	CASSLSLWEQDQYNEQFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	54	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-01	01	2	0	8	4	7	10	18	33	44	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSLWEQDQYNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAAGCATGAACACTGAAGCTTTCTTTGGACAA	CASSLSMNTEAFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	6	7	0	0	1	18	-1	36	33	37						01,02								CASSLSMNTEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTCGCCATCTCGCCCCCCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	15	1.4200376783330651E-4		52	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	2	4	6	7	6	11	18	33	41	39	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTCCCAGGGTCCCTATGGCTACACCTTCGGTTCG	CASSLGSQGPYGYTF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	4	5	3	18	34	44	39	47														CASSLGSQGPYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAAGCCGGGACACAAAACTATGGCTACACCTTCGGTTCG	CASSQAGTQNYGYTF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	2	6	3	18	30	42	36	45														CASSQAGTQNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG	CASSSGTGGYEQYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	3	2	0	18	31	-1	33	44														CASSSGTGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTCCTGCCTCGGGCAGACAATCAGCCCCAGCATTTTGGTGAT	CASSPLLPRADNQPQHF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	8	0	3	13	3	18	30	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLLPRADNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCAAATCTAGCGGACACAGATACGCAGTATTTTGGCCCA	CASSANLADTDTQYF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	5	2	6	1	18	30	43	36	44						01,02								CASSANLADTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAAGTAGCGGGAACCTTCTTGAGACCCAGTACTTCGGGCCA	CASSQSSGNLLETQYF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	5	3	5	5	8	18	30	43	35	51														CASSQSSGNLLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAAACGTCGGCGGGGAGTTCTACGAGCAGTACTTCGGGCCG	CASSPNVGGEFYEQYF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	3	3	10	4	18	30	46	40	50														CASSPNVGGEFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAACCCCGGACAAGTTGAGGGATGGCTACACCTTCGGTTCG	CASSSTPDKLRDGYTF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	4	1	6	6	7	9	18	31	43	38	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSTPDKLRDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGGCCAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLEGPSNQPQHF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	7	0	1	0	2	18	-1	40	35	42														CASSLEGPSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGCCGTCACCAATGAGCAGTTCTTCGGGCCA	CASSLDAVTNEQFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	0	3	7	6	7	0	18	35	-1	42	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDAVTNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGAGGGGATGGTCAGCCCCAGCATTTTGGTGAT	CASSLGGDGQPQHF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	0	6	0	5	18	-1	39	32	44														CASSLGGDGQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGCCAGGGGGAGGGGAGGTAGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	20	1.8933835711107535E-4		53	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	4	1	4	6	11	18	30	43	36	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTCATACAGGGTAGATGAATTCACCCCTCCACTTTGGGAAC	CASSPHTG*MNSPLHF	Stop	VDJ	1	20	1.8933835711107535E-4		48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	7	6	6	18	30	42	36	48														CASSPHTG*MNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGAGGGGGCGGGTGGAGACCCAGTACTTCGGGCCA	CASSLERGRVETQYF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	5	1	5	18	35	43	36	48														CASSLERGRVETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGCAGGGGGCGTTCAATGAGCAGTTCTTCGGGCCA	CASSLQGAFNEQFF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	0	6	1	3	18	32	41	33	44														CASSLQGAFNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGGATAACTGAAAAACTGTTTTTTGGCAGT	CASSLQGITEKLFF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	2	7	0	5	18	-1	39	33	44														CASSLQGITEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGAAAGAGGATCTCTGAAGCTTTCTTTGGACAA	CASSPGKRISEAFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	3	6	1	10	18	30	36	31	46														CASSPGKRISEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTCGGGACATTTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVRDISNTGELFF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	0	4	3	18	30	40	34	43														CASSVRDISNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACCTCCGCTTCGGACGGCTACACCTTCGGTTCG	CASSLGTSASDGYTF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	1	7	8	0	13	18	-1	38	34	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGTSASDGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTCCGGGACAGGGGGTGATTACTACGAGCAGTACTTCGGGCCG	CASSFSGTGGDYYEQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	0	1	3	4	6	18	32	47	36	53														CASSFSGTGGDYYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGGGACACCGTCCTACGAGCAGTACTTCGGGCCG	CASSLGTPSYEQYF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	1	3	3	18	30	39	33	42														CASSLGTPSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGCTGGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	2.2720602853329043E-4		41	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	4	0	9	18	-1	34	30	43														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCAGGGGTCGAGCGGGGAGCTGTTTTTTGGAGAA	CASSFQGSSGELFF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	2	7	1	5	18	32	39	33	44														CASSFQGSSGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTACTCAGGGGCTACGTACGAGCAGTACTTCGGGCCG	CASSLYSGATYEQYF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	4	5	5	18	32	43	37	48														CASSLYSGATYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCCGGGACAGGGTTCTATGCTAACTATGGCTACACCTTCGGTTCG	CASSPGTGFYANYGYTF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	0	3	7	18	30	42	33	49														CASSPGTGFYANYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAAAATTCTAATTCACCCCTCCACTTTGGGAAC	CASSPGQNSNSPLHF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	6	2	6	18	30	38	32	44														CASSPGQNSNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGACAGTTTAGGGGCCACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	2.461398642443979E-4		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	5	3	2	11	18	31	38	33	49														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGGACTAGCGGGGAAGGAGACCCAGTACTTCGGGCCA	CASSWGLAGKETQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	5	1	3	18	31	45	32	48														CASSWGLAGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACCTCGGGAATTGAGCCGGGGGAGCAGTACTTCGGGCCG	CASTSGIEPGEQYF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	8	3	7	15	0	18	28	-1	43	48						01,02								CASTSGIEPGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCAGACAGGGGTTGGAATAATTCACCCCTCCACTTTGGGAAC	CASSADRGWNNSPLHF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	2	5	3	5	18	30	41	33	46														CASSADRGWNNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACTAGCGGGGGACTTAGAGACCCAGTACTTCGGGCCA	CASSPGLAGDLETQYF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	4	3	4	18	30	46	33	50														CASSPGLAGDLETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATATCGAGTTCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	28	2.650736999555055E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	5	5	9	0	18	35	-1	44	47						01,02								X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACACTTCTTTTATCTCAGCCCCAGCATTTTGGTGAT	CASSPTLLLSQPQHF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	5	3	6	6	3	11	18	30	36	33	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTLLLSQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGTGGGCAAATGAAAAACTGTTTTTTGGCAGT	CASSLQWANEKLFF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	5	2	6	18	30	36	32	42														CASSLQWANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGACAGCCTCTGGAAACACCATATATTTTGGAGAG	CASSFGTASGNTIYF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	0	5	0	1	1	18	32	40	33	41														CASSFGTASGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGCGGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSRGTGSYEQYF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	1	3	0	18	30	-1	33	42														CASSRGTGSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATTAACCGGGACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	32	3.0294137137772055E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	2	7	0	18	30	-1	37	47														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCGACAGGGTCGTACGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSSPTGSYATNEKLFF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	54	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	3	0	4	7	18	31	42	35	49														CASSSPTGSYATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATAGGGCAGGGCCCCTACGAGCAGTACTTCGGGCCG	CASSIGQGPYEQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	2	2	2	18	34	41	36	43														CASSIGQGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTCCGGGATGAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	3.1240828923327434E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	3	3	2	6	18	32	39	34	45														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCTAGCAGCCCTCGAGCGGGAGCGGGGGGCGGTGAGCAGTTCTTCGGGCCA	CASSPRAGAGGGEQFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	6	1	9	11	3	18	30	50	41	53														CASSPRAGAGGGEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTCAATGCAGCAAAACTGTTTTTTGGCAGT	CASSSGLNAAKLFF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	0	10	10	1	9	18	31	38	32	47						01,02								CASSSGLNAAKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCACAGGGGGGGAAAAGAGACCCAGTACTTCGGGCCA	CASSHRGGKETQYF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	1	3	2	4	18	29	39	31	43														CASSHRGGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGACAGCTAACACTGAAGCTTTCTTTGGACAA	CASSFGTANTEAFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	5	2	1	2	18	32	40	33	42														CASSFGTANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGTATTTGAAAAACTGTTTTTTGGCAGT	CASSSGTVFEKLFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	7	2	4	18	31	40	33	44														CASSSGTVFEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTAGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLVGSGANVLTF	In	VDJ	1	44	4.1654438564436575E-4	5.152104166178778E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	1	5	3	1	1	0	18	34	-1	35	39				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGSGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACCTCCCGCAAGGATCTAGCGTACCAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	45	4.2601130349991954E-4		58	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	6	2	15	4	18	30	51	45	55						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGCACTTTCCGTGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	45	4.2601130349991954E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	3	9	0	6	0	12	18	-1	35	32	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGGATTGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRDWGTDTQYF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	6	1	3	7	0	18	30	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDWGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCATCGGGACCCCCGGTTACTGAAGCTTTCTTTGGACAA	CASSASGPPVTEAFF	In	VDJ	1	48	4.5441205706658086E-4	5.62047727219503E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	0	7	5	5	8	18	30	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSASGPPVTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTATAGGCCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPYRPDTGELFF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	5	5	4	3	6	4	18	30	39	36	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPYRPDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGYTGELFF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	3	2	1	18	30	42	32	43														CASSPGQGYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGACCCCTCGCGGGGGCCCAATACGAGCAGTACTTCGGGCCG	CASSGPLAGAQYEQYF	In	VDJ	1	55	5.206804820554572E-4	6.440130207723473E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	4	9	5	18	30	46	39	51														CASSGPLAGAQYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGACTAGGTGGGGACACTGAAGCTTTCTTTGGACAA	CASSRLGGDTEAFF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	2	8	3	1	6	18	30	37	31	43						01,02								CASSRLGGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACCCTCTATCCTACGAGCAGTACTTCGGGCCG	CASSLDPLSYEQYF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	9	1	4	0	18	35	-1	39	42						01,02								CASSLDPLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAGCCGGGGACAGGGGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	58	5.490812356221185E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	1	4	6	0	18	30	-1	36	47														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACTGTTAGCGGAAACCAAGAGACCCAGTACTTCGGGCCA	CASTVSGNQETQYF	In	VDJ	1	62	5.869489070443335E-4	7.259783143251915E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	5	5	0	4	2	18	28	38	32	40						01,02								CASTVSGNQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCGGGGCTAGCGGGCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	62	5.869489070443335E-4		50	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	4	4	2	7	3	18	31	46	38	49						01,02								X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCTAGACTCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	67	6.342834963221024E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	10	0	4	1	18	34	42	38	43						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACGCCCAGTCCCTACAGGGGACCTCTCCTACGAGCAGTACTTCGGGCCG	CASSLRPVPTGDLSYEQYF	In	VDJ	1	68	6.437504141776562E-4	7.962342802276293E-4	57	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	3	2	0	12	4	18	33	52	45	56														CASSLRPVPTGDLSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTAGGCGTCTCTGGAAACACCATATATTTTGGAGAG	CARSLGVSGNTIYF	In	VDJ	1	69	6.532173320332099E-4	8.079436078780357E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	6	0	0	1	18	-1	37	34	38						01,02								CARSLGVSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCGACTAGCGGGGGACCTAACTGGGAGCAGTACTTCGGGCCG		Out	VDJ	1	69	6.532173320332099E-4		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	2	2	7	1	10	18	27	40	28	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGCGGGGGGATGTACAATGAGCAGTTCTTCGGGCCA	CASSFSGGMYNEQFF	In	VDJ	1	70	6.626842498887637E-4	8.19652935528442E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	5	1	4	0	3	18	-1	42	32	45														CASSFSGGMYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCACATCTCTCGGGGACCCCAGCACAGATACGCAGTATTTTGGCCCA	CASTSLGDPSTDTQYF	In	VDJ	1	72	6.816180855998712E-4	8.430715908292546E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	7	0	7	0	9	3	18	28	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTSLGDPSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCTGGCGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPLAGTNEKLFF	In	VDJ	1	77	7.2895267487764E-4	9.016182290812861E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	7	4	1	6	0	18	30	-1	36	41						01,02								CASSPLAGTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD02-01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATTGGGCGGCCGCTCTGGAAACACCATATATTTTGGAGAG	CASSLLGGRSGNTIYF	In	VDJ	1	82	7.762872641554089E-4	9.601648673333177E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	2	8	0	0	2	5	18	33	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGGRSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCATGACTAGCGGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	88	8.330887712887315E-4		46	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	5	2	3	1	18	30	42	33	43						01,02								X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGCGGGGGGGGACAGATACGCAGTATTTTGGCCCA	CASSRRGGTDTQYF	In	VDJ	2	91	8.614895248553929E-4	0.0010655488161869745	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	3	2	1	18	30	41	32	42														CASSRRGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCTTCCCGGACGTTCGCTAATGAAAAACTGTTTTTTGGCAGT	CASSPSRTFANEKLFF	In	VDJ	2	94	8.898902784220541E-4	0.0011006767991381934	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	5	1	7	3	7	5	18	30	41	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSRTFANEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACTAGACAGGGGGAGGTTGGCTACACCTTCGGTTCG	CASSTRQGEVGYTF	In	VDJ	2	97	9.182910319887154E-4	0.0011358047820894124	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	1	7	4	4	18	30	43	34	47														CASSTRQGEVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGCCGTCCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPSPYNEQFF	In	VDJ	2	118	0.0011170963069553445	0.001381700662747945	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	5	10	0	2	2	6	18	30	34	32	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPSPYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGGGGACCTCTGGAAACACCATATATTTTGGAGAG	CASSLVGTSGNTIYF	In	VDJ	2	120	0.0011360301426664521	0.0014051193180487577	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	1	0	7	0	2	0	18	34	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGTSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCAGGGTTTGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPRVWANTGELFF	In	VDJ	2	127	0.0012022985676553284	0.0014870846116016019	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	0	2	6	18	30	37	32	43														CASSPRVWANTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCGGCGGGGGCCGTGAAGCTTTCTTTGGACAA	CASSLGGGGREAFF	In	VDJ	2	133	0.0012591000747886512	0.0015573405775040398	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	2	7	3	3	18	34	44	37	47														CASSLGGGGREAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCCGGGGACTAGCGGGAACAATGAGCAGTTCTTCGGGCCA	CASSPPGTSGNNEQFF	In	VDJ	2	136	0.0012875008283553123	0.0015924685604552587	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	0	3	5	6	0	18	30	-1	36	49														CASSPPGTSGNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATTTTAGACTAGTCGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	139	0.0013159015819219737		41	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	4	8	2	0	3	18	-1	39	35	42						01,02								X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCACCCGCGGGACAGCCTATGGCTACACCTTCGGTTCG	CASSPTRGTAYGYTF	In	VDJ	3	166	0.0015715083640219253	0.001943748389967448	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	4	9	1	18	30	46	39	47														CASSPTRGTAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGACAGGGATCACTGAAGCTTTCTTTGGACAA	CASSLGTGITEAFF	In	VDJ	3	170	0.0016093760354441405	0.0019905857005690732	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	4	1	2	18	32	42	33	44														CASSLGTGITEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCTTGGCACGGCCAGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	3	172	0.001628309871155248		46	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-02	01	0	9	0	8	4	7	18	35	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTTCCGGGACAGCTTATGAAAAACTGTTTTTTGGCAGT	CASSSGTAYEKLFF	In	VDJ	3	173	0.0016377767890108016	0.002025713683520292	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	6	4	3	18	29	40	33	43														CASSSGTAYEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCCCTCGGGGGACCCTGGGACTATGGCTACACCTTCGGTTCG	CASSLSLGGPWDYGYTF	In	VDJ	3	177	0.0016756444604330168	0.0020725509941219174	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	2	3	5	8	18	33	44	38	52														CASSLSLGGPWDYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTCCGGGAAGGGGGCCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	178	0.0016851113782885706		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	5	0	2	8	0	18	32	-1	40	47														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTGAACTGGGGGCAGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLVNWGQAGELFF	In	VDJ	3	186	0.0017608467211330007	0.0021779349429755742	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	6	0	6	8	3	18	32	46	40	49														CASSLVNWGQAGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGGCGAAATTCACCCCTCCACTTTGGGAAC	CASSLQGRNSPLHF	In	VDJ	4	213	0.0020164535032329524	0.0024940867895365446	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	2	7	0	3	18	-1	39	33	42														CASSLQGRNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATGGACAGGGGACGAGTGGGAAAAACTGTTTTTTGGCAGT	CASSPWTGDEWEKLFF	In	VDJ	5	257	0.002432997888877318	0.0030092972061544227	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	2	8	4	8	18	30	43	34	51														CASSPWTGDEWEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAACAGGGTAGGTCACCCCTCCACTTTGGGAAC	CASSLEQGRSPLHF	In	VDJ	5	267	0.0025276670674328557	0.003126390482658486	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	3	10	3	4	18	32	41	35	45														CASSLEQGRSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTTCCATTTCGTCTCCCTACGAGCAGTACTTCGGGCCG	CASSLSISSPYEQYF	In	VDJ	5	274	0.002593935492421732	0.00320835577621133	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	5	4	6	2	5	9	18	30	37	35	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSISSPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGCGGGGGCTTAGATACGCAGTATTTTGGCCCA	CASSFGGGLDTQYF	In	VDJ	6	332	0.0031430167280438507	0.003887496779934896	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	5	2	3	18	32	41	34	44														CASSFGGGLDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCATCGAACGGGGGGAACACAGATACGCAGTATTTTGGCCCA	CASSPSNGGNTDTQYF	In	VDJ	7	420	0.003976105499332582	0.004917917613170651	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	1	2	8	2	18	30	45	38	47														CASSPSNGGNTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGTCTGTCAGAAACTATGGTGGGCTACACCTTCGGTTCG	CASSLSLSETMVGYTF	In	VDJ	21	1197	0.01133190067309786	0.014016065197536358	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	3	9	8	12	5	18	33	49	45	54						01,02								CASSLSLSETMVGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGTAGGGACAGGGCATGGCTACACCTTCGGTTCG	CASSLVGTGHGYTF	In	VDJ	38	2137	0.0202308034573184	0.025022833188918292	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	6	4	1	18	32	45	36	46														CASSLVGTGHGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGGCAGGGGGCAGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	48	2710	0.02565534738855071		47	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	3	4	4	18	32	44	36	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGCAGCTTGGGACAGTAAACACTGAAGCTTTCTTTGGACAA	CASSQQLGTVNTEAFF	In	VDJ	91	5102	0.04830021489903532	0.05974098967237301	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	2	9	2	18	30	46	39	48														CASSQQLGTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAATCCGGAGGGGTCCTATGGCTACACCTTCGGTTCG	CASNPEGSYGYTF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	12	10	0	4	9	3	26	31	46	40	49														CASNPEGSYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACGCCCGGGTTGGGACTAGCGGGGGGACCCGCATATACGCAGTATTTTGGCCCA	CASTPGLGLAGGPAYTQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	57	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	0	1	7	15	8	24	29	59	44	67														CASTPGLGLAGGPAYTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCCCCAGGGTACCTATGGCTACACCTTCGGTTCG	CASAPQGTYGYTF	In	VDJ	1	27	2.556067820999517E-4	3.1615184656097044E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	4	5	3	26	36	46	41	49														CASAPQGTYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGTAGTGGGAGCCTCCCGTCTCTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	3.3134212494438187E-4		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	2	5	3	12	26	43	51	46	63														X+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACTCAACCCAGCGGGGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASTQPSGGAYNEQFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	48	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	6	0	4	13	2	26	31	54	44	56														CASTQPSGGAYNEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCAATAATAGCGGGGGTCGAGCAGTACTTCGGGCCG		Out	VDJ	1	41	3.8814363207770444E-4		41	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	2	6	7	1	26	37	53	44	54														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTGAACAGGGCCCGGGGGAGCAGTACTTCGGGCCG	CASGEQGPGEQYF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	7	2	7	26	38	46	40	53														CASGEQGPGEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGCTCTCATACCGGGGAGCTGTTTTTTGGAGAA	CASSHTGELFF	In	VDJ	1	58	5.490812356221185E-4	6.791410037235662E-4	33	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-02	01	9	4	6	5	4	1	26	34	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSHTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTACCGAGGGGGCGAGGAAAAACTGTTTTTTGGCAGT	CASYRGGEEKLFF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	12	5	0	8	9	3	26	31	47	40	50														CASYRGGEEKLFF+TCRBV12-05+TCRBJ01-04	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTGCCGACAGAGCCGCTGAAGCTTTCTTTGGACAA	CASGADRAAEAFF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	6	3	5	26	38	46	41	51														CASGADRAAEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCATCGAGGCGAATAGCGGGGGCATTGGGGATACGCAGTATTTTGGCCCA	CASIEANSGGIGDTQYF	In	VDJ	2	88	8.330887712887315E-4	0.0010304208332357556	51	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	5	2	6	15	7	26	31	55	46	62														CASIEANSGGIGDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCGGCAGCGTGGGGAACACTGAAGCTTTCTTTGGACAA	CAGSVGNTEAFF	In	VDJ	2	95	8.993571962776079E-4	0.0011123861267885997	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	12	6	6	1	4	4	26	31	39	35	43						01,02								CAGSVGNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTGGACACAGGGTCTAACTATGGCTACACCTTCGGTTCG	CASALDTGSNYGYTF	In	VDJ	43	2434	0.02304247806041787	0.02850050350108897	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	3	0	8	1	26	36	50	44	51														CASALDTGSNYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCATCTTGGACAGGGGGCGGGAGACCCAGTACTTCGGGCCA	CAILDRGRETQYF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	1	0	5	4	2	20	27	42	31	44														CAILDRGRETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAACAGAAAACACTGAAGCTTTCTTTGGACAA	CASSQSTENTEAFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	5	2	1	2	20	37	42	38	44														CASSQSTENTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGGGTACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRVPNTGELFF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	6	0	10	0	0	3	20	-1	33	31	36				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVPNTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGAAGGGGCGGGGGCACTGAAGCTTTCTTTGGACAA	CASRRGGGTEAFF	In	VDJ	1	72	6.816180855998712E-4	8.430715908292546E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	7	2	4	5	0	20	31	-1	36	43														CASRRGGGTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTGGCAGGAAAAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSGRKRGNQPQHF	In	VDJ	2	90	8.520226069998391E-4	0.0010538394885365682	45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-05	01	5	4	4	2	2	7	20	32	38	34	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRKRGNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTCAGCACAGGGTGGGATTGGCGAAAAACTGTTTTTTGGCAGT	CASSSAQGGIGEKLFF	In	VDJ	2	102	9.656256212664842E-4	0.001194351420341444	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	3	8	6	10	20	31	43	37	53														CASSSAQGGIGEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAAAAGTCAGGGGGACAGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	235	0.0022247256960551353		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	5	2	9	0	20	30	-1	39	46														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGGGCGGGGGGGCCGTGATACGCAGTATTTTGGCCCA	CASSYEGRGGRDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	0	6	5	4	23	38	52	43	56														CASSYEGRGGRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAAGCGGGGGCCCGCGGGGTACGCAGTATTTTGGCCCA	CASSYSSGGPRGTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	2	8	1	9	23	40	49	41	58														CASSYSSGGPRGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTACAGGGGAATTCACCCCTCCACTTTGGGAAC	CASSYLQGNSPLHF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	3	2	7	1	0	23	39	-1	40	47														CASSYLQGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCCGGGACCGGTGGAAACACCATATATTTTGGAGAG	CASRAGTGGNTIYF	In	VDJ	1	16	1.5147068568886028E-4	1.8734924240650103E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	6	0	7	3	4	3	23	34	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAGTGGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGCGAGGACAGATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	1.5147068568886028E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	2	6	2	23	35	47	41	49														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCTAGAGGGGGGCGCCTATGGCTACACCTTCGGTTCG	CASLEGGAYGYTF	In	VDJ	1	18	1.704045213999678E-4	2.1076789770731365E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	8	5	1	4	4	4	23	32	42	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLEGGAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTCAGACAGGGGGTCACGGCTTTCTTTGGACAA	CASSVRQGVTAFF	In	VDJ	1	19	1.798714392555216E-4	2.2247722535771996E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	11	4	5	23	35	48	39	53														CASSVRQGVTAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACGAATTTTCAGCCCCAGCATTTTGGTGAT	CASSSGTNFQPQHF	In	VDJ	1	20	1.8933835711107535E-4	2.3418655300812627E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	0	7	6	2	6	23	36	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTNFQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCCGTCGGACCAGATACGCAGTATTTTGGCCCA	CASSDSVGPDTQYF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	1	7	4	4	0	23	40	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSVGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGATCCGGACTAGCGGGGGGCCAAAGCTCCTACGAGCAGTACTTCGGGCCG	CASSRSGLAGGQSSYEQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	1	1	0	7	6	23	34	55	41	61														CASSRSGLAGGQSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTTGGGGCCCGCGGCTACGAGCAGTACTTCGGGCCG	CASSVGARGYEQYF	In	VDJ	1	22	2.0827219282218288E-4	2.576052083089389E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	7	0	3	3	6	23	35	43	38	49														CASSVGARGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACGTCAGCGGGGGGACCAGATACGCAGTATTTTGGCCCA	CASSTSAGGPDTQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	1	4	5	2	23	35	49	40	51														CASSTSAGGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGGGAGGATGGTCTAACTATGGCTACACCTTCGGTTCG	CASKGGWSNYGYTF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	9	1	0	1	5	23	33	40	34	45														CASKGGWSNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGACAGGGGAGAGACCCAGTACTTCGGGCCA	CASSDRGETQYF	In	VDJ	1	24	2.2720602853329043E-4	2.810238636097515E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	2	4	1	0	23	34	-1	35	43														CASSDRGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGTCTTTCCGTAGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	2.2720602853329043E-4		50	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	23	35	-1	54	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTACAAGCGGGCCAAGCACAGATACGCAGTATTTTGGCCCA	CASSPTSGPSTDTQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	6	4	0	6	3	23	35	47	41	50						01,02								CASSPTSGPSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGGGGCGGCAGGGGGGGTCCAGCCCCAGCATTTTGGTGAT	CASRGAAGGVQPQHF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	4	1	7	8	4	23	34	49	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGAAGGVQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTTGGGGGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGGSNQPQHF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	9	0	1	3	0	23	34	-1	37	44														CASSLGGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACGCGGCTTATGCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	28	2.650736999555055E-4		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	7	5	4	3	14	23	36	43	39	57						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCCCCCAAGGGTGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	2.7454061781105924E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	5	3	4	9	3	23	35	48	44	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGGACACTAAACTATGGCTACACCTTCGGTTCG	CASSSGTLNYGYTF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	6	2	2	3	23	36	44	38	47														CASSSGTLNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGACAGGCCATAATTCACCCCTCCACTTTGGGAAC	CASGTGHNSPLHF	In	VDJ	1	29	2.7454061781105924E-4	3.395705018617831E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	4	5	0	2	23	-1	40	32	42														CASGTGHNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGGGGACAGGAGGAGCGTTAGACATTCAGTACTTCGGCGCC	CASSGGTGGALDIQYF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	0	4	8	3	11	23	35	46	38	57														CASSGGTGGALDIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCCGATCAGAAAGCCCGAACACTGAAGCTTTCTTTGGACAA	CAIRSESPNTEAFF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	10	4	5	1	6	7	23	30	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAIRSESPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTGGACAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSPGQGSYEQYF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	1	3	0	4	0	23	34	-1	38	46														CASSPGQGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGGACAAAAGCTATGGCTACACCTTCGGTTCG	CASSRDKSYGYTF	In	VDJ	1	31	2.9347445352216676E-4	3.6298915716259574E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	6	4	1	4	23	35	42	36	46														CASSRDKSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCTTCACAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	31	2.9347445352216676E-4		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	5	0	7	0	23	35	-1	42	46														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGCTGCACGGCGACAGGGTCAACGAGCAGTACTTCGGGCCG	CASKLHGDRVNEQYF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	3	5	11	3	23	33	51	44	54														CASKLHGDRVNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACTTACAGGGTAACACTGAAGCTTTCTTTGGACAA	CASSNLQGNTEAFF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	3	2	1	1	23	39	46	40	47														CASSNLQGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCGGAACACTGAAGCTTTCTTTGGACAA	CASSYSRNTEAFF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	7	6	1	0	0	23	-1	-1	40	43						01,02								CASSYSRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCTCTAGCGGACAAGAGACCCAGTACTTCGGGCCA	CAISVSSGQETQYF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	5	2	4	1	23	35	46	39	47						01,02								CAISVSSGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCTCGGTGGGGTGGAATCAAGAGACCCAGTACTTCGGGCCA	CAISVGWNQETQYF	In	VDJ	1	32	3.0294137137772055E-4	3.7469848481300205E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	10	6	2	2	7	6	23	30	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISVGWNQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSARGNTEAFF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	3	0	23	35	-1	38	43														CASSARGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAAGACAGGAGCCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	34	3.218752070888281E-4		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	2	1	3	23	37	44	38	47														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTGCCGACAATGAGCAGTTCTTCGGGCCA	CASSYSTADNEQFF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	2	10	5	0	4	23	-1	44	40	48						01,02								CASSYSTADNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGGACAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASRGDSSYNSPLHF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	0	2	0	23	34	-1	36	43														CASRGDSSYNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTACCACAGGGAACACTGAAGCTTTCTTTGGACAA	CAISTTGNTEAFF	In	VDJ	1	36	3.408090427999356E-4	4.215357954146273E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	1	3	0	23	35	-1	38	43														CAISTTGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCGGGACCGCGAACACTGAAGCTTTCTTTGGACAA	CASSYPGTANTEAFF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	0	7	1	3	3	23	38	46	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPGTANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGAAGGCGGGGGGTCTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	37	3.502759606554894E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	1	3	6	3	23	40	54	46	57														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTGGGCAGGGTAACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRLGRVTGANVLTF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	3	2	6	3	23	34	45	40	48														CASRLGRVTGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACATTAGCGGGAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDISGRNTGELFF	In	VDJ	1	41	3.8814363207770444E-4	4.8008243366665885E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	5	2	1	5	0	23	35	-1	40	49														CASSDISGRNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACACCGCAGGGCTCCTACGAGCAGTACTTCGGGCCG	CASTPQGSYEQYF	In	VDJ	1	45	4.2601130349991954E-4	5.269197442682841E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	3	0	5	0	23	33	-1	38	43														CASTPQGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATCCGGACTAGCGGGGGGGGAGTGGATACGCAGTATTTTGGCCCA	CASSIRTSGGGVDTQYF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	0	6	4	5	23	35	54	39	59														CASSIRTSGGGVDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATAGAGACAGGGGGACCCTACGAGCAGTACTTCGGGCCG	CASIETGGPYEQYF	In	VDJ	1	46	4.354782213554733E-4	5.386290719186904E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	2	1	2	4	2	23	33	46	37	48														CASIETGGPYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAGGAAGGGTGAGGCTACACCTTCGGTTCG		Out	VDJ	1	47	4.4494513921102707E-4		37	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	6	5	3	8	7	3	23	34	45	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTGGAAAAGGCAGGGGTTCGTCGAGACCCAGTACTTCGGGCCA	CASWKRQGFVETQYF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	4	2	5	9	6	23	32	47	41	53														CASWKRQGFVETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCGGACCTCTACGAGCAGTACTTCGGGCCG	CAISADLYEQYF	In	VDJ	1	47	4.4494513921102707E-4	5.503383995690967E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	1	7	3	2	2	23	35	41	37	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISADLYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGACAGCAAAGAGCTAGGGATACGCAGTATTTTGGCCCA	CASSRQQRARDTQYF	In	VDJ	1	49	4.638789749221346E-4	5.737570548699093E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	6	2	12	23	34	41	36	53														CASSRQQRARDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCTTCGGGCGACAGGGGTCTGATCAGCCCCAGCATTTTGGTGAT	CASSTFGRQGSDQPQHF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	5	10	4	23	35	53	45	57														CASSTFGRQGSDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCAAAAAACACCACAACACTGAAGCTTTCTTTGGACAA	CASIKKHHNTEAFF	In	VDJ	1	51	4.828128106332421E-4	5.97175710170722E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	6	2	7	4	23	33	43	40	47														CASIKKHHNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGTCGGCCCAGGCTAAAAACATTCAGTACTTCGGCGCC	CASKSAQAKNIQYF	In	VDJ	1	52	4.922797284887959E-4	6.088850378211283E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	7	4	4	4	8	2	23	33	45	41	47														CASKSAQAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGACGGACATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRRTYSNQPQHF	In	VDJ	1	54	5.112135641999034E-4	6.323036931219409E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	1	6	0	4	2	23	32	41	36	43														CASRRTYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCACAGGGAGGGAATGAGCAGTTCTTCGGGCCA	CASSAQGGNEQFF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	7	5	0	23	35	-1	40	47														CASSAQGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTGTGGGACTAGTGAGTAATGAGCAGTTCTTCGGGCCA	CASGVGLVSNEQFF	In	VDJ	1	56	5.30147399911011E-4	6.557223484227536E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	0	8	7	5	5	23	32	45	37	50						01,02								CASGVGLVSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATTCGGGTAGGAAAGCTTTCTTTGGACAA	CASSDSGRKAFF	In	VDJ	1	59	5.585481534776723E-4	6.908503313739725E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	9	4	5	23	35	43	39	48						01,02								CASSDSGRKAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGCCGTGGGAACACTGAAGCTTTCTTTGGACAA	CASSSRGNTEAFF	In	VDJ	1	64	6.058827427554411E-4	7.493969696260041E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	4	5	1	0	6	23	-1	37	34	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSRGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGGGTAAAGGCTACACCTTCGGTTCG	CASSPGGKGYTF	In	VDJ	1	67	6.342834963221024E-4	7.84524952577223E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	2	8	2	4	23	35	43	37	47														CASSPGGKGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGCCGGGTGGGGGACACTGAAGCTTTCTTTGGACAA	CASRRRVGDTEAFF	In	VDJ	1	70	6.626842498887637E-4	8.19652935528442E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	6	6	1	3	9	0	23	34	-1	43	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRRVGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGAGAGAAGGGGCATAGAGATACGCAGTATTTTGGCCCA	CASSREKGHRDTQYF	In	VDJ	1	78	7.384195927331938E-4	9.133275567316925E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	2	5	8	5	23	34	47	42	52														CASSREKGHRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGCACCTACGAGCAGTACTTCGGGCCG	CASSYSRGTYEQYF	In	VDJ	1	82	7.762872641554089E-4	9.601648673333177E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	0	5	2	2	1	2	23	40	46	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTGGGGACTCCTACCAAAAACATTCAGTACTTCGGCGCC	CASSDLGTPTKNIQYF	In	VDJ	1	83	7.857541820109627E-4	9.71874194983724E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	1	0	10	2	2	4	23	39	47	41	51						01,02								CASSDLGTPTKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACTCCGGGGCCTCTGGAAACACCATATATTTTGGAGAG	CASDSGASGNTIYF	In	VDJ	2	85	8.046880177220702E-4	9.952928502845366E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	8	7	0	0	6	0	23	32	-1	38	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASDSGASGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGGACAGGCTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASNGQANSNQPQHF	In	VDJ	2	94	8.898902784220541E-4	0.0011006767991381934	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	4	0	2	4	23	33	42	35	46														CASNGQANSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGCCTCGCTTTGCTAGCGGGGGGGAGAAGACCCAGTACTTCGGGCCA		Out	VDJ	2	95	8.993571962776079E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	0	6	11	3	23	39	62	50	65														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGGGACTATGGCTACACCTTCGGTTCG	CASSWGDYGYTF	In	VDJ	2	96	9.088241141331617E-4	0.001124095454439006	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	9	1	3	0	0	23	-1	-1	36	42														CASSWGDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGGACAGGTTGGACCGGGGAGCTGTTTTTTGGAGAA	CASSAGTGWTGELFF	In	VDJ	2	99	9.37224867699823E-4	0.001159223437390225	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	4	5	3	4	23	35	46	38	50														CASSAGTGWTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGACAGGGGCTAGGCGGGGAGCTGTTTTTTGGAGAA	CASSSRQGLGGELFF	In	VDJ	2	100	9.466917855553768E-4	0.0011709327650406313	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	2	7	3	5	23	36	47	39	52														CASSSRQGLGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTCCTAGGGACTGAAGCTTTCTTTGGACAA	CASSDFLGTEAFF	In	VDJ	2	101	9.561587034109306E-4	0.0011826420926910376	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	5	3	5	4	0	23	39	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDFLGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGAAGCGCCGGGGAGACCCAGTACTTCGGGCCA	CASSYGSAGETQYF	In	VDJ	2	107	0.001012960210544253	0.0012528980585934755	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	6	6	5	3	5	23	38	45	41	50						01,02								CASSYGSAGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATCCACAGGGAGGAGGCTACACCTTCGGTTCG	CASSDPQGGGYTF	In	VDJ	2	108	0.0010224271283998069	0.0012646073862438818	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	3	3	8	5	4	23	35	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPQGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCGGGCCGGGGCAGTTGTCCTTTTGTCCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	108	0.0010224271283998069		56	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	7	0	2	6	15	23	34	45	40	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACCCGCTAGACAGGGGGATGGCTACACCTTCGGTTCG	CASRPARQGDGYTF	In	VDJ	2	119	0.0011265632248108983	0.0013934099903983514	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	6	8	0	23	34	-1	42	51														CASRPARQGDGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGCACAAATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	139	0.0013159015819219737		40	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	3	6	2	3	3	23	35	41	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGACAAGAAGCTTTCTTTGGACAA	CASSYRGQEAFF	In	VDJ	3	149	0.0014105707604775114	0.0017446898199105407	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	8	2	1	23	38	46	40	47														CASSYRGQEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSYSGLAKNIQYF	In	VDJ	3	172	0.001628309871155248	0.002014004355869886	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	0	10	0	0	0	23	-1	-1	40	46						01,02								CASSYSGLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01	TCRBJ02-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTACTCCAGGGGGCCCGAGAGACCCAGTACTTCGGGCCA	CASRLLQGARETQYF	In	VDJ	3	177	0.0016756444604330168	0.0020725509941219174	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	0	4	7	3	23	34	49	41	52														CASRLLQGARETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCGACAGGGCCAGATACGCAGTATTTTGGCCCA	CAISSTGPDTQYF	In	VDJ	3	179	0.0016945782961441244	0.00209596964942273	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	3	4	3	1	23	34	44	37	45														CAISSTGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAAGGGGGACAGGGGGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	4	207	0.00195965199609963		43	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	3	5	0	23	34	-1	39	50														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGGCTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	4	220	0.002082721928221829		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	0	6	0	0	23	-1	-1	38	45														X+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGACAGGCGGAACACTGAAGCTTTCTTTGGACAA	CASSPDRRNTEAFF	In	VDJ	4	223	0.0021111226817884902	0.002611180066040608	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	1	2	2	23	35	44	37	46														CASSPDRRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGACAGGGAGTGAAAAACTGTTTTTTGGCAGT	CASGTGSEKLFF	In	VDJ	4	241	0.002281527203188458	0.0028219479637479217	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	0	3	7	0	2	23	-1	41	32	43														CASGTGSEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTGGGGGCCGGTGAAGCTTTCTTTGGACAA	CASSVGAGEAFF	In	VDJ	5	267	0.0025276670674328557	0.003126390482658486	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	6	0	7	2	3	23	35	43	37	46														CASSVGAGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTGCCACGGACAGGGGTGAGCACTGAAGCTTTCTTTGGACAA	CASSLPRTGVSTEAFF	In	VDJ	5	286	0.0027075385066883777	0.0033488677080162057	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	4	7	4	23	35	51	42	55														CASSLPRTGVSTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTCAGAATACAGGGGCTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	6	338	0.0031998182351771734		49	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	0	8	2	23	36	51	44	53														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATCCTTACGACAGGGTATCGGGAAACACCATATATTTTGGAGAG	CASRDPYDRVSGNTIYF	In	VDJ	12	669	0.006333368045365471	0.007833540198121824	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	3	4	10	5	23	34	51	44	56														CASRDPYDRVSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACGACTACAGGGGTCACGAGCAGTACTTCGGGCCG	CASDDYRGHEQYF	In	VDJ	26	1466	0.013878501576241823	0.017165874335495657	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	3	2	5	7	2	23	32	46	39	48														CASDDYRGHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACACTTACTCTGGAAACACCATATATTTTGGAGAG	CASSRDTYSGNTIYF	In	VDJ	31	1731	0.01638723480796357	0.020268846162853328	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	6	0	1	4	23	35	42	36	46														CASSRDTYSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCCAATGGGAGGCTCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	41	2308	0.021849646410618095		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	9	1	0	7	4	23	35	48	42	52														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGGGACCGGGACTAGCAAGGCCGGGGAGCTGTTTTTTGGAGAA	CAIGTGTSKAGELFF	In	VDJ	50	2806	0.02656417150268387	0.032856373387040116	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	10	0	7	6	8	4	23	30	47	38	51						01,02								CAIGTGTSKAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGCAACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSATGGTDTQYF	In	VDJ	1	15	1.4200376783330651E-4	1.7563991475609471E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	1	4	0	24	35	-1	39	46													Vb 18	CASSATGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCGACAGGGTGATAATTCACCCCTCCACTTTGGGAAC	CASSPRQGDNSPLHF	In	VDJ	1	21	1.9880527496662911E-4	2.458958806585326E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	3	5	2	2	24	38	47	40	49													Vb 18	CASSPRQGDNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCCGACAGGGGACCCTGTGGAGCAGTACTTCGGGCCG	CASSPPTGDPVEQYF	In	VDJ	1	23	2.1773911067773664E-4	2.693145359593452E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	2	7	3	8	24	38	49	41	57													Vb 18	CASSPPTGDPVEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGCACAGATACGCAGTATTTTGGCCCA		Out	VJ	1	25	2.366729463888442E-4		37	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	1	0	0	0	0	0	24	-1	-1	-1	40													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCAACAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSPPTGTGELFF	In	VDJ	1	25	2.366729463888442E-4	2.927331912601578E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	3	5	4	0	24	38	-1	42	48													Vb 18	CASSPPTGTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGGGACTAGCGGGGGTGGATACGCAGTATTTTGGCCCA	CASSPSGLAGVDTQYF	In	VDJ	1	26	2.461398642443979E-4	3.0444251891056413E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	0	2	6	2	2	24	39	55	41	57													Vb 18	CASSPSGLAGVDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAAGGGGGGCGGAGAGACCCAGTACTTCGGGCCA	CASSPKGGGETQYF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	5	1	4	1	4	24	39	46	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPKGGGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGAAGGGAGGACAATCAGCCCCAGCATTTTGGTGAT	CASSPGREDNQPQHF	In	VDJ	1	28	2.650736999555055E-4	3.278611742113768E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	9	1	3	5	1	24	38	49	43	50													Vb 18	CASSPGREDNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATTCAGGGCGGAGTACACTGAAGCTTTCTTTGGACAA	CASSFRAEYTEAFF	In	VDJ	1	30	2.8400753566661303E-4	3.5127982951218943E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	3	2	6	24	36	43	38	49													Vb 18	CASSFRAEYTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPPRSTDTQYF	In	VDJ	1	33	3.1240828923327434E-4	3.8640781246340836E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	11	2	0	0	1	24	-1	44	41	45													Vb 18	CASSPPRSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGACAGGGGGAAGAACACTGAAGCTTTCTTTGGACAA	CASSPTDRGKNTEAFF	In	VDJ	1	34	3.218752070888281E-4	3.9811714011381467E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	1	1	4	2	24	38	51	42	53													Vb 18	CASSPTDRGKNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACGGGCACAAGAGACCCAGTACTTCGGGCCA	CASSSRAQETQYF	In	VDJ	1	37	3.502759606554894E-4	4.332451230650336E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	2	0	1	24	-1	44	40	45													Vb 18	CASSSRAQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGGSYNEQFF	In	VDJ	1	38	3.597428785110432E-4	4.449544507154399E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	2	6	1	1	0	1	24	-1	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGGSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCAATGCCAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPMPVNTEAFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	0	4	0	24	39	-1	43	46													Vb 18	CASSPMPVNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGCCACAGGGTACGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGTATGELFF	In	VDJ	1	39	3.692097963665969E-4	4.566637783658462E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	1	5	3	4	0	6	24	-1	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPQGTATGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCTTCTAGCGGCCTGGGCACAGATACGCAGTATTTTGGCCCA	CASSPASSGLGTDTQYF	In	VDJ	1	40	3.786767142221507E-4	4.6837310601625254E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	4	5	1	5	5	24	38	50	43	55						01,02							Vb 18	CASSPASSGLGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGGGGCCCGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	42	3.9761054993325823E-4		44	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	5	2	5	1	5	24	41	47	42	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTGATAGGGGGTGCCTACGAGCAGTACTTCGGGCCG	CASSPLIGGAYEQYF	In	VDJ	1	59	5.585481534776723E-4	6.908503313739725E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	5	1	2	4	2	24	40	50	44	52													Vb 18	CASSPLIGGAYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGCGGTCAATAGACGGTGAGCAGTTCTTCGGGCCA	CASSPRSIDGEQFF	In	VDJ	1	62	5.869489070443335E-4	7.259783143251915E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	5	9	0	11	24	-1	42	38	53						01,02							Vb 18	CASSPRSIDGEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGGGACAGACTATGGCTACACCTTCGGTTCG	CASSGTDYGYTF	In	VDJ	1	63	5.964158248998873E-4	7.376876419755978E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	3	0	0	24	-1	-1	36	43													Vb 18	CASSGTDYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCCCGGAACACTGAAGCTTTCTTTGGACAA	CASSPSRNTEAFF	In	VDJ	1	66	6.248165784665487E-4	7.728156249268167E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	6	1	4	0	24	38	-1	42	44						01,02							Vb 18	CASSPSRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAAACTAGCGGGGGGGACCTACGAGCAGTACTTCGGGCCG	CASSPKLAGGTYEQYF	In	VDJ	1	83	7.857541820109627E-4	9.71874194983724E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	3	0	2	2	1	24	39	54	41	55													Vb 18	CASSPKLAGGTYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACTAGCGGGGACCAATGAGCAGTTCTTCGGGCCA	CASSPGLAGTNEQFF	In	VDJ	2	88	8.330887712887315E-4	0.0010304208332357556	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	0	3	6	0	2	24	-1	51	38	53													Vb 18	CASSPGLAGTNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCAACGGGCAGTCTTACAATGAGCAGTTCTTCGGGCCA	CASSSNGQSYNEQFF	In	VDJ	2	91	8.614895248553929E-4	0.0010655488161869745	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	5	8	0	4	6	5	24	36	46	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSNGQSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGACGTCGGGACAAAGCCCCGAGCAGTACTTCGGGCCG	CASSTSGQSPEQYF	In	VDJ	2	95	8.993571962776079E-4	0.0011123861267885997	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	6	6	6	6	24	35	47	41	53													Vb 18	CASSTSGQSPEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSRGTNEKLFF	In	VDJ	2	96	9.088241141331617E-4	0.001124095454439006	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	5	1	2	0	0	24	-1	-1	36	42													Vb 18	CASSRGTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCCCGGGGGGACAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPRGDSSYNSPLHF	In	VDJ	2	109	0.0010318940462553606	0.0012763167138942883	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-06	01	6	0	5	0	8	0	24	35	-1	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRGDSSYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01		TCRBJ01-06*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTAGCGGGGGGGCTCTACGAGCAGTACTTCGGGCCG	CASSPLAGGLYEQYF	In	VDJ	2	123	0.0011644308962331135	0.0014402473009999766	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	4	0	3	1	2	24	38	51	39	53													Vb 18	CASSPLAGGLYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGTGACTATTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPGDYFSYNEQFF	In	VDJ	2	136	0.0012875008283553123	0.0015924685604552587	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	2	9	0	3	3	24	39	47	42	50						01,02							Vb 18	CASSPGDYFSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCGCCTCAACCTGGAAACACCATATATTTTGGAGAG	CASSPAPQPGNTIYF	In	VDJ	3	191	0.0018081813104107696	0.0022364815812276058	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	3	9	0	2	0	8	24	-1	41	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPAPQPGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPTATNEKLFF	In	VDJ	5	282	0.0026696708352661625	0.0033020303974145805	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	5	0	0	0	24	-1	-1	38	43													Vb 18	CASSPTATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSPTGNTEAFF	In	VDJ	6	326	0.003086215220910528	0.003817240814032458	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	1	0	0	24	-1	-1	38	44													Vb 18	CASSPTGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGACAGAACTGAAGCTTTCTTTGGACAA	CASSLDRTEAFF	In	VDJ	6	360	0.0034080904279993563	0.004215357954146273	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	5	2	1	24	37	44	39	45													Vb 18	CASSLDRTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTCGATCTTCGACGGCAGCTTTCTTTGGACAA	CASSPPRSSTAAFF	In	VDJ	10	566	0.005358275506243433	0.006627479450129974	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	2	7	10	9	3	24	41	53	50	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPRSSTAAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	1941A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				2150	1738	389	21	0	955	769	173	13	0	105631	85402	19155	1074	0	0.206316099	7.60892057	0.194397882	7.97494316				23715	0.0822391585	0.0668602586	0.0540561005	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:10	Age (Range):45-65 Years (Late Adulthood),Age:57 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1204,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 628,type of chemo:carbo/taxol	0.8083720709899253	MSKCC- Snyder- P01-02		1950.0	
